Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),-0.7687667973824116,-2.455354117582435,0.0,0.0,0.0,7/22,8.27%,ALDH1A2;RBP1;PTGDS;RBP4;CYP26B1;ABCA4;CRABP2
prerank,I-SMAD binding (GO:0070411),-0.7726517697352592,-2.0814315392315845,0.0,0.011445481581814434,0.02,5/13,4.03%,SMAD6;CTNNB1;SMAD7;SMAD9;TGFBR1
prerank,insulin-like growth factor I binding (GO:0031994),-0.7076567229826546,-1.8891201860421396,0.003003003003003003,0.09753540826241866,0.224,6/13,5.85%,IGF1R;IGFBP2;IGFBP3;ITGA6;IGFBP5;INSR
prerank,voltage-gated ion channel activity (GO:0005244),0.8135305220551934,1.850728182773613,0.0,0.2874432793867938,0.207,5/14,6.77%,KCNK15;CACNA1E;VDAC2;ANO6;KCND2
prerank,serine-type peptidase activity (GO:0008236),0.5943225804349204,1.7952312549607812,0.0,0.39260545477220615,0.483,13/96,7.59%,HGFAC;KLK12;MMP2;FAP;HTRA3;CORIN;PARL;HTRA1;NAALAD2;PCSK4;PCSK6;KLK1;KLK6
prerank,insulin-like growth factor binding (GO:0005520),-0.6374253153340532,-1.7759340272853537,0.003115264797507788,0.23637407614616765,0.545,6/15,5.85%,IGF1R;IGFBP2;IGFBP3;ITGA6;IGFBP5;INSR
prerank,solute:anion antiporter activity (GO:0140323),-0.6343174279723317,-1.765051461229305,0.0,0.2113930685197727,0.583,4/14,8.07%,SLC7A11;SLC26A7;SLC26A2;SLC4A3
prerank,neuropeptide receptor activity (GO:0008188),0.689206255332597,1.7616222954207486,0.00258732212160414,0.43633956580550465,0.67,4/29,2.34%,SSTR1;SORCS2;SORCS1;SORCS3
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.45296506452428364,-1.758457639695322,0.0,0.18760637201495833,0.603,19/55,14.59%,SLC7A2;SLC13A3;SLC16A12;SLC16A6;SLC6A12;SLC6A6;SLC22A4;SLC6A13;SLC7A5;SLC38A11;SLC16A11;PDPN;SLC38A7;SLC16A2;SLC6A11;SLC38A5;SLC16A9;SLC38A10;SLC36A4
prerank,ligand-gated ion channel activity (GO:0015276),0.6712457907699891,1.7393244999153206,0.003787878787878788,0.44318345340995213,0.778,12/30,14.38%,GRIA1;GRIK3;GRIA3;CHRNA4;GRIN2B;GRIK5;GRIK2;GRID2;GRIK1;ANXA6;GRIN2D;GRIN2A
prerank,serine-type endopeptidase activity (GO:0004252),0.5823297436332643,1.7323418840206448,0.0011037527593818985,0.3871971143238136,0.801,10/80,7.59%,HGFAC;KLK12;MMP2;FAP;CORIN;PARL;PCSK4;PCSK6;KLK1;KLK6
prerank,ligand-gated channel activity (GO:0022834),0.6739177604251233,1.727561876288221,0.005128205128205128,0.3445313174531605,0.816,12/29,14.38%,GRIA1;GRIK3;GRIA3;CHRNA4;GRIN2B;GRIK5;GRIK2;GRID2;GRIK1;ANXA6;GRIN2D;GRIN2A
prerank,pyridoxal phosphate binding (GO:0030170),0.7093967729831003,1.7067666674461677,0.007989347536617843,0.38645310981768544,0.891,9/20,13.39%,PYGL;CTH;CBS;PDXK;PSAT1;PNPO;PLPBP;OAT;SRR
prerank,acetylcholine receptor activity (GO:0015464),0.6921988182286114,1.7036479379908804,0.011126564673157162,0.35404599046422164,0.901,3/22,4.08%,CHRM3;ANXA9;CHRNA4
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.6718987579939173,1.6971667992765689,0.006765899864682003,0.3403025738926889,0.912,8/23,8.71%,RAG2;PLEKHA4;PLEKHA5;SESTD1;WIPI1;MAPKAP1;GBF1;HIP1
prerank,ionotropic glutamate receptor activity (GO:0004970),0.720116424180691,1.681982135613573,0.014005602240896359,0.36726637822695923,0.941,9/17,14.38%,GRIA1;GRIK3;GRIA3;GRIN2B;GRIK5;GRIK2;GRIK1;GRIN2D;GRIN2A
prerank,lipoprotein particle receptor binding (GO:0070325),0.6495280229296206,1.6534404580276185,0.011780104712041885,0.46407931423328735,0.981,5/27,8.86%,RELN;HSPG2;LRP1;SYT1;ANKRA2
prerank,transcription corepressor binding (GO:0001222),0.6267779264987439,1.625490184880273,0.007957559681697613,0.5640364930592197,0.994,9/27,14.16%,RORA;USP11;EED;ZBTB16;ESR1;HDAC6;PER3;PER1;LCOR
prerank,tau-protein kinase activity (GO:0050321),-0.5387605547308518,-1.6175241306726682,0.015503875968992248,0.5256390733909063,0.958,8/20,10.39%,ROCK2;SIK3;MARK1;ROCK1;TTBK2;GSK3B;GSK3A;MARK2
prerank,ephrin receptor binding (GO:0046875),0.6685392316911422,1.6086803827609177,0.014388489208633094,0.6154876330798971,0.997,13/21,19.23%,EFNA4;EFNA5;CHN1;ANKS1B;FYN;PTPN1;CBL;EFNB1;ANKS1A;EFNB3;ABL1;EFNB2;GRB2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.5843136121896468,-1.6080634795650217,0.022653721682847898,0.4905384117075469,0.967,5/15,10.35%,SLC26A7;SLC26A2;SLC4A3;SLC39A8;SLC4A8
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.5423275578935771,-1.6078190426985617,0.016129032258064516,0.43636589682936966,0.967,7/17,15.21%,LBR;PTGR2;BLVRA;BDH2;DECR2;PECR;DHCR24
prerank,telomerase RNA binding (GO:0070034),-0.511313387361309,-1.5877497860981267,0.007352941176470588,0.45005624098230324,0.981,12/22,19.33%,XRN1;DCP2;NAF1;DKC1;SNRPD3;WRAP53;SNRPB;TERT;PINX1;EXOSC10;GAR1;TENT4B
prerank,microtubule plus-end binding (GO:0051010),-0.5181403615912161,-1.5853636592239946,0.015810276679841896,0.41683267705469645,0.983,9/20,14.33%,CLIP4;TTBK2;CLIP3;CLIP1;PAFAH1B1;DCTN1;NUMA1;STIM1;KIF18A
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.6295408363029926,-1.583635447963672,0.04735376044568245,0.38698997870105906,0.985,4/10,5.09%,SLCO3A1;SLCO2A1;SLCO1C1;SLC22A6
prerank,NAD binding (GO:0051287),-0.49804733802283446,-1.578916450932259,0.028037383177570093,0.37038956450045635,0.987,11/26,16.85%,ALDH1A1;ZC3HAV1;CRYL1;ME1;ALDH2;SIRT3;SORD;BDH2;HPGD;NNT;QDPR
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.49055739304301144,-1.5783747667784842,0.02127659574468085,0.34521278609497447,0.988,9/25,16.87%,ZC3HAV1;PARP3;PARP4;PARP10;PARP1;SIRT3;PARP6;PARP14;SIRT4
prerank,potassium channel regulator activity (GO:0015459),0.5611572680325894,1.574304716638476,0.016766467065868262,0.790576326655913,1.0,15/49,14.35%,WNK2;SLC5A3;WNK3;RASA1;DPP10;ENSA;KCNMB2;KCNMB3;FLNA;SGK3;SGK2;KCNAB2;KCNIP4;NEDD4L;SUMO1
prerank,chemoattractant activity (GO:0042056),0.6153629944150617,1.5731912239582975,0.025032938076416336,0.7473525264056639,1.0,5/26,3.14%,LGALS3;CXCL10;FGF2;FGF10;VEGFA
prerank,steroid hydroxylase activity (GO:0008395),0.6896684473061528,1.571721857093073,0.028530670470756064,0.708655349725151,1.0,5/16,14.24%,CYP2S1;CYP39A1;CYP1B1;CYP7B1;CYP27A1
prerank,sodium channel activity (GO:0005272),0.5884197410711659,1.5694486448463427,0.02345679012345679,0.6809913643025107,1.0,9/37,8.05%,SCN7A;SCN2A;GRIK3;KCNK1;GRIK5;GRIK2;SCN5A;SCN3A;GRIK1
prerank,alpha-tubulin binding (GO:0043014),0.5923261793730727,1.5645204314905934,0.030729833546734954,0.6717581711259701,1.0,13/31,16.43%,DLEC1;EFHC1;TBCE;FYN;PACRG;SETD2;HDAC6;CDK5R1;ARL8A;TRAPPC14;SNCA;WASHC1;DIP2B
prerank,sterol binding (GO:0032934),0.5450448694585565,1.5445662784978471,0.024,0.7618591081931654,1.0,9/56,6.31%,APOD;RORA;PTCH1;VDAC2;ERLIN2;NPC1;OSBPL5;GRAMD1A;RORC
prerank,sodium channel regulator activity (GO:0017080),0.57139081245252,1.5391831123771114,0.03620474406991261,0.7576183578123351,1.0,12/37,16.79%,FXYD3;FGF13;FGF12;FGF14;SGK3;SGK2;FXYD6;FXYD1;NEDD4L;PKP2;GPLD1;SGK1
prerank,translation elongation factor activity (GO:0003746),-0.5644688409854892,-1.536733131423971,0.04713804713804714,0.42908944573677654,0.997,9/14,16.83%,GTPBP2;GTPBP1;EEF1A1;GFM2;GFM1;EIF5AL1;EIF5A;TSFM;EEF1B2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.7168614111927614,1.5317820127138149,0.04617834394904458,0.7714754417389708,1.0,1/11,0.09%,ROR2
prerank,tau protein binding (GO:0048156),-0.420427490643127,-1.5260145081746526,0.02247191011235955,0.4300142074732782,0.999,19/40,22.87%,ROCK2;MARK1;MAP2;ROCK1;TTBK2;STUB1;GSK3B;GSK3A;MARK2;DCTN1;PPP2CB;LGMN;HSP90AA1;TAOK2;APOE;HSP90AB1;MARK3;CLU;BRSK2
prerank,transaminase activity (GO:0008483),0.7123039267679809,1.5259322332134375,0.04579025110782865,0.774694692005871,1.0,4/11,10.45%,AADAT;PSAT1;GOT2;OAT
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.6308188095311857,-1.5198801399808624,0.045714285714285714,0.4212873936712873,0.999,7/10,18.41%,SHANK3;SHISA6;NSF;SHANK2;SQSTM1;GNAS;SHISA7
prerank,glutamate receptor activity (GO:0008066),0.6482573287348974,1.5175805151174184,0.052840158520475564,0.7948344460910691,1.0,8/19,13.46%,GRIA1;GRIK3;GRIK5;GRIK2;GRID2;GRIK1;GRM5;GRIN2D
prerank,intracellular chloride channel activity (GO:0061778),0.650085993622718,1.5166582926847854,0.05106382978723404,0.7360951659167874,1.0,6/16,18.43%,ANO2;ANO6;TTYH3;TTYH1;ANO10;TTYH2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.650085993622718,1.5166582926847854,0.05106382978723404,0.7360951659167874,1.0,6/16,18.43%,ANO2;ANO6;TTYH3;TTYH1;ANO10;TTYH2
prerank,protein tyrosine kinase activator activity (GO:0030296),0.6363190044993755,1.5116832757929426,0.037383177570093455,0.7364819161881682,1.0,5/19,9.79%,ERBB3;EFNA5;NRG3;ALKAL2;GRM5
prerank,LRR domain binding (GO:0030275),-0.5456152470351787,-1.508803809897308,0.06984126984126984,0.4266897650573043,0.999,2/14,0.37%,PAWR;ROBO1
prerank,sodium:proton antiporter activity (GO:0015385),-0.5977378900025261,-1.5036875045997709,0.05191256830601093,0.416646958818087,0.999,6/11,11.85%,SLC9A6;SLC9A2;SLC9A8;SLC9B2;SLC9A9;SLC9A7
prerank,heme binding (GO:0020037),0.5111675246051883,1.4954228764909365,0.027180067950169876,0.808098056709421,1.0,11/65,8.36%,CYP2S1;CYB561D2;STEAP4;SUOX;CBS;PXDN;PGRMC2;CYP1B1;PTGES2;SDHC;RSAD1
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.39060324246756517,-1.494623478027203,0.012269938650306749,0.4184069962604164,0.999,16/47,14.59%,SLC7A11;SLC7A2;SLC47A1;SLC6A6;SLC22A4;SLC6A13;SLC7A5;SLC38A11;PDPN;SLC38A7;SLC16A2;SLC66A1;SLC38A5;SLC6A1;SLC38A10;SLC36A4
prerank,death receptor binding (GO:0005123),0.6640588449149359,1.4928033224701227,0.04775687409551375,0.7962278993466937,1.0,3/15,2.66%,EDA;NGF;FADD
prerank,deoxyribonuclease activity (GO:0004536),0.6536256410781909,1.4865803470530352,0.057663125948406675,0.8069686010034632,1.0,4/14,5.66%,ZRANB3;MBD4;ERCC5;ERCC4
prerank,chemokine receptor binding (GO:0042379),0.5461280560261463,1.486163933998249,0.061946902654867256,0.7823732000498854,1.0,4/35,9.37%,CCL11;CXCL10;CCL4;CKLF
prerank,CXCR chemokine receptor binding (GO:0045236),0.6882023452534727,1.485740877230292,0.057003257328990226,0.7594292149337951,1.0,2/11,12.46%,CXCL10;YARS1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6481087184374718,1.484748816377039,0.059334298118668596,0.7414559330001247,1.0,8/15,20.48%,KMT2A;SETD3;CXXC1;SETMAR;PRDM9;ASH2L;SETD4;KMT2D
prerank,chemokine activity (GO:0008009),0.5575603296033893,1.4824908273991846,0.05905511811023622,0.7321897492562982,1.0,4/31,9.37%,CCL11;CXCL10;CCL4;CKLF
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.6007589823120658,1.4812572444938816,0.0723055934515689,0.7168996813318715,1.0,4/21,9.79%,GRIA1;ANXA9;CHRNA4;GRM5
prerank,endodeoxyribonuclease activity (GO:0004520),0.6088612059453199,1.4812329399318225,0.04610951008645533,0.6966171421993139,1.0,6/20,10.47%,ZRANB3;MBD4;ERCC5;ERCC4;SETMAR;ENDOV
prerank,carbohydrate:cation symporter activity (GO:0005402),0.6893681457240437,1.4807186730925939,0.0730593607305936,0.6803269409721889,1.0,2/11,2.62%,SLC5A3;SLC17A5
prerank,ion gated channel activity (GO:0022839),0.5949444036468599,1.4805700545612732,0.05013192612137203,0.6626435143976563,1.0,7/24,13.34%,ANO2;TMEM63A;ANO6;TTYH3;TTYH1;KCNT2;ANO10
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.5026234644701021,-1.4746830329996528,0.06293706293706294,0.45018894221803446,1.0,7/18,13.69%,ALDH1A2;ALDH1A1;ALDH2;FAR2;ALDH3A2;ALDH9A1;ALDH18A1
prerank,potassium channel activity (GO:0005267),0.4884401468667314,1.4719713045216445,0.020105820105820106,0.6865060607177533,1.0,17/89,10.11%,KCNK15;KCNA2;KCNH8;GRIK3;KCNK1;KCNA1;KCNA6;GRIK5;GRIK2;KCND1;KCND2;KCND3;GRIK1;KCNMB2;KCNMB3;TMEM38B;KCNT2
prerank,microtubule minus-end binding (GO:0051011),-0.5590927953036635,-1.468311640608584,0.08433734939759036,0.44555947865332163,1.0,7/13,16.76%,MACF1;TUBGCP4;TUBGCP3;TUBGCP6;NUMA1;HAUS7;TUBGCP2
prerank,active ion transmembrane transporter activity (GO:0022853),-0.40982503983244334,-1.4651394358669545,0.039603960396039604,0.4339330408409646,1.0,18/37,24.40%,SLCO3A1;SLC22A8;SLCO2A1;SLC22A4;SLCO1C1;COX6B1;SLC22A6;COX6A1;COX4I1;UQCR11;COX5B;COX5A;SLC16A7;UQCR10;UQCRH;SLCO5A1;UQCRFS1;UQCRC1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.6477512816434252,1.463712422605431,0.07338129496402877,0.709530096147389,1.0,3/14,9.94%,CAPN5;CAPN1;CAPN6
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.6941307939136375,1.4528770743867598,0.0847457627118644,0.7487546887441361,1.0,2/10,2.40%,KAT2B;CDKN2B
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5653264349049139,-1.4509520364402166,0.07079646017699115,0.4510183249413543,1.0,6/12,23.07%,AOX1;SDHB;ISCA1;XDH;FXN;CIAPIN1
prerank,peptidase inhibitor activity (GO:0030414),0.5579540283200692,1.4463855270236354,0.05388471177944862,0.7646914606887222,1.0,5/33,6.24%,GPC3;A2M;RECK;CSTB;UCHL5
prerank,peptidase activator activity (GO:0016504),-0.45424578377630437,-1.443437762566414,0.06060606060606061,0.45109131062100644,1.0,14/22,33.18%,PSMD14;MAL;PCOLCE2;APH1B;CAV1;PCOLCE;PINK1;PSENEN;CASP8AP2;ADRM1;VCP;PSME3;VSIR;PSME2
prerank,platelet-derived growth factor binding (GO:0048407),0.6611234389945231,1.4233372152479478,0.08728943338437979,0.8731799038747494,1.0,4/11,14.62%,PDGFRA;COL3A1;COL1A2;COL1A1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.5531749554458099,1.4216860616338374,0.07343124165554073,0.8614913357652817,1.0,12/29,20.03%,DUSP4;MAPK7;MAPKAPK3;MAPKAPK2;DUSP6;PTPRJ;MAPK14;PRMT1;ABL1;NBR1;DUSP16;DUSP1
prerank,cholesterol binding (GO:0015485),0.510189922865912,1.4117641625574613,0.06443914081145585,0.8974749461246836,1.0,7/47,5.51%,APOD;PTCH1;VDAC2;ERLIN2;NPC1;OSBPL5;GRAMD1A
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.4763448331644715,1.4085684732740422,0.06627906976744186,0.8942457237694144,1.0,13/60,7.80%,ROR2;ROR1;PDGFRA;ERBB3;NTRK3;EPHB6;ERBB2;EGFR;ACVR1;EPHB2;NTRK2;TGFBR2;FGFR1
prerank,phosphatase binding (GO:0019902),0.46525291579204325,1.4046098775511444,0.03492063492063492,0.8978411234716874,1.0,42/105,22.88%,LGALS3;ANK1;ERBB2;EGFR;PTPRT;EIF2AK3;MAST2;SH3YL1;SPRED1;PDLIM4;SHOC2;RCAN3;ANAPC7;PIK3R1;MAPK14;MAPK1;MAGI2;FBXL2;TBK1;PPP1R3F;HSP90B1;RPA2;CRY1;IQGAP1;MET;ELL;JUP;SYTL2;TP53;TERF2IP;VRK3;KIF3A;STX17;STAT3;CDC27;SIRPA;ANAPC4;PXN;DLG4;ANAPC5;STAT6;KIFAP3
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.570403931562224,-1.403134943657083,0.09722222222222222,0.539621919260328,1.0,4/10,12.22%,SLC6A12;SLC6A13;SLC6A11;SLC6A1
prerank,low-density lipoprotein particle binding (GO:0030169),-0.4833448934464575,-1.4011154086433586,0.08360128617363344,0.5255337549498498,1.0,5/16,11.93%,CDH13;PLTP;THBS1;SCARF1;STAB1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.48996658871911236,-1.3955567092529526,0.08417508417508418,0.5038757438806584,1.0,4/16,0.62%,PTPRK;PTPRM;PTPRB;PTPRG
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.48996658871911236,-1.3955567092529526,0.08417508417508418,0.5038757438806584,1.0,4/16,0.62%,PTPRK;PTPRM;PTPRB;PTPRG
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4716318027887366,1.3878065662131496,0.07520564042303172,0.9755682981397292,1.0,11/60,4.52%,ROR2;ROR1;EFEMP1;PDGFRA;ERBB3;NTRK3;EPHB6;ERBB2;EGFR;EPHB2;NTRK2
prerank,growth factor receptor binding (GO:0070851),0.4565149983651424,1.3809780938760559,0.047304730473047306,0.9954309327602914,1.0,19/95,11.99%,EFEMP1;PDGFRA;GLMN;FGF2;PYCARD;FGF10;VEGFA;PSEN1;ATXN2;FYN;HIP1;BTC;TRIP6;ERBB4;PTPRJ;NCSTN;ARF4;IL6ST;FGF7
prerank,ADP binding (GO:0043531),-0.4376424604535034,-1.3803550566119596,0.09913793103448276,0.5275869379582463,1.0,8/25,15.16%,PRKAG2;MYH9;ME1;PGK1;ABCG1;ATP5F1D;MYH10;ERN1
prerank,mechanosensitive ion channel activity (GO:0008381),0.6363008153959436,1.379345613704244,0.1297709923664122,0.9849883832503444,1.0,2/12,2.96%,PIEZO2;TMEM63A
prerank,methylation-dependent protein binding (GO:0140034),0.4790237826570589,1.3771654513393305,0.0676779463243874,0.9777678603977397,1.0,18/57,18.95%,RAG2;LRWD1;KDM8;CXXC1;KAT8;SPIN1;ATRX;MBTD1;CDYL;MSH6;ING4;PHF8;MSL3;PYGO1;PHF19;ING1;ZMYND11;KMT2E
prerank,potassium:proton antiporter activity (GO:0015386),-0.5645884741326008,-1.3764970040609363,0.14171122994652408,0.5205205971555608,1.0,5/10,11.85%,SLC9A6;SLC9A2;SLC9A8;SLC9A9;SLC9A7
prerank,filamin binding (GO:0031005),-0.5385995408514895,-1.375254533637817,0.10933333333333334,0.5071156988899032,1.0,4/11,20.86%,NEBL;SYNPO2;CEACAM1;RFLNA
prerank,symporter activity (GO:0015293),0.6667940673322285,1.3735710054075656,0.12658227848101267,0.9790392328037998,1.0,1/10,0.36%,SLC28A1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.5455621701800837,-1.3721953174525623,0.13313609467455623,0.4998312681301993,1.0,3/11,9.86%,ITPR1;RASA3;MCOLN1
prerank,methylated histone binding (GO:0035064),0.4744600142260938,1.3720384179380645,0.05813953488372093,0.9685705999600032,1.0,20/62,18.95%,RAG2;LRWD1;KDM8;CXXC1;KAT8;SPIN1;ATRX;MBTD1;CDYL;MSH6;ING4;PHF8;TAF7;MSL3;PYGO1;PHF19;ING1;ZMYND11;TAF1;KMT2E
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.6045383270770517,1.3713651313515398,0.12,0.953621566693522,1.0,2/15,1.57%,SLC1A3;SLC1A5
prerank,aspartic-type endopeptidase activity (GO:0004190),0.6281957978798318,1.3710485581396137,0.12917271407837447,0.9377609787763377,1.0,3/12,4.32%,BACE2;HM13;PSEN1
prerank,solute:sodium symporter activity (GO:0015370),0.5474457064284919,1.370502281977705,0.09492847854356307,0.9236607830431639,1.0,2/27,2.53%,SLC28A1;SLC5A3
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.4566638645421208,1.3700423407106646,0.05200433369447454,0.909885318491982,1.0,15/91,8.71%,STXBP6;RAG2;PLEKHA4;PLEKHA5;SESTD1;GSN;ANXA9;PLCB1;WIPI1;MAPKAP1;LAPTM4B;FZD7;GBF1;RPH3A;HIP1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.544314616966943,1.3672996618471982,0.12689655172413794,0.9085765959906913,1.0,7/25,8.71%,RAG2;PLEKHA4;SESTD1;NCF1;MAPKAP1;GAB2;HIP1
prerank,serotonin receptor activity (GO:0099589),0.5541972625091567,1.363420099685784,0.10124826629680998,0.8819601108989917,1.0,3/22,9.86%,CHRM3;HRH1;HTR2C
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5541972625091567,1.363420099685784,0.10124826629680998,0.8819601108989917,1.0,3/22,9.86%,CHRM3;HRH1;HTR2C
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5541972625091567,1.363420099685784,0.10124826629680998,0.8819601108989917,1.0,3/22,9.86%,CHRM3;HRH1;HTR2C
prerank,lipoprotein particle binding (GO:0071813),-0.4399572894401819,-1.3594150652478634,0.0975609756097561,0.5173591853631414,1.0,8/20,21.76%,CDH13;PLTP;THBS1;SCARF1;STAB1;MAPT;LPL;COLEC12
prerank,pentosyltransferase activity (GO:0016763),-0.39094913529791986,-1.356765197348013,0.06179775280898876,0.5107101843711485,1.0,12/36,21.08%,ZC3HAV1;PARP3;PARP4;PARP10;PARP1;SIRT3;PARP6;PARP14;SIRT4;QTRT2;QPRT;LARGE1
prerank,poly(A) binding (GO:0008143),0.5570706478033594,1.3566614364144727,0.12431693989071038,0.9021125002929113,1.0,5/21,4.57%,PABPC5;RBMS3;HNRNPDL;ELAVL4;PABPC1
prerank,glucuronosyltransferase activity (GO:0015020),0.5602616355586012,1.355434577647509,0.14722222222222223,0.8936846434481057,1.0,3/19,8.60%,EXT1;CSGALNACT1;CHSY1
prerank,ubiquitin-specific protease binding (GO:1990381),0.5647012400217827,1.350484621849484,0.1401098901098901,0.9043788107823642,1.0,7/19,14.35%,PTEN;PRKN;RHBDD2;DERL2;SELENOS;LCOR;SUMO1
prerank,endonuclease activity (GO:0004519),0.4753196998479086,1.3487482104984625,0.09494451294697903,0.8988236168804382,1.0,10/49,10.78%,ZRANB3;INTS11;MBD4;ERCC5;ERCC4;NOB1;SETMAR;ZC3H12B;REXO4;RCL1
prerank,WW domain binding (GO:0050699),0.5317760528278725,1.347013148047689,0.11497326203208556,0.8931311844747315,1.0,5/26,15.92%,ENAH;KIF20B;TRAF4;NDFIP1;TCEAL8
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.47364651758383913,-1.344619020257137,0.10240963855421686,0.5264368605819093,1.0,5/15,12.61%,ALDH1A2;ALDH1A1;ALDH2;ALDH3A2;ALDH9A1
prerank,phospholipase A2 activity (GO:0004623),0.5306350782117042,1.3438180616579507,0.11447368421052631,0.8952594082305609,1.0,6/26,13.50%,PRDX6;PLA2G7;PLA2G12A;PLAAT5;PLAAT3;PNPLA8
prerank,protein phosphatase 2A binding (GO:0051721),-0.43297520141375745,-1.3400317091115834,0.10150375939849623,0.5232373859681654,1.0,14/23,26.05%,MFHAS1;PTPA;PPME1;STRN4;CTTNBP2NL;ARPP19;MAPT;IGBP1;SPHK1;MASTL;GRIN3A;BOD1;SMG5;BOD1L1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.417674854584826,-1.33969033483915,0.10245901639344263,0.5102537120753062,1.0,12/26,12.63%,ABCG2;SLC16A12;SLC16A6;SLC6A12;SLC6A6;SLC6A13;SLC16A11;SLC16A2;SLC6A11;SLC6A1;SLC16A9;SLC5A6
prerank,leak channel activity (GO:0022840),0.5685610453473882,1.3392514885352278,0.15083798882681565,0.9054112012678097,1.0,2/18,3.10%,KCNK15;KCNK1
prerank,single-stranded DNA binding (GO:0003697),0.447203233711031,1.3381123325577315,0.05370569280343716,0.8976342827540557,1.0,31/93,21.94%,DDX11;RAD23B;SSBP2;MEIOB;APTX;ERCC5;ERCC4;STN1;RPA3;SETMAR;REXO4;TDP1;FBH1;MCM4;RPA2;POLR2G;RAD52;BLM;HNRNPU;FAM111A;FUBP1;PARK7;TOP1;HMCES;FUBP3;HSPD1;SSBP1;CTC1;MLH1;TOP3A;RBMS1
prerank,endopeptidase activity (GO:0004175),0.41812404793067226,1.3374853630412302,0.01616161616161616,0.8873103907950667,1.0,68/257,21.21%,HGFAC;KLK12;MMP2;ADAMTS12;ADAM19;ADAMTS20;FAP;BACE2;HTRA3;CORIN;USP35;USP11;PARL;KDM8;MIPEP;PSEN1;PCSK4;PCSK6;MMP15;CTSK;CTSO;ADAMTS1;CASP6;KLK1;KLK6;CTSB;PSMB7;UCHL1;ADAMTS4;USP46;PMPCB;THOP1;MMP16;USP33;ADAMTSL1;USP48;GZMM;MALT1;MMP19;TYSND1;USP40;ADAM33;PSEN2;USP14;CASP2;ADAMTS2;THSD4;USP1;USP25;PSMB2;USP2;ADAMTSL4;USP37;PIK3IP1;CASP7;ADAMTS14;MASP2;USP5;KLK2;SENP1;CPNE1;MBTPS1;PCSK7;USP13;PSMA8;PLAT;FURIN;RHBDD1
prerank,potassium ion leak channel activity (GO:0022841),0.5809075100824187,1.3320123634984469,0.1483050847457627,0.90054591577323,1.0,2/15,3.10%,KCNK15;KCNK1
prerank,nucleosomal DNA binding (GO:0031492),0.5466972064242132,1.3319174311188078,0.1307901907356948,0.8883135708310628,1.0,11/21,20.78%,MTA2;MBD2;HDAC2;RCC1;SMARCC2;RBBP4;SMARCC1;SMARCE1;SMARCA4;HNRNPC;GATAD2B
prerank,voltage-gated anion channel activity (GO:0008308),0.5808988890721835,1.3314849237697646,0.14156626506024098,0.8781180748088527,1.0,3/15,3.48%,VDAC2;CLCN5;ANO6
prerank,anion channel activity (GO:0005253),0.45931761604257476,1.3299059885055295,0.09942857142857142,0.8737858611801883,1.0,7/61,6.83%,FXYD3;ANO2;VDAC2;CLCN5;ANO6;LRRC8D;TTYH3
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.5254698730086297,1.3279540358297,0.1293213828425096,0.8707617603309236,1.0,3/28,4.68%,EDA;FADD;TRAF4
prerank,voltage-gated cation channel activity (GO:0022843),0.4382152997989827,1.3251750298541558,0.07462686567164178,0.871423862469901,1.0,31/97,22.87%,CACNA1E;KCNA2;KCNH8;CACNA2D1;CACNG7;KCNK1;NCS1;KCNA1;CACNA1A;GRIN2B;KCNA6;KCND1;CACNB4;KCND2;KCND3;TPCN2;GRIN2D;GRIN2A;KCNH2;CACNA2D4;KCNMA1;CACNA2D2;KCNA5;HCN1;KCNS3;KCNH7;LRRC55;PKD2;KCNQ3;KCNA4;KCNC1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.4528923235430236,1.324973786742004,0.09910913140311804,0.8607879867167606,1.0,11/72,8.71%,STXBP6;RAG2;PLEKHA4;SESTD1;GSN;ANXA9;PLCB1;MAPKAP1;FZD7;RPH3A;HIP1
prerank,phospholipid transfer activity (GO:0120014),-0.4306801961562974,-1.3158313661979861,0.11469534050179211,0.5589529165807837,1.0,10/21,19.90%,PITPNM2;ABCA3;PLTP;PITPNA;GLTP;OSBPL2;TNFAIP8L3;C2CD2L;PRELID2;CERT1
prerank,actin monomer binding (GO:0003785),-0.41122202691907794,-1.3138355923628862,0.11507936507936507,0.5498807455610848,1.0,10/22,27.66%,MTSS1;NOS3;ABL2;PFN2;TMSB4X;LIMA1;ABITRAM;TMSB10;MYL4;TWF2
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.3686254289021359,-1.3102202328761436,0.1044776119402985,0.546203141192803,1.0,4/35,3.34%,GPCPD1;MPPED2;PLCL1;PLCB3
prerank,metalloendopeptidase activity (GO:0004222),0.44454952684339955,1.3076650383802817,0.08066298342541436,0.9313193469104405,1.0,18/76,18.59%,MMP2;ADAMTS12;ADAM19;ADAMTS20;MIPEP;MMP15;ADAMTS1;ADAMTS4;PMPCB;THOP1;MMP16;ADAMTSL1;MMP19;ADAM33;ADAMTS2;THSD4;ADAMTSL4;ADAMTS14
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.5076386177570685,1.3030176792723585,0.14973958333333334,0.941708662120408,1.0,10/28,21.01%,GRIK3;CHRNA4;GRIK5;GRIK2;GRID2;GRIK1;GABRG2;GABRA3;GABRA2;GRID1
prerank,CCR chemokine receptor binding (GO:0048020),0.5058593860326386,1.3022489104913273,0.1509933774834437,0.9336169885150739,1.0,6/28,15.86%,CCL11;CCL4;CCR2;NES;CCL14;CNIH4
prerank,chloride transmembrane transporter activity (GO:0015108),-0.45934034328698026,-1.2955417664388265,0.16828478964401294,0.5713736064196887,1.0,7/16,30.83%,SLC26A7;SLC26A2;SLC4A8;SLC26A6;SLC26A8;SLC1A1;CLCN6
prerank,protease binding (GO:0002020),0.4289330054598051,1.294358112481418,0.1,0.9610696092633277,1.0,27/99,16.11%,A2M;FAP;PYCARD;PTEN;BCL2;PRKN;FADD;ANXA9;RHBDD2;NTRK2;PRNP;CSTB;BIN1;ADAMTS4;COL3A1;DERL2;SELENOS;COL1A2;NFRKB;TYSND1;LCOR;SUMO1;COL1A1;ITGB1;CRADD;TP53;POLG
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.3759963457939812,-1.2925971421290703,0.10294117647058823,0.5667885803346245,1.0,7/30,9.03%,SLC30A10;SLC31A1;ATP7A;SLC40A1;SLC39A8;SLC39A6;SLC30A1
prerank,protein tyrosine kinase activity (GO:0004713),0.4196725630235947,1.2919583314246375,0.10281385281385282,0.9610623449743164,1.0,19/108,10.95%,ROR2;ROR1;PDGFRA;ERBB3;NTRK3;PKDCC;PEAK1;EPHB6;ERBB2;EGFR;EPHB2;TEC;NTRK2;CSK;FGFR1;FYN;ERBB4;TYK2;STYK1
prerank,phosphatidylglycerol binding (GO:1901611),-0.48077068378745985,-1.2892935849978213,0.17159763313609466,0.5625476816990612,1.0,7/13,29.59%,PLTP;PITPNA;STOML2;GSDMD;GSDME;UQCC3;MME
prerank,gated channel activity (GO:0022836),0.5792874015418965,1.286857892399702,0.1898355754857997,0.9741364065085888,1.0,2/14,2.96%,PIEZO2;TMEM63A
prerank,syntaxin-1 binding (GO:0017075),-0.40845351474255864,-1.2863465801969127,0.14285714285714285,0.5568807357459046,1.0,6/22,10.71%,DAPK1;UNC13C;STXBP1;NSF;CPLX1;UNC13B
prerank,aspartic-type peptidase activity (GO:0070001),0.6002248803352594,1.283229692803234,0.20401854714064915,0.9795829486847706,1.0,2/10,4.32%,BACE2;PSEN1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6003401426070547,1.2810202047696528,0.18798151001540833,0.9784374644532551,1.0,6/12,22.29%,SULF1;GALNS;IDS;SGSH;ARSK;SULF2
prerank,calcium ion binding (GO:0005509),0.39853131391165153,1.2799783884928555,0.02721774193548387,0.972346558784874,1.0,67/323,16.37%,DCHS1;CDH19;PCDHA4;ASTN2;S100A4;DHH;PLSCR4;GSN;LRP1;C2CD5;EFHD1;ANXA9;NCS1;LETM1;CAPN1;CD320;HPCA;NUCB1;DSG2;CDH10;NRXN1;PRNP;CDH22;EML1;CABCOCO1;CDH8;AOC1;SYT1;PPP3CB;ITSN1;RCN1;S100A6;RPH3A;PPP3CA;S100A16;ANXA11;RCN3;SPARC;FKBP9;SYT11;SYT12;CDH20;CDH7;MCTP1;GLCE;ANXA6;CALU;ADGRL3;SLC25A23;CDK5R1;HSP90B1;OTOF;CCDC47;SRR;SMOC2;KCNIP4;SNCA;SCUBE1;PVALB;CALM1;GALNT3;IQGAP1;IDS;CALM2;CDH18;LRP2;SLC25A24
prerank,epidermal growth factor receptor binding (GO:0005154),0.5072313294479358,1.2784551149243075,0.1671018276762402,0.9680393692759283,1.0,12/25,24.52%,EFEMP1;ATXN2;HIP1;BTC;ERBB4;ARF4;SNX1;HBEGF;GRB2;CCDC88A;SNX4;LINGO1
prerank,dipeptidyl-peptidase activity (GO:0008239),0.6151307378200223,1.2778388676002141,0.18421052631578946,0.9598250175078425,1.0,3/10,7.13%,FAP;NAALAD2;DPP10
prerank,gamma-tubulin binding (GO:0043015),-0.4136570283618881,-1.2727419831505933,0.14606741573033707,0.5790894414693069,1.0,7/22,8.62%,CENPJ;NDRG1;DIXDC1;TUBGCP4;TUBGCP3;TUBGCP6;BRCA2
prerank,transcription coactivator binding (GO:0001223),0.5270812467270034,1.2710243358009166,0.19257221458046767,0.9813998250523926,1.0,2/20,2.29%,RORA;VGLL4
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.43076048813752194,-1.270435813308733,0.16721311475409836,0.5727822965892667,1.0,12/17,20.42%,ATP10A;PITPNM2;ABCA3;ABCA1;PLTP;PITPNA;ABCG1;ATP8B2;ABCB4;ATP10B;ABCA7;PCTP
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.5157855985083735,-1.2695563914290688,0.18232044198895028,0.563088665429954,1.0,5/10,20.87%,PML;ANKRD13B;LAPTM5;ANKRD13A;FAAP20
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.517475554077227,1.269301897537925,0.18664850136239783,0.9786102831317529,1.0,7/22,14.90%,RBMS3;ELAVL4;EXOSC8;CPEB3;ZFP36L2;CPEB1;KHSRP
prerank,neuropeptide binding (GO:0042923),0.5449545046030875,1.268456144629203,0.21602288984263232,0.9720991183722023,1.0,3/18,16.76%,SSTR1;GPR37;OPRK1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.4665969967228753,1.2627169166533458,0.16645807259073842,0.9873468083543008,1.0,7/38,9.31%,PLEKHA4;PLEKHA5;SESTD1;WIPI1;BBS5;HIP1;LANCL2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.5500889024326432,1.2607015376141757,0.19722650231124808,0.985693996697389,1.0,2/14,4.89%,AASS;ALDH1L1
prerank,H4 histone acetyltransferase activity (GO:0010485),0.5970698876929444,1.260108092006414,0.2161764705882353,0.978347463908159,1.0,4/10,15.62%,HAT1;KAT8;ATF2;MSL3
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5547681718731224,1.2592985887937955,0.2125984251968504,0.9713703349075253,1.0,3/14,3.46%,LXN;NGF;RECK
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.5153231321845783,1.2546934759876744,0.2018716577540107,0.9726979585375916,1.0,6/21,8.84%,CDK8;CDKL3;CDK13;CDK6;CDK15;CDK19
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.5153231321845783,1.2546934759876744,0.2018716577540107,0.9726979585375916,1.0,6/21,8.84%,CDK8;CDKL3;CDK13;CDK6;CDK15;CDK19
prerank,"DNA binding, bending (GO:0008301)",-0.4624725186630001,-1.2539673581268957,0.19375,0.5906965312552394,1.0,6/14,24.49%,LEF1;FOXL1;HMGA2;HHEX;HMGB2;FOXD1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.4754708003106679,-1.2536476529188187,0.20294117647058824,0.579658902859162,1.0,4/12,10.79%,PIK3R3;PIK3C2A;PIK3C2B;PIK3R6
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.5930117149163008,1.25321167718101,0.20330578512396694,0.9594387779574842,1.0,4/10,20.03%,DUSP4;DUSP6;DUSP16;DUSP1
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.5930117149163008,1.25321167718101,0.20330578512396694,0.9594387779574842,1.0,4/10,20.03%,DUSP4;DUSP6;DUSP16;DUSP1
prerank,monocarboxylic acid binding (GO:0033293),0.5331439060608657,1.2526753950940737,0.20874471086036672,0.9522968632399844,1.0,1/18,0.79%,PYGL
prerank,fibroblast growth factor receptor binding (GO:0005104),0.5074470076702152,1.2522715012775247,0.20885200553250347,0.9448571072247431,1.0,2/21,1.62%,FGF2;FGF10
prerank,transcription coregulator binding (GO:0001221),0.44322070200771346,1.250825679442016,0.16121212121212122,0.942027000213428,1.0,12/50,15.33%,RORA;USP11;VGLL4;EED;ZBTB16;ESR1;HDAC6;PER3;PER1;AHR;LCOR;MED25
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.46653572974088353,-1.250804260550773,0.19934640522875818,0.5755330653211786,1.0,4/13,11.82%,SLC7A2;SLC38A7;SLC66A1;SLC38A5
prerank,tropomyosin binding (GO:0005523),-0.45165075471284954,-1.2500315632952486,0.16718266253869968,0.565977150260593,1.0,3/16,0.81%,NEBL;CALD1;TMOD3
prerank,metal ion transmembrane transporter activity (GO:0046873),0.49694320542587955,1.2497023447355877,0.18375499334221038,0.9378482593451813,1.0,9/27,13.78%,SLC12A3;MRS2;KCNA1;ATP2B3;SLC12A2;SLC8A2;MAGT1;ATP2B1;TUSC3
prerank,ion channel activity (GO:0005216),0.4231798710124999,1.2490403844128557,0.14,0.9316697801551457,1.0,16/80,14.38%,PIEZO2;GRIA1;TMEM63A;GRIK3;CALHM6;GRIA3;CHRNA4;GRIN2B;GRIK5;GRIK2;GRID2;GRIK1;ANXA6;TMEM120A;GRIN2D;GRIN2A
prerank,cAMP response element binding (GO:0035497),0.5952869927179008,1.2461176533354028,0.21553090332805072,0.9358759492792821,1.0,3/10,10.50%,CREB3L1;CREB3L2;ATF2
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.46612516936905735,-1.2436516517825522,0.20977011494252873,0.5709032502876495,1.0,5/13,12.61%,ALDH1A2;ALDH1A1;ALDH2;ALDH3A2;ALDH9A1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.531001011288555,1.2410282557892203,0.21664275466284075,0.949674059475957,1.0,9/19,21.01%,GRIK3;GRIK5;GRIK2;GRID2;GRIK1;GABRG2;GABRA3;GABRA2;GRID1
prerank,histone acetyltransferase activity (GO:0004402),0.4812452865712415,1.2384403841355387,0.20310478654592498,0.951552337905615,1.0,11/30,18.82%,KAT2B;BAZ1A;HAT1;KAT8;MCM3AP;ATF2;TAF9;EPC1;NCOA3;EPC2;TAF1
prerank,cytokine activity (GO:0005125),0.3959410205800363,1.2379478469538234,0.1148577449947313,0.9447840974367585,1.0,11/131,5.52%,BMP5;CCL11;CXCL10;IL16;FGF2;CRLF1;VEGFA;TGFB1;CCL4;GDF9;WNT5A
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.4206389009712007,1.2364830518661805,0.168141592920354,0.9420917315016453,1.0,15/73,21.42%,SORCS2;SORCS1;SORCS3;PTH2R;LGR5;TSHR;MAS1;GPR37;GLP2R;OPRK1;APLNR;S1PR2;VIPR2;ADCYAP1R1;MC5R
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.5876942130739629,1.2345563184801425,0.2302839116719243,0.9415345521684421,1.0,1/10,1.91%,DPEP1
prerank,bHLH transcription factor binding (GO:0043425),-0.4021648208916506,-1.2344210378576574,0.18021201413427562,0.5823003946792998,1.0,6/19,19.57%,FHL2;KDM1A;LMO2;TCF12;CREBBP;TWIST1
prerank,mRNA 5'-UTR binding (GO:0048027),-0.39047305934143867,-1.231268683924961,0.1732283464566929,0.5790237464899577,1.0,9/24,24.72%,RPS14;RPL5;MYH10;IGF2BP3;UTP23;RPL26;MRPS11;RPL41;IGF2BP2
prerank,receptor ligand activity (GO:0048018),0.38302869042060733,1.2306358568432632,0.0800405268490375,0.9500833486681394,1.0,32/245,12.11%,LGALS3;BMP5;CCL11;EDA;CXCL10;IL16;CRH;FGF2;FGF10;SEMA3E;CRLF1;NGF;SEMA6C;NRG3;VEGFA;PTHLH;SEMA3A;TGFB1;CCL4;GDF9;WNT5A;TAFA4;TAFA1;IL18;BTC;AMELX;GDNF;DAND5;BMP7;EDN3;FGF7;GRN
prerank,ligand-gated cation channel activity (GO:0099094),0.41795446929848645,1.2286296943371227,0.16310461192350956,0.9496356476009006,1.0,14/75,16.10%,GRIA1;GRIK3;KCNK1;GRIA3;CHRNA4;GRIN2B;GRIK5;GRIK2;GRIK1;GRIN2D;KCNJ3;GRIN2A;KCNJ10;KCNH2
prerank,poly-purine tract binding (GO:0070717),0.4805079651340659,1.2276423489283086,0.22838709677419355,0.9453596679608536,1.0,5/27,4.57%,PABPC5;RBMS3;HNRNPDL;ELAVL4;PABPC1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.4743696851199039,1.22623605984945,0.21944809461235218,0.9429054248800429,1.0,12/30,23.11%,DPEP1;MT3;CSTB;UBE2Z;PRDX3;SNCA;UBE2O;XIAP;CAST;PTTG1;RPS6KA3;CARD16
prerank,voltage-gated sodium channel activity (GO:0005248),0.49692911775491316,1.223563777903587,0.23328785811732605,0.9463190108157316,1.0,4/22,6.94%,SCN7A;SCN2A;SCN5A;SCN3A
prerank,chloride channel inhibitor activity (GO:0019869),0.578040525747042,1.2234095934047517,0.23483670295489892,0.9386126948229758,1.0,2/10,3.54%,WNK2;WNK3
prerank,chloride channel regulator activity (GO:0017081),0.5403504832785518,1.223180031395378,0.24164133738601823,0.9315054825928876,1.0,5/14,16.79%,WNK2;WNK3;SGK3;STX8;SGK1
prerank,poly(U) RNA binding (GO:0008266),0.5122432899641144,1.2230783944445054,0.23324022346368714,0.9239719077534099,1.0,9/20,21.94%,PABPC5;RBMS3;PABPC1;DAZAP1;PNPT1;SSB;MCRS1;HNRNPC;RBMS1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.5025493585403265,1.22273160450722,0.2217573221757322,0.9175845404815303,1.0,6/22,18.00%,HSPG2;SYT1;ANKRA2;HSP90B1;APBB3;DNAJA1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.47714952117648385,1.2226256627197563,0.21914357682619648,0.9103450610954577,1.0,13/31,21.69%,UBE2T;UBE2E2;UBE2K;UBE2Z;UBE2J2;AKTIP;UBE2O;UBE2Q1;TAF1;UBE2L3;UBE2G1;UBE2E1;UBE2D3
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5859608391837698,1.2220677746945279,0.22919937205651492,0.9048704419650995,1.0,6/10,12.67%,SETD3;SETMAR;PRDM9;SETD2;NSD2;SETD5
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.44447948460880166,1.2219168761232975,0.2113022113022113,0.8981536787796702,1.0,19/44,21.43%,PRDM16;SUV39H1;KMT2A;SETD3;CXXC1;EED;SETMAR;MEN1;PRDM9;SETD2;NSD2;SETD5;ASH2L;SETD4;KMT2E;N6AMT1;SETDB1;KMT2D;NSD1
prerank,ankyrin binding (GO:0030506),0.5102758503872609,1.2215393613209269,0.21529745042492918,0.8921298925436013,1.0,4/19,6.45%,NRCAM;SCN5A;SPTBN1;PLEC
prerank,leucine zipper domain binding (GO:0043522),-0.49475689966621883,-1.2189194630515998,0.23255813953488372,0.5993238041955687,1.0,1/10,0.14%,PAWR
prerank,protein tyrosine phosphatase activity (GO:0004725),0.42209115115213075,1.2181283270024237,0.1706758304696449,0.8988658568173188,1.0,20/71,15.42%,PTPRH;UBASH3B;PTPDC1;PTEN;PTPN22;DUSP4;PTPRT;PTPN2;PTPN13;PTPN1;DUSP11;PTPRJ;PTPN11;CDC25B;PTPRA;PTPN18;PTPRZ1;PTPN21;PTPRF;CDC14A
prerank,alkali metal ion binding (GO:0031420),-0.4553364410472953,-1.2177156238632942,0.21739130434782608,0.592022118250191,1.0,5/13,11.44%,ATP1A2;DRG1;ATP1A1;IMPA1;HDAC4
prerank,semaphorin receptor activity (GO:0017154),-0.46621320682944395,-1.2165175523417981,0.21084337349397592,0.5846118620852114,1.0,5/11,13.22%,PLXNA2;NRP1;PLXNB1;PLXNA1;PLXNA4
prerank,voltage-gated potassium channel activity (GO:0005249),0.4080096984783375,1.2142508604369469,0.18201754385964913,0.9072781873170496,1.0,28/80,26.20%,KCNA2;KCNH8;KCNK1;KCNA1;KCNA6;KCND1;KCND2;KCND3;KCNT2;KCNJ3;KCNJ10;KCNH2;KCNMA1;KCNA5;HCN1;KCNS3;KCNH7;LRRC55;PKD2;KCNQ3;KCNK6;KCNA4;KCNC1;KCNJ13;KCNQ5;KCNN2;HCN2;HCN3
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.4880847733570722,-1.2139878844668186,0.24861878453038674,0.5809952492864447,1.0,5/10,20.87%,USP15;ANKRD13B;LAPTM5;ANKRD13A;FAAP20
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.5602818571752384,1.2138076368080002,0.2626728110599078,0.9017586431182187,1.0,2/12,11.19%,RHO;GPR88
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.584005740467509,1.2130781353576212,0.23644578313253012,0.8972408188325455,1.0,3/10,9.76%,NCF1;NOX1;NCF2
prerank,GTPase inhibitor activity (GO:0005095),0.5465790793082957,1.212794679056887,0.2383808095952024,0.8912721091513424,1.0,5/13,14.88%,RTKN;IQGAP2;ARL2;RHOH;IQGAP1
prerank,poly-pyrimidine tract binding (GO:0008187),0.48843907183363605,1.210596568938794,0.23392612859097128,0.89325252544633,1.0,10/23,21.94%,PABPC5;RBMS3;PABPC1;DAZAP1;PNPT1;HNRNPU;SSB;MCRS1;HNRNPC;RBMS1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.4523195229317773,1.2073096863852952,0.22885572139303484,0.8989444427463987,1.0,12/33,17.40%,ERBB2;WAC;ZNF326;ERCC5;RPRD1A;URI1;GTF2B;ELP2;ELP4;HNRNPU;CDC73;NCOA3
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.45361930140803597,1.2057769204945028,0.2296954314720812,0.8983006950742636,1.0,12/33,17.40%,WAC;ZNF326;ERCC5;RPRD1A;URI1;DRAP1;GTF2B;ELP2;ELP4;HNRNPU;CDC73;NCOA3
prerank,chloride channel activity (GO:0005254),0.41820905106806344,1.205626326862802,0.23032407407407407,0.8920168412153836,1.0,14/59,20.49%,FXYD3;ANO2;CLCN5;ANO6;TTYH3;TTYH1;FXYD1;CLIC1;CLCN2;GABRG2;TTYH2;GABRA3;GLRB;GABRA2
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.3639693977708294,-1.2055602982036344,0.1937984496124031,0.591598696544075,1.0,11/27,14.85%,SLC8A3;SLC41A1;SLC8B1;SLC9A6;SLC9A2;SLC9A8;SLC9B2;SLC4A8;SLC9A9;SLC9A7;CNNM4
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.46596904821464513,1.2001254020404142,0.25095541401273885,0.9062308732815931,1.0,7/31,11.14%,KCNA2;SLC12A3;KCNK1;KCNA1;SLC12A2;TMEM38B;SLC12A4
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.426426233277811,-1.199253681926526,0.23232323232323232,0.5962092486994484,1.0,6/15,14.93%,HS3ST3A1;HS3ST1;NDST3;NDST1;HS3ST2;HS3ST3B1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.5283166407495647,1.1992048386060612,0.26555386949924126,0.9028810959083547,1.0,5/13,19.00%,AGPAT2;AGPAT5;GPAT3;GPAT4;LPCAT2
prerank,nucleotidase activity (GO:0008252),0.5188396982079971,1.19679647823043,0.2555391432791728,0.9054186754807014,1.0,6/15,18.57%,NT5DC2;NT5C2;BPNT1;BPNT2;NT5C3B;NT5C
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3781525181479176,1.1967337488395828,0.144912641315519,0.8989344359276917,1.0,30/173,15.14%,OSR2;CREB3L1;PRDM16;MYC;ZNF25;ZBTB20;OTP;ZBTB37;SATB1;NFX1;FOXP2;ZEB1;ZBTB16;RORC;MLX;TRPS1;E2F6;LRRFIP1;TBX18;ZBTB6;NFATC3;ZGPAT;PATZ1;FOXP4;ZBTB1;GATA3;ZBTB39;NACC2;CREM;ZEB2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.5110437798490373,1.1948642899589124,0.2545454545454545,0.8995858217230427,1.0,4/18,6.44%,STXBP6;PAK4;CNN3;BAIAP2
prerank,metal ion binding (GO:0046872),0.3686956613966345,1.1947284448500146,0.054,0.8937066929920943,1.0,92/477,15.79%,DCHS1;CDH19;PCDHA4;ASTN2;S100A4;DHH;IDH2;PLSCR4;GSN;PSPH;LRP1;C2CD5;EFHD1;ANXA9;NCS1;PDXK;IRAK3;LETM1;SIK2;CAPN1;CD320;MAST2;HPCA;DXO;NUCB1;DSG2;CDH10;NRXN1;GSS;PRNP;MT3;PGM1;CDH22;EML1;CABCOCO1;UBA2;ACVR1C;CDH8;AOC1;SYT1;HMGCLL1;PPP3CB;ITSN1;NUDT22;POSTN;RCN1;S100A6;RPH3A;CSGALNACT1;PPP3CA;S100A16;RPE;ANXA11;RCN3;SPARC;FKBP9;SYT11;SYT12;CDH20;CDH7;MCTP1;ENDOV;GLCE;PI4K2A;MSH6;ANXA6;CALU;ADGRL3;SLC25A23;CDK5R1;NUDT3;GNAI1;HSP90B1;OTOF;CCDC47;SRR;EXD2;SMOC2;KCNIP4;SNCA;SCUBE1;PVALB;IDH3A;CALM1;GALNT3;IQGAP1;OPA1;IDS;ABL1;CALM2;PAPOLA;CDH18
prerank,sulfotransferase activity (GO:0008146),-0.34603080752998305,-1.19410831025785,0.1724137931034483,0.5992102896016398,1.0,15/33,22.82%,HS3ST3A1;HS3ST1;CHST15;CHST11;TPST1;GAL3ST1;CHST2;UST;CHST3;CHST12;HS3ST2;CHST10;CHST1;SULT4A1;GAL3ST2
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.48395258498769117,1.194067513589736,0.24861111111111112,0.8899956913397598,1.0,2/23,4.92%,CHRM3;PLCB1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.3746151776119894,1.1940542618774728,0.14504596527068436,0.8836360767773506,1.0,58/188,21.34%,SOX6;KLF15;CREB3L1;PRDM16;ZBTB20;SUV39H1;SOX11;GLI1;RFX3;CREB3L2;GATA6;TBX18;MEN1;CHD3;ATMIN;TFAM;BRCA1;SOX12;SOX5;CARM1;ARID4B;PRDM9;ERBB4;NFE2L2;SP1;TAF9;SFPQ;TAF2;CREBZF;PER3;XRCC6;ATF5;PER1;GATA3;AHR;SNCA;TAF7;RUNX1;TP53;KCNH2;FOXJ1;PAX2;GABPB2;GABPB1;RNF10;ASH2L;EGR1;BCOR;PPARG;JUN;STAT3;TFE3;KMT2D;PBX1;ZBED4;HNRNPL;NFKB1;THRA
prerank,acid-thiol ligase activity (GO:0016878),0.5406762962748269,1.191520090109814,0.2648809523809524,0.8868748329731264,1.0,3/13,7.11%,ACSS2;ACSS3;ACSS1
prerank,NAD+ binding (GO:0070403),-0.45847883408971346,-1.1899119325721765,0.26959247648902823,0.5997621922064665,1.0,4/12,14.79%,ZC3HAV1;CRYL1;SIRT3;HPGD
prerank,receptor tyrosine kinase binding (GO:0030971),0.4169850062665076,1.1871611771137542,0.2429245283018868,0.8970855642097447,1.0,12/56,10.65%,SHC4;LRP4;CBLB;PTPN2;NRG3;SOCS5;ALKAL2;GAB2;GRB14;PTPN1;PIK3R1;CBL
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.550775318574,1.1866908321735161,0.2709867452135493,0.8923338552019336,1.0,1/11,0.66%,SLC22A3
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.4407940791609401,-1.186232219982172,0.25696594427244585,0.5995504034039044,1.0,4/13,15.84%,PIK3C2A;PIP5K1B;PIK3C2B;PIP4K2B
prerank,cytokine receptor activity (GO:0004896),0.39925774242996886,1.1806378876164771,0.21776814734561215,0.9094584614150228,1.0,14/83,17.14%,GFRA1;IL2RA;CRLF1;IL20RB;GFRA4;CCR2;IL1RL2;CSF3R;IL6ST;PRLR;ACKR4;GFRA2;IL1RAP;CD74
prerank,frizzled binding (GO:0005109),-0.3430574413620533,-1.1796364169802749,0.1875,0.6060363357969435,1.0,12/34,21.39%,WNT4;WNT5B;ZNRF3;WNT6;WNT9A;RYK;FZD1;RNF43;CCDC88C;WNT16;DVL2;WNT11
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.544971421722791,1.1772165728536255,0.28378378378378377,0.9159194255508976,1.0,5/12,11.40%,CDK8;CDK13;CDK6;CDK19;MAPK1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.4884545443990067,1.1765114728391997,0.26740947075208915,0.9122551060543558,1.0,9/20,23.17%,MAGI3;DTYMK;DLG2;AK3;AK6;AK2;AK8;CARD11;CMPK1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.504421414677773,1.1710084491998136,0.2905109489051095,0.9270323585932065,1.0,3/15,9.31%,PLEKHA5;SESTD1;LANCL2
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.47175048879353876,-1.1701905562634638,0.27371273712737126,0.6196242927493479,1.0,3/10,10.28%,PIK3R3;PIK3C2A;PIK3C2B
prerank,FAD binding (GO:0071949),0.468910270954988,1.1685401451544375,0.2827586206896552,0.929910247467016,1.0,4/24,8.74%,STEAP4;SQLE;DAO;MTRR
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.559160322427708,1.1658433404514779,0.3068362480127186,0.9339470390679631,1.0,4/10,19.50%,KDM8;KDM4B;PHF8;RIOX2
prerank,hexose transmembrane transporter activity (GO:0015149),0.5350344789929866,1.1627096082760489,0.31164901664145234,0.9398991257249488,1.0,3/12,10.56%,SLC5A3;MFSD4A;SLC2A2
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.35463260109097194,-1.1613137093963477,0.23673469387755103,0.633163149829018,1.0,9/27,13.05%,SLC22A8;SLC26A7;SLC26A2;ANO1;SLC22A6;SLC5A5;SLC39A8;SLC25A30;LRRC8A
prerank,amyloid-beta binding (GO:0001540),0.39479629649441267,1.1583420010796215,0.24831460674157305,0.9500985235852224,1.0,20/79,18.25%,HSPG2;LRP1;GRIA1;EPHB2;GRIA3;CACNA1A;PRNP;GRIN2B;NLGN1;APBB2;GSAP;CRYAB;NGFR;APBA1;CLSTN1;GRIN2A;TM2D1;CD74;APBB3;PGRMC1
prerank,methyl-CpG binding (GO:0008327),0.4735667179592501,1.15539826159534,0.2947067238912732,0.9549428595988244,1.0,6/22,16.09%,LRWD1;MBD1;MBD2;ZBTB38;PRMT1;TET3
prerank,ubiquitin protein ligase binding (GO:0031625),0.3630967162630406,1.1527756997939858,0.16532258064516128,0.9589129939748786,1.0,69/254,19.98%,PRDX6;UBE2T;ERBB3;GLMN;PTPN22;BCL2;CBS;HM13;PRKN;EGFR;ERLIN2;FBXW7;BLZF1;TRAF4;SCN5A;SPOP;FBXO7;YWHAZ;LAPTM4B;RALB;NAE1;PACRG;BAG5;BRCA1;UBE2K;ANKRA2;UCHL1;CASC3;HIF1A;SYT11;CUL3;GPR37;SLF2;NGFR;UBE2J2;HDAC6;PATZ1;PRKACA;PER1;DET1;RPA2;NEDD8;SUMO1;RTN4;JKAMP;WASHC1;GABARAPL2;CCDC50;UBB;UBOX5;TP53;KCNH2;USP25;DBT;USP2;CUL4B;RIPK1;DNAJA1;HSPA9;MDM2;MID1;POLR2A;MAGEC2;NKD2;BCL10;UBE2L3;JUN;RRAGA;UBE2G1
prerank,CoA-ligase activity (GO:0016405),0.5080515317916866,1.152595931654333,0.2995529061102832,0.9532281865825313,1.0,3/14,7.11%,ACSS2;ACSS3;ACSS1
prerank,retinoic acid binding (GO:0001972),-0.4394481538694216,-1.1507316868598518,0.26409495548961426,0.649655487176467,1.0,2/12,19.29%,CYP26B1;RARA
prerank,carbohydrate kinase activity (GO:0019200),0.533638630683768,1.150622216313279,0.29475308641975306,0.9546540336935487,1.0,6/11,22.83%,NAGK;FGGY;GNE;GALK2;HK2;HK1
prerank,transforming growth factor beta binding (GO:0050431),-0.3584499380468233,-1.1498018515715898,0.24152542372881355,0.6424759176019894,1.0,8/23,11.39%,ACVRL1;ENG;TGFBR1;THBS1;CD109;TWSG1;LRRC32;VASN
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.5095116136092572,1.1493356516425015,0.31478770131771594,0.9530697723500801,1.0,2/14,8.29%,RDH10;DHRS3
prerank,phosphate ion binding (GO:0042301),0.5590838861667136,1.1491441465410457,0.30672926447574334,0.9477050889708338,1.0,2/10,7.66%,ADSS1;RPH3A
prerank,delayed rectifier potassium channel activity (GO:0005251),0.43320267697194403,1.1489212558736916,0.30166880616174585,0.9424342625652722,1.0,10/32,24.76%,KCNA2;KCNA1;KCNA6;KCNH2;KCNA5;KCNS3;KCNQ3;KCNA4;KCNC1;KCNQ5
prerank,transmitter-gated ion channel activity (GO:0022824),0.449478702287928,1.1484351914113895,0.3022959183673469,0.9382380388981942,1.0,10/29,21.01%,GRIK3;GRIK5;GRIK2;GRID2;GRIK1;GRIN2D;GABRG2;GABRA3;GABRA2;GRID1
prerank,transcription cis-regulatory region binding (GO:0000976),0.35299319948196656,1.1469231854429591,0.136,0.9379936926515209,1.0,77/406,17.15%,RORA;OSR2;SOX6;KLF15;LHX5;CREB3L1;PRDM16;MYC;HOXB8;ZNF25;ZBTB20;SOX9;SUV39H1;OTP;SATB1;TFCP2;NFX1;SOX11;RFXANK;GLI1;E2F2;PHOX2A;HOXD3;RFX3;MLX;TRPS1;CREB3L2;XRN2;TWIST2;DRAP1;E2F6;GATA6;TBX18;MEN1;FOXM1;CHD3;ATMIN;TFAM;BRCA1;SOX12;SOX5;CARM1;BBX;HIF1A;ARID4B;PRDM9;ERBB4;ATF2;NFE2L2;SP1;TAF9;SFPQ;RBAK;TAF2;CREBZF;PER3;XRCC6;ATF5;PER1;GATA3;AHR;SALL2;POLRMT;SNCA;TAF7;CREM;RUNX1;PURG;TAF4;TP53;SP3;KCNH2;FOXJ1;PAX2;GABPB2;GABPB1;RNF10
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5049075085058042,1.146609122265866,0.30185979971387694,0.9332266713993804,1.0,5/15,21.50%,P2RY14;P2RY12;P2RY1;PTAFR;P2RX7
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.3752731143018706,-1.1445974791823943,0.24436090225563908,0.6467763442940853,1.0,8/20,26.20%,SLC30A10;SLC39A8;SLC39A6;SLC30A1;SLC39A3;SLC39A10;SLC39A13;SLC39A1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.44958421458198033,-1.1442620105800911,0.2868421052631579,0.638606006641421,1.0,4/11,8.81%,UBE4B;PPIL2;STUB1;UBE4A
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.439048736636198,1.1433099465947847,0.2866004962779156,0.9401330518572376,1.0,17/34,27.07%,UBE2T;UBE2E2;UBE2K;UBE2Z;UBE2J2;AKTIP;UBE2O;UBE2Q1;TAF1;UBE2L3;UBE2G1;UBE2E1;UBE2D3;UBE2Q2;UBE2I;UBE2R2;UBE2J1
prerank,cysteine-type peptidase activity (GO:0008234),0.3837584189240255,1.1430369049303672,0.26101694915254237,0.935294211699396,1.0,25/73,19.06%,USP50;USP35;USP11;OTUD7B;CTSK;CTSO;CASP6;OTULIN;CTSB;UCHL1;USP46;USP33;USP48;MALT1;USP40;USP14;CASP2;USP1;USP25;USP21;ATG4C;USP2;USP37;CASP7;USP5
prerank,cysteine-type endopeptidase activity (GO:0004197),0.3838579043108856,1.1430348233475687,0.27109111361079863,0.9295623548455804,1.0,26/78,19.10%,PYCARD;CAPN5;USP35;USP11;CAPN1;CTSK;CTSO;CASP6;CTSB;UCHL1;USP46;CAPN6;USP33;CASP12;USP48;MALT1;USP40;USP14;CASP2;USP1;USP25;USP2;USP37;CASP7;USP5;CAPN11
prerank,flavin adenine dinucleotide binding (GO:0050660),0.40124428407654256,1.142609039906769,0.28537735849056606,0.9253905015186723,1.0,8/53,8.74%,STEAP4;GCDH;POR;SQLE;DAO;ETFA;ACOX1;MTRR
prerank,calcium activated cation channel activity (GO:0005227),0.4919579686319885,1.1425887517605442,0.32011331444759206,0.9198488438719064,1.0,6/17,17.39%,TMEM63A;ANO6;KCNMB2;KCNMB3;ANO10;KCNMA1
prerank,cell-cell adhesion mediator activity (GO:0098632),0.41686556454331397,1.1410354975335493,0.2852112676056338,0.9200694835096871,1.0,11/42,11.58%,STXBP6;PAK4;CNN3;LRRC4C;BAIAP2;NTNG1;CNTN6;CNTN2;DSCAM;PALLD;PPP1CA
prerank,FMN binding (GO:0010181),0.5326110469517139,1.1410037347259163,0.31521739130434784,0.9146260554036546,1.0,3/11,8.74%,POR;PNPO;MTRR
prerank,metallopeptidase activity (GO:0008237),0.3701609103969291,1.1388839002242692,0.26498422712933756,0.9170332463994145,1.0,21/113,16.42%,MMP2;ADAMTS12;ADAM19;ADAMTS20;DPEP1;ADAM23;MIPEP;MMP15;ADAMTS1;ADAMTS4;PMPCB;LNPEP;THOP1;MYSM1;MMP16;ADAMTSL1;MMP19;ADAM33;PAPPA2;ADAMTS2;THSD4
prerank,cation channel activity (GO:0005261),0.37579061261666313,1.1331260623178125,0.2707659115426106,0.9319638511656558,1.0,10/94,4.32%,PIEZO2;CACNA1E;KCNA2;TMEM63A;KCNK1;ANXA9;ANO6;KCNA1;CALHM6;PSEN1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.39977901636537766,1.1323557495891001,0.2893815635939323,0.9293685156791831,1.0,18/57,19.87%,CYB561D2;UQCRQ;CYBRD1;NDUFS5;NDUFA4;NDUFB2;NDUFA8;NDUFS8;COX10;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;CYB5A;NDUFA5
prerank,tubulin binding (GO:0015631),0.35492899515260856,1.131368209885681,0.20724346076458752,0.9273892335478034,1.0,76/296,19.59%,DLEC1;SGIP1;SAXO2;DNM1;FGF13;EFHC1;KIF20B;PRKN;KIF19;TTLL5;MAP4K4;MAP1B;GAS2L3;ARL3;TBCE;MAST2;TTLL11;STARD9;PRNP;EML1;PAK1;NDE1;MACO1;KIF21A;CCDC170;FYN;PACRG;BRCA1;CEP57;SETD2;CAPN6;DYNC1I1;TUBGCP5;VAPA;MID2;AGBL4;KIF5C;CLASP1;TTLL4;HDAC6;EMD;STMN4;AGBL1;CEP295NL;APC2;CDK5R1;UNC5C;KATNB1;RMDN2;ARL8A;ATF5;CKAP5;TRAPPC14;SNCA;MDM1;KIF22;TPGS1;WASHC1;OPA1;GABARAPL2;MAP6D1;EML5;NAV3;DIP2B;DCX;KIF21B;HTT;KIF3A;MAPRE3;CAMSAP1;MID1;KIF2A;HOOK2;IFT81;MAP6;CCDC66
prerank,TBP-class protein binding (GO:0017025),0.46199792666378003,1.1298386710965127,0.3175287356321839,0.927698087378357,1.0,10/21,21.34%,DRAP1;GTF2B;ESR1;TAF11;AHR;PSMC1;TAF1;RUVBL2;YEATS2;THRA
prerank,four-way junction DNA binding (GO:0000400),0.485731652624815,1.1283701936541357,0.32285714285714284,0.9277139069081296,1.0,6/17,17.24%,MEN1;MSH6;XRCC3;ABL1;BLM;WRN
prerank,DNA binding (GO:0003677),0.34648478595651583,1.1282161917880988,0.109,0.9229750861002121,1.0,157/694,20.70%,RORA;OSR2;RAG2;SOX6;NKX6-2;MEOX1;MEOX2;TSHZ3;GLI2;SOX8;DDX11;PRDM16;CRLF3;MYC;RAD23B;BCL2;BANF2;CBFB;SOX9;SSBP2;HMGN1;MEIOB;EGFR;C1D;OTP;HOXA7;SATB1;APTX;MBD4;TFCP2;FOXP2;CHTF18;KDM5B;RFX2;ERCC5;TIPIN;EZH1;MBD1;GLI1;E2F2;ERCC4;TIGD2;MPG;DDB2;STN1;RFX3;ZBTB16;RPA3;MLXIPL;MLX;SETMAR;DRAP1;DEDD;LRRFIP1;MEN1;CHD3;TFAM;RARG;BRCA1;XPA;RARB;SOX12;REXO4;HIF1A;TDP1;NHEJ1;ZBTB6;CHD2;PRDM9;HDAC2;HUWE1;PSIP1;ENDOV;FBH1;NFE2L2;MCM4;LIN9;SP1;TAF9;MSH6;SFPQ;ZMYM6;CREBZF;ZGPAT;PATZ1;NR6A1;XRCC6;ATF5;GATA3;AHR;DDB1;POLRMT;RPA2;ORC1;POLR2G;PAX3;PDS5B;CRY1;ZNF638;POLG2;CREM;SLTM;ZEB2;GTF3C1;CGAS;POU3F1;ABL1;MEIS3;MSL3;RAD52;TAF4;BLM;TP53;TAF4B;PHF19;POLG;TRNP1;HNRNPU;QRICH1;FOXJ1;FAM111A;PAX2;CUL4B;FUBP1;WRN;NR5A1;PCID2;CSRNP3;AIFM1;MLF1;IRF3;ZNF496;ZMYND11;RNF4;PARK7;BATF;TAF1;CGGBP1;POLR2A;EGR1;CNBP;TOP1;CENPC;FOXJ3;PPARG;JUN;STAT3;PRDM2;HMCES;HP1BP3;MBD6;SMARCA4;FUBP3;KMT2D;SPO11;PBX1;MEIS1
prerank,sequence-specific DNA binding (GO:0043565),0.3473140029573335,1.1274809695967545,0.129,0.920367912749958,1.0,88/590,16.44%,RORA;OSR2;RAG2;ETV1;NKX6-2;KLF15;MEOX1;ETV4;MEOX2;LHX5;TLX3;GLI2;CREB3L1;SOX8;PRDM16;TGIF2;BCL2;CBFB;HOXB8;ZBTB20;LRWD1;SOX9;HIVEP1;ZBTB37;HOXA7;KMT2A;SATB1;TFCP2;EGR3;FOXP2;UPF3A;KDM5B;RFX2;ZNF276;MBD1;E2F2;PHOX2A;CXXC1;HOXD3;STN1;RFX3;RORC;MLX;GATA6;TBX18;TFAM;RARG;MBD2;XPA;RARB;SOX12;BBX;KLF5;HIF1A;PRDM9;HDAC2;ZBTB38;NFATC3;ATF2;ESR1;NFE2L2;SP1;PRMT1;UPF1;KLF13;ZGPAT;NR6A1;XRCC6;ATF5;GATA3;AHR;ZNF250;POLRMT;PAX3;CREM;SLTM;IRX5;HOXB7;ZEB2;POU3F1;ABL1;MEIS3;SP3;TET3;SMG6;SREBF2;TERF2IP;HNRNPU
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.43471253092429296,-1.1262997862198747,0.30337078651685395,0.6752419441908856,1.0,6/12,11.85%,SLC9A6;SLC9A2;SLC9A8;SLC9B2;SLC9A9;SLC9A7
prerank,protein phosphatase binding (GO:0019903),0.3662481910962809,1.1254326170923328,0.2792413066385669,0.9221948860529429,1.0,39/117,22.88%,LGALS3;ANK1;ERBB2;EGFR;PTPRT;EIF2AK3;PPP1R15A;PPP3CB;ENSA;PDLIM4;SHOC2;ANAPC7;PIK3R1;MAPK14;FBXL2;TBK1;PPP1R3F;HSP90B1;STRN;RPA2;AKAP11;IQGAP1;MET;JUP;TP53;SLC9A1;VRK3;KIF3A;STX17;STAT3;CDC27;ADCY8;SIRPA;ANAPC4;PXN;DLG4;ANAPC5;STAT6;KIFAP3
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.5017245314267715,1.1218604594052202,0.3323170731707317,0.928697723825999,1.0,2/13,8.12%,GPSM2;GDI2
prerank,actin binding (GO:0003779),-0.24081275659507043,-1.12045946278175,0.11764705882352941,0.6807573393009629,1.0,40/170,15.12%,MACF1;PAWR;ABLIM1;CALD1;SORBS1;PHACTR1;CAPZB;PDLIM5;SYNE2;MYH9;MYRIP;MTSS1;PHACTR4;PARVB;NOS3;P4HB;MICAL3;ABL2;TPM1;GIPC1;MICAL2;EPS8;PFN2;EPS8L2;TMSB4X;MAEA;MAPT;PDLIM1;FXYD5;MYH10;DAG1;LIMA1;KIF18A;CAP1;SYNPO2;SHROOM2;AVIL;CEACAM1;TPM2;TMOD1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.5265964558459125,1.119847148242629,0.3548895899053628,0.9304067327557857,1.0,6/11,19.95%,GNPTAB;PTDSS1;PIGN;SGMS2;DPAGT1;PIGO
prerank,organic cation transmembrane transporter activity (GO:0015101),0.4883849688681483,1.1196282071350845,0.33666191155492153,0.9260034511364917,1.0,3/16,11.77%,SLC22A3;SLC44A2;SLC7A8
prerank,iron ion binding (GO:0005506),-0.29323738537467,-1.118323908714631,0.24528301886792453,0.6771528868169132,1.0,19/48,21.72%,AOX1;PHF2;ABCE1;PHYH;FBXL5;FTH1;EGLN2;FTL;TET1;CDO1;ALKBH3;ETHE1;TYW5;FXN;CYP2R1;EGLN3;ACO2;JMJD6;DNAJC24
prerank,MAP kinase phosphatase activity (GO:0033549),0.5040914686520618,1.11745940959149,0.3542319749216301,0.9286543424246202,1.0,4/12,20.03%,DUSP4;DUSP6;DUSP16;DUSP1
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.35168969829571606,1.1157476057238176,0.23107971745711403,0.9295218558244205,1.0,69/269,19.98%,PRDX6;UBE2T;ERBB3;GLMN;PTPN22;BCL2;CBS;HM13;PRKN;EGFR;ERLIN2;FBXW7;BLZF1;TRAF4;SCN5A;SPOP;FBXO7;YWHAZ;LAPTM4B;RALB;NAE1;PACRG;BAG5;BRCA1;UBE2K;ANKRA2;UCHL1;CASC3;HIF1A;SYT11;CUL3;GPR37;SLF2;NGFR;UBE2J2;HDAC6;PATZ1;PRKACA;PER1;DET1;RPA2;NEDD8;SUMO1;RTN4;JKAMP;WASHC1;GABARAPL2;CCDC50;UBB;UBOX5;TP53;KCNH2;USP25;DBT;USP2;CUL4B;RIPK1;DNAJA1;HSPA9;MDM2;MID1;POLR2A;MAGEC2;NKD2;BCL10;UBE2L3;JUN;RRAGA;UBE2G1
prerank,anion:anion antiporter activity (GO:0015301),-0.382401676349993,-1.1155811769412916,0.29372937293729373,0.675263508141692,1.0,3/17,8.07%,SLC26A7;SLC26A2;SLC4A3
prerank,receptor antagonist activity (GO:0048019),0.48636378663381635,1.1143227291410402,0.34820143884892085,0.9293948005581848,1.0,2/17,9.20%,PXDN;DKK3
prerank,sialyltransferase activity (GO:0008373),-0.3678349661411108,-1.1136821091864493,0.30742049469964666,0.6710666569548042,1.0,5/20,7.54%,ST6GALNAC3;ST3GAL6;ST8SIA4;ST3GAL1;ST6GALNAC2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.36628796020723553,1.1132820296833845,0.30686695278969955,0.9279227953289564,1.0,17/100,9.31%,RAG2;PLEKHA4;PLEKHA5;SESTD1;IQGAP2;OSBPL5;WIPI1;MAPKAP1;LAPTM4B;GBF1;RPH3A;ARHGAP9;BBS5;GAB2;HIP1;DENND1C;LANCL2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.4699813343492135,1.1130962031745597,0.3402777777777778,0.9235764632865027,1.0,5/18,14.61%,SOSTDC1;ACVR1;TGFBR2;LTBP1;BMPR1A
prerank,sequence-specific mRNA binding (GO:1990825),0.5346418905141249,1.111920873272457,0.35852090032154343,0.9227094387819261,1.0,3/10,25.00%,ETF1;SSB;FMR1
prerank,protein kinase C activity (GO:0004697),0.503997043166163,1.1117464678483002,0.34894259818731116,0.9184271009952624,1.0,3/14,5.78%,PRKCA;PRKCQ;PKN1
prerank,ion channel inhibitor activity (GO:0008200),0.419202038855014,1.1100906650160458,0.34017971758664955,0.9194285879329243,1.0,9/35,15.54%,WNK2;WNK3;RASA1;ENSA;KCNMB2;STX8;NEDD4L;CALM1;CALM2
prerank,G protein-coupled receptor binding (GO:0001664),0.35785824067623134,1.1095501675927193,0.29735449735449737,0.916445206831355,1.0,21/132,15.49%,PTCH1;PTCH2;GNA14;BICD1;PRKN;GPRC5B;GPRASP2;NPB;WNT5A;FZD7;ARHGEF11;PACRG;FLNA;USP33;DVL1;MYOC;GNAI1;HOMER2;PENK;PDCD6IP;HOMER1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.46403740808550126,1.10837908115294,0.35661218424962854,0.9156448619221669,1.0,1/18,1.35%,HSD17B7
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.2887219540960788,-1.1079727645727009,0.28,0.6757810429610436,1.0,21/54,25.72%,HDAC8;ACER2;TGM2;UPB1;NTAQ1;ASPG;NIT1;HDAC4;HINT3;ASAH2;AMDHD2;ASRGL1;SIRT4;HDAC11;HDAC3;HDAC5;SUDS3;MIER2;SIRT7;FAAH;HDAC10
prerank,metal ion:proton antiporter activity (GO:0051139),-0.41522290501017833,-1.10357763139664,0.33236994219653176,0.6788816583728394,1.0,6/13,11.85%,SLC9A6;SLC9A2;SLC9A8;SLC9B2;SLC9A9;SLC9A7
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.42489631576316306,-1.1019905412219864,0.33238636363636365,0.6740802834524635,1.0,5/11,18.04%,LEF1;SRRM2;GATA2;HMGA2;THAP7
prerank,glutamate receptor binding (GO:0035254),-0.38110302529367734,-1.1015848414128675,0.28802588996763756,0.6664878095462442,1.0,7/17,13.98%,SHANK3;SHISA6;NSF;SHANK2;CAMK2A;SQSTM1;GNAS
prerank,RNA polymerase II complex binding (GO:0000993),0.4152648909080754,1.1003991371210755,0.3288009888751545,0.9383048975002284,1.0,11/32,17.40%,WAC;ZNF326;ERCC5;RPRD1A;URI1;GTF2B;ELP2;ELP4;HNRNPU;CDC73;NCOA3
prerank,RNA stem-loop binding (GO:0035613),0.5125789183107362,1.0995010347811893,0.3668730650154799,0.9365594943436724,1.0,5/12,25.00%,EPRS1;CPEB3;RC3H1;CSDE1;FMR1
prerank,ATPase binding (GO:0051117),0.3764872500932876,1.0991961822130334,0.3408833522083805,0.9326570429493759,1.0,14/71,12.05%,ANK1;ANK2;EGFR;PSEN1;RALB;PPP3CA;SELENOS;PIH1D1;NCSTN;ESR1;TAF9;FBL;SNX10;PDE4D
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.4139474608723435,1.096961530809373,0.3619791666666667,0.9355723224135128,1.0,6/35,10.95%,PKDCC;PEAK1;TEC;CSK;FYN;STYK1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.5109789578754381,1.0968959150601132,0.36084142394822005,0.9309717764973693,1.0,3/11,16.10%,KCND3;KCNJ3;KCNH2
prerank,SUMO transferase activity (GO:0019789),0.47249644040816596,1.0949757655369068,0.37268847795163584,0.9325920388574481,1.0,6/16,25.91%,RANBP2;CBX4;PIAS2;MDM2;UBE2I;TOPORS
prerank,phosphatase inhibitor activity (GO:0019212),0.4518952008456873,1.0938918840440042,0.34782608695652173,0.9316663570041452,1.0,4/20,11.61%,LGALS3;URI1;ENSA;ANP32E
prerank,calcium channel inhibitor activity (GO:0019855),-0.4471099420403239,-1.0930354995806546,0.33048433048433046,0.679221445368889,1.0,3/11,9.13%,ITPR1;SLC30A1;MCUB
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.4944990573580727,1.0920478897045685,0.3787425149700599,0.9331446286338361,1.0,8/14,27.32%,RPP38;PRORP;TSEN2;POP1;RPP21;TSEN34;RPP30;RPP14
prerank,hexosaminidase activity (GO:0015929),0.5052830986971993,1.0919191617320267,0.3733133433283358,0.9289021994036433,1.0,7/12,25.74%,NAGA;SPAM1;HYAL1;OGA;CEMIP;HEXB;CEMIP2
prerank,ATPase regulator activity (GO:0060590),0.4071699033234188,1.09163625921423,0.3449564134495641,0.9251754990379907,1.0,12/38,18.96%,HSPH1;TSC1;DNAJB4;BAG5;DNAJB6;AHSA1;KATNB1;DNAJC19;DNAJA2;DNAJA1;FNIP1;DNAJC10
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.41354845675337026,1.0899961602835206,0.34572490706319703,0.9210671858715039,1.0,14/34,21.97%,NDUFS5;NDUFA4;NDUFB2;NDUFA8;NDUFS8;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5;NDUFV1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.41354845675337026,1.0899961602835206,0.34572490706319703,0.9210671858715039,1.0,14/34,21.97%,NDUFS5;NDUFA4;NDUFB2;NDUFA8;NDUFS8;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5;NDUFV1
prerank,cadherin binding (GO:0045296),0.3416880789169622,1.089019176314614,0.2796780684104628,0.9199880624676403,1.0,73/315,16.32%,DCHS1;CDH19;STXBP6;PTPRH;PRDX6;ANK3;OLFM4;TBC1D10A;EGFR;PTPRT;ACVR1;PAK4;CNN3;FMNL2;PLIN3;PACSIN2;PSEN1;BZW2;CDH10;RPL23A;CDH22;CTNNA2;SPTBN1;CDH8;YWHAZ;UBAP2;CTNNA3;GOLGA3;BAIAP2;PLEC;EPS8L1;LRRFIP1;EPS15;FLNB;ZC3H15;PPP1R13L;FLNA;FASN;CDH20;CDH7;PTPN1;SLK;VAPA;PTPRJ;CBL;GLOD4;PTPN11;UBFD1;EMD;PPP1CA;CDK5R1;RAB1A;PDXDC1;AHSA1;SCRIB;CKAP5;LYPLA2;CORO1B;NCK1;RTN4;SNX1;IQGAP1;CDC42EP1;PKP2;CLIC1;ITGB1;JUP;GCN1;CDH18;NOP56;DIAPH3;OLA1;ANLN
prerank,phospholipase binding (GO:0043274),0.4928215838209766,1.0854740833718801,0.37519142419601836,0.9269763304932483,1.0,2/13,8.06%,PRKN;FYN
prerank,potassium ion antiporter activity (GO:0022821),-0.397157663665468,-1.0831738476324013,0.3419354838709677,0.6967785860538739,1.0,6/15,11.85%,SLC9A6;SLC9A2;SLC9A8;SLC24A3;SLC9A9;SLC9A7
prerank,small GTPase binding (GO:0031267),0.3437087473950737,1.0815546762491923,0.3336724313326551,0.9356733366703102,1.0,41/170,15.04%,RTKN;DOCK7;HPS6;BICD1;AKAP13;FGD4;RHOBTB3;HACE1;RANBP2;IQGAP2;NOX1;PAK1;PKN1;MAPKAP1;ALS2;CDKL5;MTSS2;AP1G1;RAB34;BRK1;FLNA;TRIP11;SIKE1;MYO9B;RCC1;NGFR;USP33;BICD2;RIMS1;STK19;RHOH;WASF1;USP6NL;CCDC186;TBC1D20;RAB3GAP2;RAB11FIP3;IQGAP1;CYFIP1;SGSM1;ANKRD27
prerank,endopeptidase activator activity (GO:0061133),-0.43602880482814393,-1.0813328001864855,0.36338028169014086,0.692916289876091,1.0,8/10,36.50%,PSMD14;APH1B;PSENEN;ADRM1;PSME3;VSIR;PSME2;NLRC4
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.4009086756228313,1.0811155362386187,0.3734793187347932,0.9324330695009289,1.0,11/40,16.85%,SUV39H1;METTL9;THUMPD3;SETD3;COMT;AS3MT;FBL;LRTOMT;THUMPD2;MEPCE;PCMTD2
prerank,sterol transfer activity (GO:0120015),-0.3777621951137304,-1.0808397067477864,0.3254237288135593,0.6857810289393577,1.0,6/17,12.30%,ABCA1;PLTP;OSBP;OSBPL2;ABCG1;STARD4
prerank,fatty acid synthase activity (GO:0004312),0.5169572761921101,1.0808109879854937,0.39819004524886875,0.9288742068381503,1.0,3/10,9.43%,OXSM;ELOVL6;ELOVL5
prerank,acetyltransferase activity (GO:0016407),0.4185946050157776,1.0805305123723667,0.3648989898989899,0.9252142546997972,1.0,9/31,18.52%,KAT2B;NAA16;PAFAH1B3;KAT8;GTF2B;DBT;SMARCE1;NAA10;NAA15
prerank,O-acyltransferase activity (GO:0008374),0.4171978695071362,1.0803783938561364,0.38235294117647056,0.9212572512724088,1.0,2/30,2.67%,PRDX6;MBOAT2
prerank,glucose transmembrane transporter activity (GO:0005355),0.46196440122014504,1.0783666757564006,0.3676056338028169,0.9232611236479877,1.0,3/17,10.56%,SLC5A3;MFSD4A;SLC2A2
prerank,beta-tubulin binding (GO:0048487),0.41777970119273433,1.0774582481107302,0.36970474967907574,0.9219074297664844,1.0,7/31,14.97%,DLEC1;FGF13;PACRG;EMD;CDK5R1;ARL8A;GABARAPL2
prerank,phospholipase C activity (GO:0004629),0.4284044735259319,1.0773515708045656,0.38082191780821917,0.9178799595115653,1.0,2/25,4.92%,CHRM3;PLCB1
prerank,Hsp90 protein binding (GO:0051879),0.4025286156676771,1.0760665899389208,0.3695652173913043,0.9177643829030782,1.0,9/33,13.21%,FKBP6;SLC12A2;TSC1;PACRG;PPID;HIF1A;HDAC6;AHSA1;AHR
prerank,cGMP binding (GO:0030553),-0.43054144443490117,-1.0753463760583468,0.38857142857142857,0.6912953786090273,1.0,2/11,12.42%,PDE5A;PDE2A
prerank,clathrin adaptor activity (GO:0035615),0.4623477768995594,1.0751993720648616,0.36324786324786323,0.9161687341211671,1.0,4/15,8.71%,STON2;STON1;AP1G1;HIP1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.39571858494139744,1.0750898965090256,0.373639661426844,0.9122432605228835,1.0,8/42,16.02%,KAT2B;CDKN2B;CCNJ;CCNC;CKS1B;CDK5R1;CDK5R2;CCND2
prerank,chemokine binding (GO:0019956),0.41837467388918104,1.074657420919126,0.3836317135549872,0.9093884559120288,1.0,5/30,15.19%,FGF2;CCR2;ACKR3;ACKR4;ITGB1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.41917108607422243,1.0743273498239914,0.38018741633199465,0.906189142259615,1.0,4/26,8.53%,LGALS3;PPP1R14C;ENSA;PPP1R8
prerank,anion transmembrane transporter activity (GO:0008509),0.4900383278036635,1.0741953870800205,0.37853949329359166,0.9024146963224313,1.0,2/12,5.60%,SLC22A3;SLCO2B1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.47905631226279605,1.0715295705024643,0.39545454545454545,0.9064483340199757,1.0,2/13,1.40%,BMP5;PYCARD
prerank,retinoid X receptor binding (GO:0046965),0.5023287852467798,1.071308466039747,0.39570552147239263,0.9030913284500175,1.0,6/11,21.43%,TACC1;RARG;NRIP1;MED25;PPARG;NSD1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3286847410991914,1.0706408209950609,0.265,0.9012808153291082,1.0,121/597,20.65%,OSR2;ETV1;SOX6;NKX6-2;KLF15;MEOX1;ETV4;MEOX2;LHX5;TLX3;GLI2;CREB3L1;SOX8;DDX11;PRDM16;TGIF2;HOXB8;ZBTB20;SOX9;SUV39H1;HIVEP1;ZBTB37;HOXA7;MBD4;TFCP2;EGR3;KDM5B;RFX2;SOX11;ZNF276;GLI1;E2F2;PHOX2A;HOXD3;RFX3;RORC;MLX;CREB3L2;GATA6;TBX18;MEN1;CHD3;ATMIN;TFAM;RARG;BRCA1;MBD2;XPA;RARB;SOX12;SOX5;CARM1;BBX;KLF5;ARID4B;PRDM9;ERBB4;NFATC3;ATF2;ESR1;NFE2L2;MCM4;SP1;TAF9;SFPQ;TAF2;CREBZF;PER3;KLF13;NR6A1;XRCC6;ATF5;PER1;GATA3;AHR;ZNF250;ORC1;SNCA;PAX3;DHX33;TAF7;CREM;IRX5;HOXB7;POU3F1;RUNX1;ABL1;MEIS3;TP53;SP3;KCNH2;SREBF2;HNRNPU;FOXJ1;PAX2;GABPB2;GABPB1;RNF10;NFIX;NR5A1;KLF16;IRF3;ORC4;ASH2L;RFX7;BATF;EGR1;CENPC;BCOR;FOXJ3;PPARG;JUN;STAT3;ONECUT2;TFE3;ORC2;JDP2;KMT2D;PBX1;ZBED4;NR1D2
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.43490498234927033,1.0668557803002774,0.38651994497936726,0.9091305184105496,1.0,6/20,19.00%,AGPAT2;MOGAT3;AGPAT5;GPAT3;GPAT4;LPCAT2
prerank,outward rectifier potassium channel activity (GO:0015271),0.4990314917889071,1.0659924764370035,0.41272189349112426,0.9077196556873071,1.0,6/11,21.49%,KCND1;KCND2;KCND3;KCNT2;KCNA5;PKD2
prerank,single-stranded telomeric DNA binding (GO:0043047),0.497932186379355,1.062495408484597,0.4180451127819549,0.9148547854647759,1.0,7/11,26.14%,STN1;RPA2;TERF2IP;CTC1;RAD50;HNRNPA2B1;NABP2
prerank,galactosyltransferase activity (GO:0008378),-0.41985749120140436,-1.0606562428787274,0.3813559322033898,0.7203246815944143,1.0,5/11,19.20%,B4GALT7;B4GALT1;A4GALT;B4GALT2;B4GALT4
prerank,voltage-gated calcium channel activity (GO:0005245),0.39519015251742484,1.0578376611281541,0.39386503067484663,0.9257043566090564,1.0,6/37,6.44%,CACNA1E;CACNA2D1;CACNG7;NCS1;CACNA1A;CACNB4
prerank,G protein-coupled receptor activity (GO:0004930),0.3313884275105667,1.055893825878394,0.3562058526740666,0.9279243277468127,1.0,28/239,15.45%,FFAR4;SSTR1;LGR6;MRGPRF;GPR63;RHO;HRH1;LPAR1;GPR65;GPR173;PTH2R;LGR5;P2RY14;TSHR;ADGRB3;MAS1;GRM5;GPR37;GPR88;S1PR3;ADGRL3;DRD2;GLP2R;P2RY12;P2RY1;ADGRG2;XPR1;TM2D1
prerank,ubiquitin binding (GO:0043130),0.3565795675847163,1.0543445636443318,0.4057649667405765,0.9285204092331383,1.0,19/73,19.06%,RAD23B;PRKN;MVB12B;FBXW7;FBXO7;CKS1B;UCHL1;RNFT1;USP33;UCHL3;TOLLIP;VPS36;MVB12A;PLAA;USP25;N4BP1;NBR1;MDM2;USP5
prerank,GTPase regulator activity (GO:0030695),0.3315724066885451,1.0539467259650603,0.3851626016260163,0.9255903907375177,1.0,42/212,14.96%,ARHGAP24;SIPA1L1;DLC1;ARHGAP32;RTKN;ARHGAP19;TBC1D10A;GPSM2;NPRL2;RANBP2;ELMOD2;IQGAP2;PLCB1;NF1;RGS11;RASA1;CHN1;ALS2;MTSS2;ARHGAP9;ARHGEF10L;TBCK;VAV3;ADGRB3;DOCK1;ARHGAP11A;ARL2;MYO9B;RIMS1;OPHN1;STXBP5;RHOH;ACAP2;USP6NL;ELMOD3;TBC1D20;RAB3GAP2;ARFGAP3;ARFGAP1;ARHGAP44;IQGAP1;SGSM1
prerank,DNA secondary structure binding (GO:0000217),0.40351069454601507,1.0530255932019041,0.388250319284802,0.9244212061249931,1.0,8/31,17.24%,KMT2A;ERCC5;MEN1;MSH6;XRCC3;ABL1;BLM;WRN
prerank,adenyl nucleotide binding (GO:0030554),0.49551995793538617,1.0528860710013432,0.4263803680981595,0.9167485423339425,1.0,2/11,8.56%,HSPH1;BAG5
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.49551995793538617,1.0528860710013432,0.4263803680981595,0.9167485423339425,1.0,2/11,8.56%,HSPH1;BAG5
prerank,carboxylic ester hydrolase activity (GO:0052689),0.3508132511223536,1.0509682839976364,0.39021739130434785,0.918789201090451,1.0,15/85,16.30%,PRDX6;CEL;PGAP1;H6PD;PLA2G7;PAFAH1B3;MRPL58;LYPLA1;PLA2G12A;PLAAT5;PLAAT3;LYPLA2;LIPC;PGLS;ABHD6
prerank,GTPase binding (GO:0051020),0.33134907717799766,1.0494440574717454,0.3975659229208925,0.9194480952426635,1.0,45/195,15.04%,RTKN;DOCK7;HPS6;BICD1;AKAP13;FGD4;EPRS1;RHOBTB3;HACE1;RANBP2;IQGAP2;NOX1;SPTBN1;PAK1;PKN1;RASA1;MAPKAP1;ALS2;CDKL5;MTSS2;AP1G1;RAB34;BNIP3;BRK1;FLNA;TRIP11;SIKE1;MYO9B;RCC1;NGFR;USP33;BICD2;RIMS1;STK19;RHOH;WASF1;USP6NL;CCDC186;TBC1D20;RAB3GAP2;RAB11FIP3;IQGAP1;CYFIP1;SGSM1;ANKRD27
prerank,NADP binding (GO:0050661),-0.3065448038349703,-1.04824863392835,0.373134328358209,0.7441679384094061,1.0,10/32,16.85%,CRYZL1;NOS3;LBR;ME1;PGD;GMDS;NOS1;NNT;SPR;QDPR
prerank,BMP binding (GO:0036122),0.4921723149996752,1.0468868679815624,0.42201834862385323,0.9232736077338284,1.0,1/11,0.48%,SOSTDC1
prerank,BMP receptor binding (GO:0070700),0.4790571833116515,1.0468687751942376,0.39906832298136646,0.9194050359122932,1.0,2/12,1.40%,BMP5;PYCARD
prerank,protein tyrosine kinase binding (GO:1990782),0.3555939818813476,1.0456210119094744,0.40939597315436244,0.9193837810938976,1.0,14/71,10.85%,SHC4;LRP4;CBLB;ACVR1;PTPN2;NRG3;PHYHIP;SOCS5;ALKAL2;GRB14;PTPN1;GRM5;CBL;PTPN11
prerank,double-stranded DNA binding (GO:0003690),0.322476593804045,1.0453655914596307,0.341,0.9162519770000526,1.0,72/531,15.55%,OSR2;ETV1;NKX6-2;KLF15;MEOX1;ETV4;MEOX2;LHX5;TLX3;GLI2;CREB3L1;SOX8;DDX11;TGIF2;HOXB8;ZBTB20;SOX9;EGFR;HIVEP1;ZBTB37;HOXA7;SATB1;APTX;TFCP2;EGR3;KDM5B;RFX2;ERCC5;ZNF276;MBD1;E2F2;PHOX2A;HOXD3;RFX3;RORC;MLX;SETMAR;GATA6;TBX18;MEN1;RARG;XPA;RARB;SOX12;BBX;KLF5;REXO4;TDP1;NFATC3;PSIP1;ATF2;FBH1;ESR1;SP1;MSH6;KLF13;NR6A1;XRCC6;GATA3;AHR;ZNF250;PAX3;CRY1;ZNF638;POLG2;CREM;IRX5;HOXB7;CGAS;POU3F1;ABL1;MEIS3
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.4316299359758522,1.0443524339570274,0.4136490250696379,0.9153990203379988,1.0,5/18,16.15%,DPEP1;MT3;PRDX3;SNCA;XIAP
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.35201566054645306,-1.0441955811793038,0.3655913978494624,0.7457545553589545,1.0,6/18,13.37%,SMAD6;SMAD7;ENG;TGFBR1;TGFB2;USP15
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.4287688445447271,1.0434089835494937,0.420391061452514,0.9145784804006887,1.0,2/21,5.11%,CHRNA4;GRIK2
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.4824421504844088,1.0431971277748122,0.4411764705882353,0.9113300898751304,1.0,5/11,18.50%,PYCARD;CASP6;CASP12;CASP2;CASP7
prerank,solute:proton symporter activity (GO:0015295),0.44887955559168347,1.042926283501419,0.4143484626647145,0.9083675016068842,1.0,2/16,5.20%,SLC17A5;SLC36A2
prerank,chemorepellent activity (GO:0045499),0.4147477071176593,1.0427518835707987,0.42567567567567566,0.9050762572876034,1.0,4/25,3.81%,SEMA3E;SEMA6C;NRG3;SEMA3A
prerank,exopeptidase activity (GO:0008238),0.3761796988014389,1.0427202950029646,0.41874258600237246,0.9013942133458559,1.0,9/50,9.81%,FAP;DPEP1;KDM8;NAALAD2;LTA4H;DPP10;TRHDE;DPEP2;LNPEP
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.40157495276500565,-1.0426489896459996,0.39221556886227543,0.7412668662567009,1.0,6/12,19.85%,PHF2;KDM1A;KDM4C;KDM4D;KDM3B;HR
prerank,general transcription initiation factor binding (GO:0140296),0.4086310454437097,1.0395235149560385,0.422283356258597,0.9073127886662169,1.0,13/25,27.54%,DRAP1;GTF2B;ESR1;TAF11;AHR;PSMC1;TAF1;RUVBL2;YEATS2;THRA;TBP;DR1;RELA
prerank,GTP binding (GO:0005525),0.3331107399346904,1.0391053619090833,0.41237113402061853,0.9047518164042627,1.0,41/172,18.39%,RHOJ;RASEF;RHOD;RAB38;RND3;RAP2B;ADSS1;RHOBTB3;RAB14;ARL3;RALB;ARL1;BMS1;RAB21;RAP1A;RAB39A;RABL3;LANCL2;TUBB6;RHOT2;ARL2;MRAS;ARL5C;ARF4;ANXA6;RAB22A;RHOH;RHOC;ATL3;ARL8A;GNAI1;RAB4A;TRIM23;GTPBP10;EIF2B2;RAC3;RAB7A;RHOT1;TUBA1A;NRAS;KRAS
prerank,SH3 domain binding (GO:0017124),0.3638030980769742,1.0390369013010918,0.39763313609467454,0.9012960521846283,1.0,7/62,4.43%,SGIP1;ENAH;PTPN22;CBLB;PRKN;WIPF1;NCF1
prerank,neurexin family protein binding (GO:0042043),0.4989904983195647,1.0389186265478956,0.43230016313213704,0.8979620239510563,1.0,2/10,5.72%,CEL;NLGN1
prerank,endopeptidase inhibitor activity (GO:0004866),0.3507534484627866,1.0372584323381835,0.4268817204301075,0.8989368988652012,1.0,13/82,15.39%,A2M;LXN;NGF;RECK;PRNP;CSTB;UCHL5;BIN1;SERPINE2;UBE2Z;PROS1;USP14;UBE2O
prerank,N-acetyltransferase activity (GO:0008080),0.4300930506194027,1.035214950790046,0.4262295081967213,0.901386036246108,1.0,7/19,27.25%,KAT2B;SMARCE1;NAA10;NAT8L;ATAT1;SAT1;NAA50
prerank,protein kinase C binding (GO:0005080),-0.2800707236770176,-1.0337508004533598,0.4161849710982659,0.7557998881069461,1.0,12/43,18.82%,GRK5;PARD6G;PDLIM5;PRKCB;RACK1;ADCY4;CAVIN3;SQSTM1;TIRAP;TRPV4;HSPB1;DACT2
prerank,PDZ domain binding (GO:0030165),0.36216890377658134,1.0315512983361248,0.4215456674473068,0.9083566414855019,1.0,12/61,8.17%,TBC1D10A;PTEN;PRKN;GRIA1;ATP2B3;PSEN1;SDC2;GRID2;NLGN1;FZD7;ACOX1;CADM1
prerank,neuropeptide hormone activity (GO:0005184),0.4221093700244224,1.0301936282656257,0.44786096256684493,0.9086172200424025,1.0,1/22,0.98%,CRH
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.4111681908986716,-1.0264794122357856,0.43490304709141275,0.7662074564521489,1.0,4/10,16.54%,B4GALT7;B3GALT1;B4GALT1;B3GALT2
prerank,phospholipase activity (GO:0004620),0.3468572954731414,1.0251520687626563,0.44306651634723787,0.9193540327508929,1.0,16/67,21.32%,PRDX6;PLBD1;LYPLA1;PLA2G12A;PLAAT5;PLAAT3;LYPLA2;PNPLA8;SEC23IP;LIPC;GPLD1;ABHD6;GDPD3;PLA2G4E;DDHD1;ABHD16A
prerank,thyroid hormone receptor binding (GO:0046966),0.4010285868891391,1.0240891002841073,0.44144144144144143,0.9188733857495069,1.0,12/28,22.78%,TACC1;GTF2B;TRIP6;BRD8;MED13;TAF11;TAF7;MED12;NCOA3;MED30;NSD1;MED24
prerank,growth factor activity (GO:0008083),0.34393133080015653,1.023081387877974,0.4489337822671156,0.9180996377775352,1.0,10/74,12.11%,FGF2;FGF10;NGF;NRG3;VEGFA;BTC;AMELX;GDNF;FGF7;GRN
prerank,cytokine receptor binding (GO:0005126),0.3428611629038484,1.0204916893704226,0.45164835164835165,0.9219453960775937,1.0,13/83,13.84%,PYCARD;CRLF1;FADD;VEGFA;PXDN;SPRED2;SPRED1;IL18;TRIP6;TYK2;IL6ST;PRLR;TGFBRAP1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.38056846947175993,1.0198793959093013,0.42177722152690866,0.9200345134456281,1.0,8/37,14.03%,IARS2;EPRS1;FARSA;SARS2;FARSB;FARS2;YARS1;HARS1
prerank,hyaluronic acid binding (GO:0005540),0.485749759608665,1.0197218850878638,0.4712286158631415,0.9168514183750803,1.0,1/10,1.24%,CHODL
prerank,Hsp70 protein binding (GO:0030544),0.39100483798200336,1.0190381376207491,0.4520725388601036,0.9151817715521533,1.0,12/31,24.26%,PRKN;TSC1;PACRG;PPID;GPR37;SNCA;FICD;DNAJA1;DNAJC10;DNAJC8;PPEF2;IQCG
prerank,glycerophospholipid flippase activity (GO:0140333),-0.39900916864765673,-1.0183554576233602,0.40443213296398894,0.7791798264761497,1.0,8/11,18.40%,ATP10A;ABCA3;ABCA4;ATP11A;ATP8B2;ABCB4;ATP10B;ATP8A1
prerank,voltage-gated chloride channel activity (GO:0005247),0.48320284066253383,1.0183229128927331,0.4718196457326892,0.9137579850598256,1.0,2/10,3.48%,CLCN5;ANO6
prerank,copper ion binding (GO:0005507),0.3709350236628697,1.0179427991354402,0.45235223160434257,0.9113281806611558,1.0,11/42,18.76%,CUTA;PRNP;MT3;AOC1;LOXL3;GPC1;SUMF1;SNCA;TP53;SNCB;PARK7
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.3177204868044971,1.0179115624935555,0.45030425963488846,0.9078924099720539,1.0,49/254,21.26%,OSR2;ETV1;KLF15;ETV4;MEOX2;CREB3L1;PRDM16;MYC;SOX9;HOXA7;TFCP2;SOX11;RFXANK;E2F2;HOXD3;ZBTB16;ATMIN;SOX12;KLF5;HIF1A;NFATC3;ATF2;ESR1;SP1;ZNF112;ATF5;GATA3;SALL2;MDM4;HOXB7;RUNX1;MEIS3;TP53;NFIA;FOXJ1;MDM2;IRF3;KLF7;EGR1;PRRX1;FOXJ3;JUN;STAT3;PRDM2;ONECUT2;MEIS1;ZSCAN21;NFKB1;MITF
prerank,damaged DNA binding (GO:0003684),0.36718211260116435,1.0178279342417687,0.4571773220747889,0.9045712257408456,1.0,9/44,13.81%,APTX;ERCC5;ERCC4;MPG;DDB2;RPA3;XPA;DDB1;RPA2
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.3906557073140065,-1.0177210177830427,0.40771349862258954,0.7725887347694524,1.0,3/12,5.85%,IGF1;IGF2;INSR
prerank,adrenergic receptor binding (GO:0031690),0.4407198200648712,1.0170277368867613,0.44798890429958393,0.9033702276528491,1.0,4/16,12.05%,SAV1;UCHL1;MAGI2;PDE4D
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.4395927100752542,1.0161770199051514,0.45321637426900585,0.9022126360170326,1.0,5/15,19.00%,AGPAT2;AGPAT5;GPAT3;GPAT4;LPCAT2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.4162754508119269,1.0158622632023782,0.46013986013986014,0.8996525467260987,1.0,7/20,19.21%,USP50;SENP3;UFSP2;SENP2;USP25;USP21;SENP1
prerank,DNA replication origin binding (GO:0003688),0.40901666007250126,1.0151295698903338,0.4536652835408022,0.8983514264298645,1.0,8/23,24.06%,DDX11;MCM4;ORC1;ORC4;ORC2;HSPD1;KAT7;ORC3
prerank,Tat protein binding (GO:0030957),0.49109605258771216,1.0142879875609294,0.465818759936407,0.8973763662122046,1.0,1/10,0.83%,MDFIC
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.4668386767630691,1.014237495952703,0.4546899841017488,0.894120436925902,1.0,1/11,4.08%,CHRNA4
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.39886032672673044,-1.0135340322711215,0.46629213483146065,0.7749787459582863,1.0,3/12,2.70%,CDH5;VEGFC;VEGFD
prerank,protein phosphorylated amino acid binding (GO:0045309),0.36521672989042137,1.012241763332081,0.4575,0.8961730741337394,1.0,18/42,26.99%,FBXW7;RASA1;SAMSN1;PIK3R1;PTPN11;ABL1;GRB2;SH3BP2;BCAR3;YES1;VAV2;NCK2;CRK;HCK;LDLRAP1;SYK;SHC3;PIN1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.320193514504138,-1.0119549039347688,0.4309623430962343,0.7704878196197186,1.0,7/24,11.47%,DAPK1;CAMK2G;CAMK1D;MKNK2;CAMK1;CAMK4;CAMK2A
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4517674483650661,1.0092330028830991,0.47076023391812866,0.9007869140873038,1.0,3/13,6.59%,SOX9;PRKAR1B;CSK
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.36251608107904515,-1.007627808888782,0.4459016393442623,0.7733993894957941,1.0,3/15,2.95%,PI4KA;PIK3R3;PIK3C2A
prerank,protein kinase binding (GO:0019901),0.31012503981351697,1.004488412921999,0.48946840521564694,0.9105708995673404,1.0,107/480,18.70%,ROR2;SHC4;BCL2L14;DNM1;UTRN;CNKSR2;RHOD;BICD1;ANK2;KAT2B;SOX9;DUSP4;PRKN;CDKN2B;RND3;ACVR1;PTPN2;RHOBTB3;PHYHIP;MAPK7;IRAK3;GPRC5B;MAPKAPK3;NBEA;PRKCSH;MAPKAPK2;PPP1R15A;DUSP6;PRKAR1B;SLC12A2;PDE3B;SCN5A;FBXO7;SOCS1;CKS1B;PKN1;YWHAZ;MAPKAP1;NELL2;SPRED2;CSK;FAM83H;PRKAB2;UFL1;SPRED1;GATA6;FOXM1;TBL2;LAX1;BAG5;ANKRA2;HIF1A;SYN1;SV2A;PTPN1;GRM5;PIH1D1;SPRED3;SIKE1;HINT1;ATF2;PTPRJ;ESR1;PTPN11;SLC12A4;CDC25B;CDK5R1;ERCC6L2;UNC5C;RHOH;RHOC;DVL1;PRKACA;PRDX3;TPCN2;CALM1;SPAG9;PKD1;IQGAP1;TICAM1;PKP2;ITGB1;ACSL3;DACT1;ABL1;CALM2;STX1B;TP53;CCND2;FAM83F;MYH6;RAC3;TRAP1;CSPG4;SUFU;FBXO5;TPRKB;JTB;RPTOR;NBR1;DCX;USP37;DUSP16;GYS1;INKA1;MAPRE3;MAP3K11
prerank,Wnt-activated receptor activity (GO:0042813),0.44399124071680296,1.0039653296546227,0.47569955817378495,0.9086965453255679,1.0,4/15,15.53%,ROR1;FZD7;PKD1;FZD9
prerank,antiporter activity (GO:0015297),0.42867531996165376,1.0030649595125074,0.45064377682403434,0.9078117425847727,1.0,8/20,17.17%,SLC35C2;SLC35E2B;SLC35E2A;SLC35A1;SLC25A10;SLC25A11;SLC35E1;SLC35E3
prerank,semaphorin receptor binding (GO:0030215),0.403171087693566,1.0015575929605283,0.47908232118758437,0.9085659761817438,1.0,3/23,3.81%,SEMA3E;SEMA6C;SEMA3A
prerank,endopeptidase regulator activity (GO:0061135),0.3715982452527138,1.0012450155143224,0.46153846153846156,0.9059920621777172,1.0,7/40,14.92%,A2M;RECK;CSTB;UCHL5;APH1A;PROS1;USP14
prerank,wide pore channel activity (GO:0022829),-0.3092894356759771,-0.9996180612218595,0.432,0.7855673745840057,1.0,4/23,10.76%,GJA1;GJB6;GJC1;GJD3
prerank,mRNA binding (GO:0003729),0.3144229987622824,0.9975080618137886,0.5237134207870837,0.9130516950120745,1.0,86/249,26.28%,PABPC5;RBFOX1;CSTF3;RBMS3;CELF5;QKI;ELAVL4;TRA2B;DXO;PABPC1;CPSF6;ETF1;HNRNPAB;METTL3;LUC7L2;SRBD1;UNK;CPEB3;ZC3H12B;KHDRBS3;PPP1R8;DCP1B;NCBP1;EIF4G1;PCBP4;DAZAP1;ADARB1;CPEB1;RBM4B;CELF6;DHX33;NOVA1;SRSF6;YTHDC1;KHSRP;LUC7L;EIF4ENIF1;TP53;HNRNPU;RBM46;N4BP1;SRRM3;FUBP1;RC3H1;RNPS1;SSB;SF1;AUH;CLUH;RBFOX3;PARK7;MARF1;CNBP;SYNCRIP;HNRNPC;FUBP3;ZFP36;CELF4;HNRNPL;RBFOX2;EIF4G3;DDX6;RBMS1;FYTTD1;RIDA;SNIP1;PTBP2;ZC3H12C;YBX3;DENR;RBM25;XPO5;TUT1;PCBP2;G3BP2;THOC5;GNL3;FMR1;CIRBP;NSRP1;RBM4;RNF20;YTHDF3;RBM15;HNRNPA2B1;CPEB4
prerank,GTPase activator activity (GO:0005096),0.31050758737750395,0.995612495461922,0.5,0.9147367441961345,1.0,73/313,17.47%,ARHGAP24;SIPA1L1;DLC1;ARHGAP32;ARHGAP19;TBC1D10A;DENND2A;AKAP13;FGD4;FRMD7;NPRL2;ARHGEF28;NUCB1;RANBP2;ELMOD2;IQGAP2;DOCK5;PLCB1;NF1;ARHGEF10;RGS11;RASA1;CHN1;ALS2;MTSS2;EPS8L1;DOCK10;ITSN1;RAP1A;EIF2B5;ARHGAP9;RGL1;LAMTOR2;ARHGEF11;ARHGEF10L;TBCK;VAV3;ADGRB3;DENND1C;DOCK1;ARHGAP11A;SPATA13;MYO9B;FARP2;RCC1;OPHN1;DNMBP;STXBP5;RCC1L;ACAP2;USP6NL;ELMOD3;TBC1D20;RAB3GAP2;ARFGAP3;ARFGAP1;ARHGAP44;RAB3IL1;IQGAP1;SGSM1;ANKRD27;ELMO1;CYTH3;RIC8B;ARFGEF1;RAP1GAP;HPS1;ELMOD1;ARHGEF4;EIF2B2;DENND10;GARNL3;RALGAPB
prerank,androgen receptor binding (GO:0050681),-0.3084182764585681,-0.9927351317860229,0.48068669527896996,0.7952730893600043,1.0,7/25,11.45%,FOXP1;KDM1A;PRKCB;SNW1;DDX5;KDM4C;PRMT2
prerank,cyclic nucleotide binding (GO:0030551),-0.3212124580015866,-0.9925689831862591,0.4426877470355731,0.7876320996841594,1.0,4/21,12.42%,PDE5A;RAPGEF4;PDE4A;PDE2A
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.30448120078216084,0.9922218352798364,0.539,0.9208135303336337,1.0,115/830,16.05%,EBF2;RORA;OSR2;ETV1;SOX6;NKX6-2;KLF15;MEOX1;EBF4;ETV4;MEOX2;LHX5;TLX3;GLI2;SOX8;PRDM16;MYC;DMRT2;TGIF2;EBF1;HOXB8;ZNF25;ZBTB20;SOX9;HIVEP1;OTP;ZBTB37;HOXA7;SATB1;TFCP2;EGR3;NFX1;FOXP2;RFX2;SOX11;RFXANK;GLI1;E2F2;ZEB1;PHOX2A;HOXD3;PGBD1;ZFP14;RFX3;ZBTB16;RORC;MLXIPL;MLX;TRPS1;TWIST2;E2F6;LRRFIP1;GATA6;TBX18;FOXM1;ZSCAN20;GTF2B;MKX;ZBTB41;RARG;RARB;SOX12;SOX5;ZNF569;BBX;KLF5;HIF1A;ZBTB6;CHD2;ZSCAN26;ZBTB38;NFATC3;ZNF260;ATF2;ZKSCAN8;ESR1;NFE2L2;MYT1;SP1;ZNF112;HDAC6;RBAK;ZFHX4;SIX5;KLF13;ZGPAT;PATZ1;FOXP4;ZBTB1;NR6A1;NRIP1;ATF5;PER1;GATA3;ZNF83;SALL2;ZNF250;ZBTB39;NACC2;KDM6A;PAX3;ZFHX2;HIVEP3;CREM;IRX5;HOXB7;ZNF235;ZEB2;POU3F1;RUNX1;MEIS3;PURG;KLF9;TP53;SP3
prerank,triglyceride lipase activity (GO:0004806),0.4101047823243702,0.9920656953607224,0.47301136363636365,0.9178759299758075,1.0,1/20,1.19%,CEL
prerank,gap junction channel activity (GO:0005243),-0.3134262277030607,-0.9916688104856689,0.44140625,0.7820150172256412,1.0,4/22,10.76%,GJA1;GJB6;GJC1;GJD3
prerank,cation transmembrane transporter activity (GO:0008324),0.35606768518776954,0.9915730613563973,0.4767025089605735,0.9158927266712448,1.0,5/48,6.18%,SLC22A3;SLC25A2;SLC1A5;SLC36A2;SLC25A38
prerank,mRNA 3'-UTR binding (GO:0003730),0.3361906669716432,0.9895863544557447,0.5080906148867314,0.917751019977442,1.0,27/79,26.28%,PABPC5;RBMS3;ELAVL4;PABPC1;EXOSC8;CPEB3;ZFP36L2;PCBP4;DAZAP1;CPEB1;KHSRP;TP53;HNRNPU;RC3H1;RNPS1;AUH;HNRNPC;ZFP36;RBMS1;YBX3;TUT1;FMR1;CIRBP;RBM4;RNF20;HNRNPA2B1;CPEB4
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.46440887055875035,0.9882164519850595,0.48992248062015503,0.918216735636852,1.0,5/11,21.65%,SLC25A23;SLC35B3;SLC25A25;SLC25A24;SLC17A9
prerank,Toll-like receptor binding (GO:0035325),0.4562927288983361,0.987973320164736,0.48522550544323484,0.9155892769337567,1.0,3/11,14.85%,TLR1;TOLLIP;UNC93B1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.37863521593905014,-0.9875943722688567,0.4685714285714286,0.7849146706137295,1.0,3/12,12.09%,NOCT;CNOT1;PAN2
prerank,ribonuclease P activity (GO:0004526),0.4600365129841584,0.9875111869347345,0.50231124807396,0.9136138726046019,1.0,6/11,27.32%,RPP38;PRORP;POP1;RPP21;RPP30;RPP14
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.3260654762412957,-0.9872390256843679,0.4690909090909091,0.7779902668054649,1.0,8/21,13.67%,PDE5A;PDE8B;PDE8A;PDE1A;PDE3A;PDE4A;PDE2A;PDE1C
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.3150884034604987,-0.9841033061226111,0.4763779527559055,0.7783313984087401,1.0,9/23,14.75%,PDE5A;PDE8B;PDE8A;PDE1A;PDE3A;PDE4A;PDE2A;PDE1C;ADPRM
prerank,ribosomal small subunit binding (GO:0043024),-0.3447615191244775,-0.9821013321540628,0.49508196721311476,0.7762161008215305,1.0,5/17,15.54%,MTIF2;NPM1;ABCE1;MTIF3;NME1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.4522244330627083,0.9818881393659115,0.5029498525073747,0.925271974521174,1.0,5/12,31.20%,TRAF4;TRAP1;TRIM37;TRAF6;TRAF3
prerank,cation:chloride symporter activity (GO:0015377),0.469106743512591,0.9810162186374761,0.5031847133757962,0.9241831196627587,1.0,3/10,11.14%,SLC12A3;SLC12A2;SLC12A4
prerank,acetylation-dependent protein binding (GO:0140033),-0.323378403046442,-0.9805749298608635,0.4383116883116883,0.7653449878412141,1.0,10/20,21.13%,MLLT3;BRD7;ZMYND8;BRD9;BRD2;ATAD2B;BAZ2A;THAP7;YEATS4;BRDT
prerank,lysine-acetylated histone binding (GO:0070577),-0.323378403046442,-0.9805749298608635,0.4383116883116883,0.7653449878412141,1.0,10/20,21.13%,MLLT3;BRD7;ZMYND8;BRD9;BRD2;ATAD2B;BAZ2A;THAP7;YEATS4;BRDT
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.40163420314568515,-0.9798877882613068,0.48292682926829267,0.7597455795226354,1.0,3/10,4.93%,PRKAG2;PKIA;PRKAR1A
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.35454269142025263,-0.9796381048224305,0.48757763975155277,0.7531163742288267,1.0,1/15,0.65%,PLA2G4A
prerank,deubiquitinase activity (GO:0101005),0.3212375336135273,0.9785319566338873,0.5174291938997821,0.9278259475920619,1.0,24/88,19.06%,USP50;USP35;USP11;MINDY4;OTUD7B;UCHL5;OTULIN;UCHL1;USP46;MYSM1;USP33;UCHL3;USP32;USP48;USP40;USP14;USP1;USP25;USP21;USP2;OTUD4;USP37;OTUD7A;USP5
prerank,peptide hormone receptor binding (GO:0051428),0.4611873469567468,0.9783591486142155,0.5,0.9250328070445722,1.0,1/11,3.66%,PTHLH
prerank,protein serine/threonine kinase activity (GO:0004674),0.3055517590631387,0.976314034180844,0.5773092369477911,0.927155503218565,1.0,85/335,19.42%,WNK2;PRKCA;STK32B;PRKCQ;STK36;EGFR;ACVR1;ALPK1;MAP4K4;PAK4;MAPK7;ARAF;IRAK3;WNK3;SIK2;EIF2AK3;RPS6KA4;MAPKAPK3;MAST2;PAK5;MAPKAPK2;DYRK4;TESK2;TNIK;ACVR1C;PAK1;PKN1;CDKL5;CDK8;CDKL3;CDK13;TGFBR2;ATP23;PRKAB2;DYRK1B;PDK3;LIMK1;CDK6;GAK;CDK15;CDK19;STK39;PASK;TLK2;MAPK9;AKT3;SGK3;SGK2;SLK;MAPK14;PKMYT1;STK32A;STK19;MAPK1;TAOK3;TBK1;STK33;CSNK1G1;PRKACA;CSNK1A1;NEK7;CDK16;TRIO;TTBK1;RPS6KA2;MAP3K4;BMPR1A;ATM;PIM2;CSNK1E;CSNK1G2;HTATIP2;SGK1;RIPK1;CHUK;PKN2;TP53RK;VRK3;MAP3K11;TAF1;CSNK2A2;TESK1;BCKDK;CSNK1G3;TOP1
prerank,nuclear receptor coactivator activity (GO:0030374),0.3482251258737627,0.9758211099207657,0.5005945303210464,0.9252365380317278,1.0,21/52,25.09%,FGF2;NCOA1;TACC1;PKN1;CARM1;ZMIZ1;NCOA2;BRD8;MED13;TMF1;MED12;NCOA3;MED30;RNF4;DCAF6;MED24;WDR77;CCDC62;ZMIZ2;NCOA7;ENY2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.3464154637325405,0.9754689809207276,0.5053003533568905,0.9228956532583773,1.0,9/53,13.82%,SLC1A3;SLC25A2;SLC1A5;SLC36A2;SLC25A38;SLC43A1;SLC7A7;SLC7A8;SLC25A15
prerank,myosin V binding (GO:0031489),0.4327490501765687,0.9740987961645405,0.5043478260869565,0.9232209920441554,1.0,7/15,25.46%,RAB14;RAB3D;RAB3A;RAB3B;RAB39B;RAB6A;RAB27B
prerank,ribonuclease activity (GO:0004540),0.3440676608509102,0.9736545036020218,0.5042117930204573,0.9211740090968503,1.0,8/56,10.78%,INTS11;RNASE6;NOB1;EXOSC8;ZC3H12B;PPP1R8;EXOSC2;RCL1
prerank,CoA hydrolase activity (GO:0016289),0.4181944056590204,0.973507168253964,0.5042857142857143,0.9184300046621005,1.0,6/16,25.87%,ACOT11;HIBCH;ACAA2;ACOT8;NUDT7;ACOT9
prerank,histone methyltransferase activity (GO:0042054),0.3711107149706745,0.9717897843926812,0.4869109947643979,0.9196529325954426,1.0,8/32,11.15%,SUV39H1;EED;MEN1;CARM1;PRDM9;SETD2;FBL;PRMT1
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.25549255770181845,-0.970279624528726,0.4620253164556962,0.7684588555301832,1.0,15/49,15.01%,MPPED2;ATP1A2;PPP1CB;PPP1CC;PXYLP1;DUSP3;LHPP;SBF1;SAMHD1;ARMT1;ACP6;PGAM5;DUSP10;PTPRO;PRUNE1
prerank,nuclear receptor binding (GO:0016922),0.3184031674192614,0.9702112862270785,0.5458377239199157,0.9204805319457354,1.0,35/111,20.22%,NCOA1;RNF6;TACC1;PKN1;WIPI1;DDX54;GTF2B;PPID;TRIP6;NCOA2;BRD8;HIF1A;MED13;ESR1;TAF11;DCAF1;TMF1;NRIP1;PRPF6;STRN;LCOR;CRY1;NCOR2;TAF7;MED12;MED25;JUP;SMARCE1;NCOA3;MED30;TACC2;PARK7;TAF1;PHB2;SMARCA4
prerank,3'-5' DNA helicase activity (GO:0043138),-0.3428274163729338,-0.9692899231695864,0.4576271186440678,0.7637891056853985,1.0,4/16,9.74%,NAV2;RECQL5;ERCC3;MCM6
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3476238043630154,0.9689977846259975,0.5234093637454982,0.9204194207542283,1.0,17/49,21.11%,CPNE8;C2CD5;ANXA9;SYT1;RPH3A;SYT11;SYT12;MCTP1;ANXA6;DOC2B;DYSF;CPNE7;SYT2;CPNE1;PLA2G4E;SYT13;CPNE3
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.43570249916289105,0.9679926885116855,0.5240174672489083,0.9198596349240541,1.0,3/14,9.76%,NCF1;NOX1;NCF2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.29741301441081175,0.9679426999746152,0.618,0.9168669624805822,1.0,102/730,16.05%,EBF2;RORA;ETV1;SOX6;NKX6-2;KLF15;MEOX1;EBF4;ETV4;MEOX2;TLX3;GLI2;CREB3L1;SOX8;PRDM16;MYC;DMRT2;TGIF2;EBF1;ZBTB20;SOX9;HIVEP1;ZBTB37;HOXA7;SATB1;TFCP2;EGR3;FOXP2;RFX2;SOX11;GLI1;E2F2;ZEB1;HOXD3;PGBD1;ZFP14;RFX3;ZBTB16;RORC;MLXIPL;MLX;CREB3L2;E2F6;LRRFIP1;GATA6;TBX18;ZSCAN20;MKX;ZBTB41;RARG;RARB;SOX12;SOX5;ZNF569;KLF5;HIF1A;ZBTB6;CHD2;ZSCAN26;ZBTB38;NFATC3;ZNF260;ATF2;ZKSCAN8;ESR1;NFE2L2;MYT1;SP1;ZNF112;HDAC6;ZFHX4;SIX5;KLF13;ZGPAT;PATZ1;FOXP4;ZBTB1;NR6A1;NRIP1;PER1;GATA3;AHR;ZNF83;SALL2;ZNF250;ZBTB39;NACC2;KDM6A;PAX3;ZFHX2;HIVEP3;CREM;IRX5;HOXB7;ZNF235;ZEB2;POU3F1;RUNX1;MEIS3;KLF9;TP53;SP3
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.3814456813704629,-0.9673411714572827,0.5,0.7616243963995798,1.0,5/11,13.02%,NDUFAF7;PRMT7;PRMT5;PRMT2;PRMT8
prerank,kinase binding (GO:0019900),0.2993744573151119,0.9662619004872669,0.5943775100401606,0.9180311222656219,1.0,104/435,19.55%,SHC4;BCL2L14;DNM1;UTRN;CNKSR2;RHOD;PTPN22;BICD1;ANK2;KAT2B;GSN;PRKN;CDKN2B;EGFR;RND3;PTPN2;RHOBTB3;IRAK3;GPRC5B;NBEA;PPP1R15A;SLC12A2;DLG2;SCN5A;FBXO7;SOCS1;CKS1B;YWHAZ;MAPKAP1;LAPTM4B;SPRED2;FAM83H;PRKAB2;UFL1;SPRED1;GATA6;FOXM1;TBL2;LAX1;FLNA;BAG5;ANKRA2;TRIP6;HIF1A;SYN1;SV2A;PTPN1;PIH1D1;SPRED3;SIKE1;ATF2;PTPRJ;ESR1;PTPN11;SLC12A4;CDC25B;TOLLIP;CDK5R1;ERCC6L2;UNC5C;TAX1BP1;SGO1;RHOH;RHOC;DVL1;PRKACA;PRDX3;TPCN2;ATF5;PER1;CALM1;PKD1;IQGAP1;TICAM1;ACSL3;EIF4ENIF1;CALM2;STX1B;TP53;CCND2;FAM83F;MYH6;RAC3;TRAP1;CSPG4;PIP5K1A;SUFU;FBXO5;TPRKB;JTB;RPTOR;DCX;USP37;PIK3IP1;GYS1;INKA1;HTT;MAPRE3;PARK7;POLR2A;KCNA5;GRB2;CAB39;BCL10
prerank,calcium-release channel activity (GO:0015278),-0.33510009471306346,-0.9652848071755965,0.4843205574912892,0.759569432584435,1.0,3/17,9.86%,ITPR1;RASA3;MCOLN1
prerank,nuclear import signal receptor activity (GO:0061608),0.4218587990604096,0.9645924438284786,0.4992721979621543,0.9192910139199341,1.0,7/15,19.83%,IPO9;KPNB1;KPNA6;KPNA1;TNPO3;IPO5;KPNA3
prerank,calcium channel activity (GO:0005262),0.32137468475288006,0.9625991112196911,0.5370165745856353,0.9210715892837503,1.0,17/84,18.10%,CACNA1E;CACNA2D1;CACNG7;ANXA9;NCS1;CACNA1A;PSEN1;CACNB4;SLC24A5;ANXA6;TPCN2;TRPC5;PKD1;CACNA2D4;CACNA2D2;SLC24A4;SLC24A2
prerank,5'-nucleotidase activity (GO:0008253),0.42955262132611594,0.9621989135986164,0.5238095238095238,0.9189966969055892,1.0,6/13,26.67%,NT5DC2;NT5C2;NT5C3B;NT5C;NT5C3A;NT5E
prerank,metalloexopeptidase activity (GO:0008235),0.34734342832560494,0.9606544351331211,0.5455607476635514,0.919645950723105,1.0,12/51,15.60%,DPEP1;AGBL3;LTA4H;MMP15;AGBL2;TRHDE;LNPEP;AGBL4;MMP16;AGBL1;CPD;RNPEPL1
prerank,cardiolipin binding (GO:1901612),-0.3909290113771873,-0.9587612590505984,0.5112994350282486,0.7684634613415232,1.0,5/10,29.59%,STOML2;GSDMD;GSDME;UQCC3;MME
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.3868033739657523,0.9585068228978497,0.5110192837465565,0.9220568142744835,1.0,4/24,9.31%,PLEKHA5;SESTD1;OSBPL5;LANCL2
prerank,nucleotidyltransferase activity (GO:0016779),0.40231853122234484,0.956242445473517,0.5345557122708039,0.9245635164712115,1.0,9/19,23.76%,PAPSS2;TUT4;CGAS;PNPT1;REV1;NUDT5;TENT2;TUT1;MOCS3
prerank,secondary active transmembrane transporter activity (GO:0015291),0.34225150936706106,0.9556510629159313,0.535840188014101,0.923028018755541,1.0,13/51,17.17%,SLC28A1;ANKH;SLC16A10;SLC35C2;SLCO2B1;SLC35E2B;SLC35E2A;SLC35A1;SLC7A8;SLC25A10;SLC25A11;SLC35E1;SLC35E3
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.4371613223058284,0.955080033567713,0.5362095531587057,0.9214666383220496,1.0,4/12,12.05%,PDE7B;PDE4B;PDE3B;PDE4D
prerank,thiol-dependent deubiquitinase (GO:0004843),0.31502198934851516,0.9540065691430719,0.5642701525054467,0.9211705791498382,1.0,23/83,19.06%,USP50;USP35;USP11;OTUD7B;UCHL5;OTULIN;UCHL1;USP46;MYSM1;USP33;UCHL3;USP32;USP48;USP40;USP14;USP1;USP25;USP21;USP2;OTUD4;USP37;OTUD7A;USP5
prerank,acyl-CoA hydrolase activity (GO:0047617),0.40853952277287175,0.9528931667361135,0.5244252873563219,0.9209218136401811,1.0,4/17,20.96%,THEM4;ACOT11;ACAA2;ACOT8
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.34873276391267743,-0.9510055863502631,0.48606811145510836,0.7792792764869094,1.0,6/14,15.56%,USP7;USP9X;OTUD5;MINDY2;USP15;MINDY3
prerank,R-SMAD binding (GO:0070412),-0.31302708891418396,-0.9508572984694718,0.5145985401459854,0.7728491120889306,1.0,4/18,12.67%,SMAD6;DDX5;RGCC;RANBP3
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.2911541945947459,0.9476928931821528,0.711,0.9304639431282142,1.0,124/731,19.75%,EBF2;RORA;ETV1;SOX6;NKX6-2;KLF15;MEOX1;EBF4;ETV4;MEOX2;TLX3;GLI2;SOX8;PRDM16;MYC;DMRT2;TGIF2;EBF1;ZBTB20;SOX9;HIVEP1;ZBTB37;HOXA7;SATB1;TFCP2;EGR3;FOXP2;RFX2;SOX11;GLI1;E2F2;ZEB1;HOXD3;PGBD1;ZFP14;RFX3;ZBTB16;RORC;MLXIPL;MLX;E2F6;LRRFIP1;GATA6;TBX18;ZSCAN20;MKX;ZBTB41;RARG;RARB;SOX12;SOX5;ZNF569;KLF5;HIF1A;ZBTB6;CHD2;ZSCAN26;ZBTB38;NFATC3;ZNF260;ATF2;ZKSCAN8;ESR1;NFE2L2;MYT1;SP1;ZNF112;HDAC6;ZFHX4;SIX5;KLF13;ZGPAT;PATZ1;FOXP4;ZBTB1;NR6A1;NRIP1;PER1;GATA3;AHR;ZNF83;SALL2;ZNF250;ZBTB39;NACC2;KDM6A;PAX3;ZFHX2;HIVEP3;CREM;IRX5;HOXB7;ZNF235;ZEB2;POU3F1;RUNX1;MEIS3;KLF9;TP53;SP3;SREBF2;HNRNPU;NFIA;FOXJ1;PAX2;NFIX;ZKSCAN1;HEYL;NR5A1;KLF16;IRF3;ZNF496;KLF7;RFX7;BATF;EGR1;MED8;RUVBL2;TOP1;PRRX1;FOXJ3;PPARG;JUN;STAT3
prerank,metalloaminopeptidase activity (GO:0070006),0.40799587381530483,0.9472660570516105,0.5273224043715847,0.928502625783087,1.0,6/16,15.60%,LTA4H;MMP15;TRHDE;LNPEP;MMP16;RNPEPL1
prerank,endoribonuclease activity (GO:0004521),0.35796715352878095,0.9472312321921726,0.5402144772117963,0.9255972775581558,1.0,5/32,10.78%,INTS11;NOB1;ZC3H12B;ENDOV;RCL1
prerank,SUMO binding (GO:0032183),0.4297854533930279,0.947040268583499,0.5385756676557863,0.9230752736545751,1.0,6/13,22.13%,UBA2;CBX4;RNF111;USP25;RNF4;TDG
prerank,histone acetyltransferase binding (GO:0035035),0.38261327750558805,0.9468143203617699,0.5384615384615384,0.9206714017022248,1.0,8/21,24.07%,HIF1A;CITED2;TAF7;KANSL1;TP53;EGR1;KANSL1L;MEF2A
prerank,hydro-lyase activity (GO:0016836),0.35046083871110045,0.946129360812079,0.5569007263922519,0.9193511065915828,1.0,10/41,20.12%,CYP2S1;CBS;HADHA;UROS;CDYL;PCBD2;AUH;EHHADH;PARK7;HACD2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.43630551520259564,0.9456375950081279,0.5356600910470409,0.9175320566259548,1.0,5/12,21.65%,SLC25A23;SLC35B3;SLC25A25;SLC25A24;SLC17A9
prerank,C-C chemokine receptor activity (GO:0016493),0.3930091726357889,0.9432339586009714,0.5245901639344263,0.9202677673241998,1.0,3/21,14.06%,CCR2;ACKR3;ACKR4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.4596422073202288,0.9420948879423867,0.5641025641025641,0.920038329912011,1.0,2/10,10.15%,APOBEC1;ADARB2
prerank,microtubule motor activity (GO:0003777),0.33480406490873543,0.9401433935462489,0.5841346153846154,0.9218479560520447,1.0,12/51,19.15%,DNAH2;KIF20B;KIF19;STARD9;KIF21A;DYNC1I1;KIF5C;DYNC1I2;KIF22;KIF21B;KIF3A;KIF2A
prerank,double-stranded RNA binding (GO:0003725),-0.22213781646109335,-0.9389698958176216,0.6341463414634146,0.7942083160298476,1.0,13/70,14.23%,DDX60;SIDT1;RFTN1;DGCR8;STRBP;AGO1;ACTN1;IFIH1;TFRC;ELAVL1;OAS2;AGO3;MSN
prerank,GTPase activity (GO:0003924),0.2981778118962246,0.9382017816760535,0.6510681586978637,0.9234710017363943,1.0,41/192,18.87%,RHOJ;GNA14;DNM1;RHOD;GNG3;RAB38;RND3;RAP2B;RHOBTB3;RAB14;RALB;ARL1;BMS1;RAB21;RAP1A;RABL3;RHOT2;ARL2;MRAS;GSPT2;TBCC;RAB22A;MTG1;RAB1A;RHOH;RHOC;ATL3;ARL8A;RAB3A;GNAI1;RAB4A;TRIM23;OPA1;GTPBP10;RAP1GAP;RAC3;RAB7A;RHOT1;NRAS;KRAS;RAB3B
prerank,NF-kappaB binding (GO:0051059),-0.2834705396456435,-0.9362720933448543,0.5763358778625954,0.7930089743463907,1.0,10/24,27.29%,NFKBIA;NPM1;GSK3B;ANXA4;COMMD7;COMMD6;HDAC3;RNF25;BRMS1;SETD6
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.3506515620997323,0.9358306186620482,0.5392535392535392,0.9259981173745848,1.0,6/34,8.26%,RAG2;IQGAP2;MAPKAP1;GBF1;ARHGAP9;GAB2
prerank,protein phosphatase regulator activity (GO:0019888),0.3299296304047345,0.9350587485121933,0.5763723150357996,0.9249947996359774,1.0,8/53,9.15%,LGALS3;PPP1R15A;RCAN1;ENSA;PPP2R3A;SHOC2;PPP2R2A;RCAN3
prerank,N-acyltransferase activity (GO:0016410),0.3567009395766885,0.9327130966930635,0.5742821473158551,0.9277434089087424,1.0,10/32,21.92%,CERS3;CERS6;PLAAT5;PLAAT3;SMARCE1;NAA10;GLYAT;PLA2G4E;CERS2;NAT8L
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.4135999097579188,0.9325703235683811,0.5358711566617862,0.9252045779410778,1.0,3/14,11.44%,PTEN;MTMR14;MTMR12
prerank,phosphotyrosine residue binding (GO:0001784),0.34580842836231146,0.9324850324366006,0.5370843989769821,0.9225272867751403,1.0,16/37,26.25%,RASA1;SAMSN1;PIK3R1;PTPN11;ABL1;GRB2;SH3BP2;BCAR3;YES1;VAV2;NCK2;CRK;HCK;LDLRAP1;SYK;SHC3
prerank,nucleoside-diphosphatase activity (GO:0017110),0.43269227287594914,0.9323232700782116,0.5724743777452416,0.9200722596143348,1.0,2/12,5.19%,NUDT15;ENTPD2
prerank,lipase activity (GO:0016298),0.3398476848939238,0.932209398619823,0.5756410256410256,0.9175281117819309,1.0,7/43,16.30%,PLBD1;CEL;LYPLA1;PNPLA8;SEC23IP;LIPC;ABHD6
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.33602307584095387,0.9320706200105018,0.5776470588235294,0.9150391724084358,1.0,16/49,23.05%,ZFAND2B;RAD23B;ZRANB3;OTUD7B;EPS15;HDAC6;ZBTB1;ZFAND6;OTUD7A;TAB3;TNIP2;WDR81;UBQLN4;TAB2;UBQLN1;UBQLN2
prerank,adenylate cyclase binding (GO:0008179),0.440620105182249,0.9295011636193167,0.5572755417956656,0.917971877288897,1.0,5/10,27.61%,AKAP6;CALM1;CALM2;ADCY5;AKAP12
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.28766837531879913,0.9271727333571917,0.7267267267267268,0.9204315606878947,1.0,92/431,18.39%,WNK2;PYGL;RHOJ;RASEF;RHOD;PEAK1;STK36;RAB38;RND3;RAP2B;ADSS1;ACVR1;MAP4K4;RHOBTB3;PDXK;IRAK3;WNK3;RAB14;SIK2;ARL3;RPS6KA4;MAST2;GSS;UBA2;KSR1;CDKL5;RALB;ARL1;PDK3;BMS1;RAB21;RAP1A;SARS2;CDK6;RAB39A;RABL3;TBCK;ACLY;TLK2;AKT3;LANCL2;TUBB6;SYN1;RHOT2;ARL2;MRAS;ARL5C;EIF4G1;MYO9B;PXK;HSPA4;PI4K2A;ARF4;MSH6;ANXA6;RAB22A;DDX25;RHOH;RHOC;ATL3;ARL8A;GNAI1;SRR;PNPLA8;RAB4A;P2RY1;HARS1;AK6;RTEL1;TRIM23;BMPR1A;GTPBP10;ABCB9;ABL1;PAPOLA;BLM;OLA1;NDUFA13;HNRNPU;ABCD2;FICD;ABCF1;EIF2B2;RAC3;SMC4;HSPA9;RAB7A;PEX1;RHOT1;TUBA1A;NRAS;KRAS
prerank,zinc ion binding (GO:0008270),0.28963821579671084,0.9261242451976559,0.6864321608040201,0.9200290907117965,1.0,57/293,19.03%,RAG2;GLI2;CSRP1;DHH;DPEP1;CBLB;PRKN;EPRS1;KMT2A;SEC24D;PDXK;KDM5B;ITGB1BP2;MT3;MBD1;GRIN2B;HHIP;LTA4H;ZEB1;AOC1;TRIM2;RPH3A;CHD3;GTF2B;TRHDE;SEC24C;PTPN1;LNPEP;MMP16;USP33;MYT1;RBAK;SIRT6;PHF8;ZFPM2;KPNB1;HPF1;SNCA;MDM4;ADAM33;GRIN2A;TRAF7;BAZ1B;PAPPA2;RCHY1;BLM;TP53;TET3;RBSN;RC3H1;ADH5;SEC24A;MDM2;KLF7;ZMYND11;TAB3;EGR1
prerank,alanine transmembrane transporter activity (GO:0022858),-0.3594184813747131,-0.9259098411845296,0.5436046511627907,0.8104784201619105,1.0,4/12,14.59%,SLC6A6;SLC38A7;SLC38A5;SLC36A4
prerank,ribosomal large subunit binding (GO:0043023),0.43211945202015467,0.9256337760747567,0.5714285714285714,0.9183077304854449,1.0,3/11,14.37%,CPSF6;EIF6;DHX33
prerank,protein heterodimerization activity (GO:0046982),0.2957417884783247,0.9255813568099759,0.6656378600823045,0.9156823858269573,1.0,32/178,17.47%,TENM2;TENM3;ERBB3;BCL2;ERBB2;IRAK3;EXT1;UBA2;FBXO7;METTL3;MLXIPL;MLX;PAFAH1B3;NAE1;MTTP;HIP1;HIF1A;RCC1;VAPA;UBA3;KATNB1;ZBTB1;TRMT112;AHR;SNX1;TAF7;ITGB1;FZD9;TP53;ABCG4;CHUK;RALGAPB
prerank,O-methyltransferase activity (GO:0008171),0.4416227446980787,0.9248155048902282,0.5590551181102362,0.9146740335846119,1.0,4/10,19.18%,COMT;LRTOMT;MEPCE;CMTR2
prerank,microtubule binding (GO:0008017),0.29175108161470403,0.924409476911953,0.6680161943319838,0.9127718061234995,1.0,50/222,19.59%,SGIP1;SAXO2;DNM1;FGF13;KIF20B;KIF19;MAP4K4;MAP1B;GAS2L3;ARL3;MAST2;STARD9;PRNP;EML1;NDE1;MACO1;KIF21A;CCDC170;CEP57;CAPN6;DYNC1I1;TUBGCP5;VAPA;MID2;KIF5C;CLASP1;HDAC6;CEP295NL;APC2;KATNB1;RMDN2;CKAP5;MDM1;KIF22;TPGS1;OPA1;GABARAPL2;MAP6D1;EML5;NAV3;DCX;KIF21B;KIF3A;MAPRE3;CAMSAP1;MID1;KIF2A;HOOK2;MAP6;CCDC66
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.40186204226364086,0.9238982794982755,0.5620542082738944,0.9112266727698572,1.0,5/16,22.13%,BST1;NEIL1;SMUG1;CD38;TDG
prerank,syntaxin binding (GO:0019905),0.31818523653131836,0.9224562335991006,0.5883720930232558,0.9115838365399896,1.0,12/61,13.44%,SNAP23;STXBP4;PTPN2;SYNPR;CACNA1A;SYT1;SNAP29;TMED10;VPS11;SYT12;STXBP5;STX8
prerank,estrogen receptor binding (GO:0030331),0.3546910701379663,0.9199187873021786,0.5917312661498708,0.9143983009913891,1.0,10/32,14.16%,NCOA1;TACC1;WIPI1;DDX54;PPID;ESR1;DCAF1;NRIP1;STRN;LCOR
prerank,phosphatidic acid binding (GO:0070300),0.38152667490696146,0.9194947128140912,0.5747126436781609,0.9126700069029587,1.0,5/19,14.92%,SESTD1;PACSIN2;MAPKAP1;GRAMD1B;OPA1
prerank,protein phosphatase activator activity (GO:0072542),-0.3384791174957131,-0.9194135468692844,0.5283018867924528,0.8183540239805471,1.0,3/13,5.07%,PHACTR4;IGFBP3;PTPA
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.3516518393410873,0.91773749295348,0.5881578947368421,0.913723801016104,1.0,5/29,7.08%,KAT2B;CDKN2B;PRKAR1B;SPRED2;SPRED1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.4181925583411042,0.9177075812101629,0.5739910313901345,0.9111030006921552,1.0,4/13,22.38%,IDI1;SREBF2;EHHADH;ECH1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.29575791101170723,0.9172663159135147,0.6488469601677149,0.9093848599953245,1.0,36/147,17.28%,DENND2A;AKAP13;FGD4;FRMD7;ARHGEF28;NUCB1;DOCK5;ARHGEF10;ALS2;EPS8L1;DOCK10;ITSN1;RAP1A;EIF2B5;RGL1;LAMTOR2;ARHGEF11;VAV3;DENND1C;DOCK1;SPATA13;FARP2;RCC1;DNMBP;RCC1L;RAB3GAP2;RAB3IL1;ANKRD27;ELMO1;CYTH3;RIC8B;ARFGEF1;HPS1;ARHGEF4;EIF2B2;DENND10
prerank,histone deacetylase activity (GO:0004407),-0.3128648298575299,-0.9154055326215924,0.5682656826568265,0.8203922145990991,1.0,10/19,25.72%,HDAC8;SIRT3;HDAC4;HDAC11;HDAC3;HDAC5;SUDS3;MIER2;SIRT7;HDAC10
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.3317078725070859,-0.9124822330048195,0.6055045871559633,0.8200936368187037,1.0,3/14,11.52%,SLC26A7;SLC26A2;SLC25A30
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.37326114805527427,0.9106709740177589,0.572987721691678,0.9207844151155548,1.0,8/21,23.01%,PRRC1;AKAP6;WASF1;PRKACA;ARFGEF1;AKAP1;PJA2;WASF3
prerank,pyrophosphatase activity (GO:0016462),0.3256973467859991,0.9105235138825843,0.6057007125890737,0.9184338004991659,1.0,11/50,12.50%,NUDT15;DXO;RNGTT;ENTPD2;BNIPL;NUDT1;NUDT22;PLPP4;NUDT10;NUDT9;NUDT3
prerank,guanyl ribonucleotide binding (GO:0032561),0.2896811633108952,0.9098989948931476,0.6978636826042727,0.9170257814712593,1.0,54/196,22.95%,RHOJ;RASEF;RHOD;RAB38;RND3;RAP2B;ADSS1;RHOBTB3;RAB14;ARL3;RALB;ARL1;BMS1;RAB21;RAP1A;RAB39A;RABL3;LANCL2;TUBB6;RHOT2;ARL2;MRAS;ARL5C;ARF4;ANXA6;RAB22A;RHOH;RHOC;ATL3;ARL8A;GNAI1;RAB4A;TRIM23;GTPBP10;EIF2B2;RAC3;RAB7A;RHOT1;TUBA1A;NRAS;KRAS;RAB3B;PDE11A;RRAGA;RHOU;RABL6;GLUD1;AGAP2;PDE10A;RAB18;GBP2;RAP2A;RAB6A;RAP2C
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.38641271948191663,0.9084569998839737,0.5853314527503526,0.9148286664322428,1.0,3/17,3.35%,EFNA4;EPHB6;EPHB2
prerank,ephrin receptor activity (GO:0005003),0.38641271948191663,0.9084569998839737,0.5853314527503526,0.9148286664322428,1.0,3/17,3.35%,EFNA4;EPHB6;EPHB2
prerank,histone demethylase activity (GO:0032452),0.3602785881085706,0.9076755275318866,0.5917843388960206,0.9137942612649776,1.0,6/27,13.88%,KDM8;KDM5B;KDM4B;PHF8;JARID2;KDM6A
prerank,myosin binding (GO:0017022),0.3199006560262082,0.9071386465866506,0.6161026837806302,0.9121975724125936,1.0,18/55,22.80%,PYCARD;GSN;RAB14;SPATA6;RAB3D;STXBP5;MYOC;RAB3A;KIRREL1;MOBP;ARFGEF1;TRAK2;RAB3B;NKD2;RAB39B;TRIOBP;LLGL1;RAB6A
prerank,lysophospholipase activity (GO:0004622),-0.3033457835062987,-0.9069014194536132,0.5902255639097744,0.8254778263012394,1.0,6/20,17.80%,PLA2G4A;PNPLA6;ASPG;MGLL;ABHD12;LYPLAL1
prerank,omega peptidase activity (GO:0008242),0.2993402027539801,0.9044660069784323,0.6444929116684842,0.9152142507671245,1.0,23/89,19.06%,USP50;USP35;USP11;OTUD7B;UCHL5;OTULIN;UCHL1;USP46;MYSM1;USP33;UCHL3;USP32;USP48;USP40;USP14;USP1;USP25;USP21;USP2;OTUD4;USP37;OTUD7A;USP5
prerank,ATPase activator activity (GO:0001671),0.3744808056067532,0.9030665494541249,0.592087312414734,0.9154944468099813,1.0,7/20,18.96%,DNAJB4;DNAJB6;AHSA1;DNAJC19;DNAJA2;DNAJA1;DNAJC10
prerank,GABA receptor binding (GO:0050811),-0.35755993202386327,-0.9023755070889341,0.6386554621848739,0.8290752448468508,1.0,6/11,20.12%,TRAK1;GABARAP;PLCL2;JAKMIP1;SHISA7;ARFGEF2
prerank,vitamin D receptor binding (GO:0042809),0.40156958233001394,0.9011880560997544,0.5773195876288659,0.916794512436019,1.0,6/14,22.78%,MED13;TAF11;TAF7;MED12;MED30;MED24
prerank,phospholipase inhibitor activity (GO:0004859),0.44068317711589733,0.9008779157641497,0.590625,0.9148016922431499,1.0,3/10,18.62%,ANXA9;SNCA;SNCB
prerank,disordered domain specific binding (GO:0097718),0.37128725227165893,0.8996474036906529,0.5902964959568733,0.9147072218813967,1.0,7/23,18.13%,KCNA1;FYN;CALM1;CALM2;TP53;NCOA3;MDM2
prerank,MAP-kinase scaffold activity (GO:0005078),0.4203985566588432,0.8953618911091507,0.5896656534954408,0.9206676909469559,1.0,4/11,14.88%,AKAP13;KSR1;SPAG9;IQGAP1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.3536870502706495,-0.8939886526338715,0.6122994652406417,0.8409539500242689,1.0,5/11,22.98%,ITPR1;TRPC6;TRPC3;TRPC7;CYTH2
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.34042201105516817,0.8927490080289463,0.6208226221079691,0.9234831342104807,1.0,11/35,23.74%,DTWD1;ELAC1;GATB;TRMT12;MRPL58;DTWD2;MTFMT;TRIT1;LCMT2;ALKBH1;NT5C3A
prerank,1-phosphatidylinositol binding (GO:0005545),0.3943610197325472,0.8900260349471134,0.6045454545454545,0.9262323066392109,1.0,4/15,12.36%,SESTD1;WDFY3;SNX10;ZFYVE9
prerank,manganese ion binding (GO:0030145),-0.2342683752500678,-0.8895890901826236,0.6933333333333334,0.8439480109537411,1.0,11/48,16.28%,MPPED2;ABL2;MTPAP;ME1;PRIMPOL;MGAT1;IMPA1;B4GALT7;ADPRM;MPPE1;B4GALT1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.278215048925158,0.8882622529449354,0.7373737373737373,0.9272260068865164,1.0,45/232,18.13%,PDZRN3;RNF157;CBLB;PRKN;DTX4;HACE1;NFX1;TRIM44;RNF6;ZNRF2;NEURL4;UFL1;TRIM2;TRIM11;CBX4;PELI1;RNFT1;VPS11;FBXO27;NEURL1B;PIAS2;CUL3;UHRF2;HUWE1;CBL;TRIM41;RNF121;FBXO17;MEX3C;MYLIP;RNF24;NEDD4L;AREL1;NEURL3;UBE2O;RNF19A;RCHY1;XIAP;RNF111;KCMF1;RNF10;RC3H1;RNF167;TRIM9;MDM2
prerank,kinase activator activity (GO:0019209),-0.26611739275805896,-0.887976082954527,0.6327433628318584,0.84063073282472,1.0,9/30,13.20%,PRKAG2;WNK1;MADD;GPRC5C;RGCC;RPLP1;MARK2;SPDYA;NCKAP1L
prerank,5'-3' RNA polymerase activity (GO:0034062),0.35032453650533407,0.8871771717484181,0.6290956749672346,0.9266741918701347,1.0,12/27,26.13%,POLR2B;POLRMT;POLR1B;POLR2G;MED21;POLR1D;POLR1C;TENT2;POLR2A;POLR3K;POLR2F;POLR3F
prerank,RNA methyltransferase activity (GO:0008173),0.37208144542070304,0.8862016513018695,0.6047156726768377,0.9260698011300952,1.0,5/19,15.73%,METTL3;TRMT12;TGS1;FBL;MEPCE
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.3275166113118784,0.8848219212728917,0.6441717791411042,0.9262428056937873,1.0,18/35,27.54%,MYC;DRAP1;GTF2B;PIH1D1;TAF4;TP53;PARK7;TAF1;RUVBL2;UBTF;SMARCA4;SNAPC3;RRN3;TBP;SMARCB1;DR1;HDAC1;RELA
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.30533073766496566,0.883817219632519,0.6610549943883277,0.925606978734961,1.0,24/69,25.41%,CERS3;KAT2B;CERS6;NAA16;KAT8;GTF2B;ZDHHC8;MOGAT3;PLAAT5;HHAT;PLAAT3;DBT;NAA10;GLYAT;NAA15;PLA2G4E;CERS2;ZDHHC21;PORCN;SCP2;ZDHHC13;DGAT2;ZDHHC15;ZDHHC17
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.3569901285120395,-0.8827841283753787,0.5636856368563685,0.8450848321383931,1.0,2/10,1.46%,CACNA1C;CACNB2
prerank,glycine binding (GO:0016594),0.40939252476559634,0.8808097196594122,0.6273932253313697,0.9287932159082288,1.0,3/11,20.39%,GRIN2B;SRR;GLRB
prerank,RNA binding (GO:0003723),0.2690190013430637,0.8793882334839976,0.949,0.9289187917580363,1.0,356/1321,23.16%,DCN;LGALS3;PABPC5;RBFOX1;DNM1;CSTF3;CSRP1;DDX11;RBMS3;S100A4;NQO1;DHX34;DHX8;CELF5;HNRNPDL;C1D;LRP1;QKI;GPATCH4;EPRS1;APTX;TRMT10B;WDR36;FNDC3B;TRA2B;NFX1;PRRC2B;ZNF326;DXO;PABPC1;CCDC9;FARSA;ANKHD1;CPSF6;RBM33;RPL23A;CSTB;ETF1;GOLGB1;ZNFX1;LTA4H;NOP2;SPTBN1;ZMAT3;HNRNPAB;TUFM;RP9;MRPL14;MRPL32;YWHAZ;ATXN2;POLR2B;UBAP2;NGRN;METTL3;UCHL5;MRPL16;CDK13;PLEC;BRIX1;NUDT1;EIF1B;XRN2;NOL8;DHX35;SON;BMS1;LUC7L2;LRRFIP1;SRP9;EIF3C;SARS2;SAMSN1;TUT4;ZC3H8;IBA57;MRTO4;SRBD1;DHX30;DDX54;UNK;CHD3;TBL2;CPEB3;UTP6;ZC3H12B;GDI2;FLNB;ADK;GOT2;SRSF11;ZC3H15;KHDRBS3;MRPS35;MRPS28;TFAM;PPP1R8;FLNA;BRCA1;HEATR1;S100A16;PEG10;DDX24;ANXA11;RBM10;FASN;FARS2;NSUN5;TRIP6;DCP1B;RCAN3;CASC3;CKAP4;APOBEC1;REXO4;PTPN1;CHD2;ALKBH5;NCBP1;ZFP36L2;PNLDC1;R3HDM1;HDAC2;ADARB2;FIP1L1;HUWE1;EIF4G1;RSRC2;EXOSC2;PSIP1;ENDOV;DUSP11;PCBP4;UBFD1;CLNS1A;RIMS1;FKBP4;RPP38;FBL;PRMT1;SFPQ;GSPT2;MRPL28;UPF1;COL14A1;CCDC137;RBM27;ZC3H18;EBNA1BP2;MEX3C;SNRNP40;HNRNPA3;DDX25;RCC1L;GRN;LSM3;SPATS2;YARS1;XRCC6;PRPF6;CCDC86;DAZAP1;HSP90B1;CFAP20;DHX57;ADARB1;DALRD3;KPNB1;SPOUT1;CCDC47;POLRMT;RBM4B;POLR2G;DDX42;PUS7;CELF6;MSI1;GLRX3;DHX32;RBM7;EIF1AX;EIF1;SUMO1;DHX33;NOVA1;SRSF6;YTHDC1;RBM45;NDUFV3;RTN4;ZNF638;WDR46;ELP5;SEC23IP;DDX10;KHSRP;SLTM;RNMT;TNS1;GTPBP10;DDX27;LUC7L;EIF4ENIF1;PSMC1;UBE2O;GTF2E2;XPOT;NIP7;GCN1;PURG;CSNK1E;PUS1;KYAT3;MEPCE;NIFK;NOP56;RPS27L;SNRPA;SLC25A11;SEC63;SMG6;PNPT1;NOC4L;SF3A1;HNRNPU;RAVER2;POP1;FSCN1;DDX56;RBM46;EIF4A2;ZYX;ABCF1;N4BP1;NXF1;SRRM3;FUBP1;AKAP1;RPP21;RC3H1;RNPS1;SSB;TRAP1;UBA1;SF1;PCID2;PKN2;POLR1G;CAST;FUS;BOP1;HSPA9;OTUD4;MRPS30;SART1;CLUH;NUDT5;NAA15;AATF;RBFOX3;DDX23;RPSA;PARK7;ACAA2;POLR2A;PNISR;RDX;GIGYF2;GRB2;IPO5;UBAP2L;CNBP;TOP1;RPN1;BZW1;SYNCRIP;FAM120A;ZNF106;VIRMA;PSTK;SRRM1;UBE2L3;HNRNPUL1;JUN;STAT3;MCRS1;TENT5A;UBTF;CSDE1;MRPS14;BCCIP;NSUN2;DBR1;HNRNPC;FUBP3;ZFP36;CELF4;R3HDM2;DDX31;HNRNPH2;ZBED4;MRPS9;SREK1;PEF1;ZCCHC9;MRPS31;HSPD1;SSBP1;DHX40;HNRNPL;MRPL1;CPNE3;MYO5A;SSRP1;PYM1;RBFOX2;MKRN1;PTCD3;DAP3;FDPS;EIF4G3;HARS2;NPM3;NOL10;DDX6;SRSF3;RBMS1;FYTTD1;VIM;HNRNPUL2;ALKBH8;ALDH6A1;RIDA;SNIP1;AHNAK;RPS11;PTBP2;DDX4;EDF1;NUP42;ZC3H12C;RBMX2;YBX3;SNRNP200;DYNC1H1;SF3B2;ALKBH1;DENR;WDR75;AFF2;DDX50;EXOSC3;RBM25;DHX29;WBP4;TBL3
prerank,cell adhesion mediator activity (GO:0098631),0.3510197848347985,0.8783522677786361,0.6287581699346405,0.9282781153479354,1.0,6/24,10.12%,LRRC4C;NTNG1;CNTN6;CNTN2;DSCAM;PALLD
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.33397708790331193,0.8780519755359192,0.6256281407035176,0.9263548034867538,1.0,5/32,11.77%,SLC1A5;SLC36A2;SLC25A38;SLC43A1;SLC7A8
prerank,protein homodimerization activity (GO:0042803),0.2730010011619074,0.8778111149135774,0.863,0.9242782326393969,1.0,111/590,18.84%,SOX6;TENM2;AADAT;TENM3;PDGFRA;GLIPR2;FAP;PYCARD;KIF20B;KYNU;BCL2;CBS;HM13;PSPH;PTPRT;ACVR1;EPRS1;KMT2A;VEGFA;PDXK;IRAK3;FOXP2;ERCC5;NTRK2;GSS;EXT1;HSPB6;AOC1;NAGA;CADM3;ALS2;ZBTB16;MLXIPL;MLX;SETMAR;MKLN1;CARD9;PNPO;PAFAH1B3;S100A6;LRRFIP1;TBX18;BNIP3;FGFR1;ACOX1;CADM1;RABL3;PDLIM4;FLNA;CEP57;S100A16;RPE;XPA;HIP1;CRYAB;PRDM9;SNX6;ERBB4;ZBTB38;SLK;MYO9B;MID2;GDNF;GLCE;GALM;SP1;MSH6;SFPQ;PHETA2;ZBTB1;NR6A1;GGCT;AHR;SRR;SYNDIG1;EXD2;NACC2;HARS1;NFS1;RAB11FIP3;BMPR1A;SNX1;PDCD6IP;CHMP4C;ABCB9;JUP;FZD9;RCHY1;BLM;FECH;KCNH2;PPCS;RAP1GAP;ALDH1A3;ABCG4;ABCD2;FICD;RIPK1;ACSL6;WRN;GSTZ1;CHUK;TRIM9;CAT;IRF3;PGRMC1;NUDT5;MAP3K11;MID1;PARK7;PEX11A
prerank,RNA polymerase binding (GO:0070063),0.37307498788746807,0.8768882276827065,0.6295774647887324,0.9235220315187048,1.0,8/18,27.45%,BIN1;BRCA1;TCERG1L;PKN2;ZFP36;CCNT2;TCERG1;ANP32B
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.4189368811999444,0.8768683418773301,0.625,0.9210436897008962,1.0,2/10,2.56%,PRDM16;SUV39H1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.3031809607844715,-0.876582745910401,0.6199261992619927,0.851288794499573,1.0,9/16,39.46%,CDO1;ETHE1;ALOX12;BCO2;HGD;ALOXE3;HAAO;ALOX5;PIR
prerank,protein phosphatase 1 binding (GO:0008157),-0.286247574147229,-0.8764360064977934,0.6156351791530945,0.8449905488945482,1.0,5/21,10.93%,PHACTR4;PPP1R16B;PPP1R3B;SH3RF2;PPP1R11
prerank,aminopeptidase activity (GO:0004177),0.3465599797416527,0.8748413379325136,0.6309677419354839,0.9223954410381755,1.0,6/26,10.51%,KDM8;LTA4H;MMP15;TRHDE;LNPEP;MMP16
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.3784600520311043,0.8744380373391667,0.6073968705547653,0.9205624985438682,1.0,3/16,11.44%,PTEN;MTMR14;MTMR12
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.3922723630932059,0.8737111097292241,0.6199095022624435,0.9194367224947383,1.0,3/13,10.53%,PDGFRA;VEGFA;PTPRJ
prerank,carboxypeptidase activity (GO:0004180),0.3317704080305874,0.8727422514583305,0.6475,0.9188593741846144,1.0,6/35,13.51%,NAALAD2;AGBL3;AGBL2;AGBL4;AGBL1;CPD
prerank,3'-5' exonuclease activity (GO:0008408),0.31615273669320687,0.8716134039401595,0.6493349455864571,0.9185609397326474,1.0,10/45,17.24%,USB1;REV3L;XRN2;REXO4;PNLDC1;EXOSC2;EXD2;POLG;PNPT1;WRN
prerank,C-C chemokine binding (GO:0019957),0.356962344546329,0.8675153156283296,0.636734693877551,0.9237846103665615,1.0,4/22,20.38%,CCR2;ACKR3;ACKR4;ZFP36
prerank,MAP kinase activity (GO:0004707),0.38619803663768393,0.8668834692081491,0.6385714285714286,0.922446482949474,1.0,4/14,11.40%,MAPK7;MAPK9;MAPK14;MAPK1
prerank,chemokine receptor activity (GO:0004950),0.35039155708829073,0.8644242638651319,0.6328437917222964,0.9246673509914716,1.0,3/24,14.06%,CCR2;ACKR3;ACKR4
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.3007542800297039,0.8615554276588235,0.7015643802647413,0.9276024557118965,1.0,11/55,18.10%,ANXA9;ATP2B3;PSEN1;SLC8A2;SLC24A5;ANXA6;ATP2B1;TRPC5;PKD1;SLC24A4;SLC24A2
prerank,telomeric DNA binding (GO:0042162),0.32763057620219205,0.860250538921688,0.6946564885496184,0.927512152975222,1.0,14/32,28.35%,UPF3A;STN1;UPF1;XRCC6;BLM;SMG6;TERF2IP;WRN;CTC1;RAD50;ACD;HNRNPA2B1;SMG1;TELO2
prerank,nuclear localization sequence binding (GO:0008139),-0.29969011895605624,-0.8588751128365242,0.6654545454545454,0.874725714790495,1.0,5/18,10.96%,NFKBIA;KPNA4;BRAP;RANBP6;NUP214
prerank,myosin II binding (GO:0045159),0.4094108785258215,0.8565907723772602,0.654320987654321,0.9319503610377164,1.0,4/10,22.41%,GSN;STXBP5;TRIOBP;LLGL1
prerank,phosphatase activity (GO:0016791),0.29326317340555635,0.856486291654944,0.6909090909090909,0.9296699068230012,1.0,20/73,21.08%,ACP5;PTPN22;DUSP4;PSPH;APTX;ACP2;BPNT2;DUSP11;PTPRJ;PLPP4;PPP1CA;PLPPR4;HDHD2;MDP1;MINPP1;DUSP16;NT5C;DUSP12;PLPPR2;PTPMT1
prerank,histone deacetylase binding (GO:0042826),0.2854550291911557,0.8556114787026012,0.7221621621621621,0.9287044487825978,1.0,16/88,16.15%,KAT2B;PRKN;PKN1;MTA2;ANKRA2;HDAC2;SP1;SFPQ;HDAC6;RBBP4;NACC2;LCOR;NCOR2;DACT1;TP53;MTA3
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.37453005206426115,0.8545382195802566,0.6384266263237519,0.9282304220690667,1.0,4/14,19.16%,KCND3;KCNJ3;KCNH2;KCNA5
prerank,neuropeptide receptor binding (GO:0071855),0.38078522856052677,0.8537461229240885,0.6549707602339181,0.9272789574919176,1.0,3/14,25.33%,NMU;NPY;SHANK1
prerank,pre-mRNA binding (GO:0036002),0.3352954439564867,0.8522330332722231,0.6507115135834411,0.927711185197155,1.0,8/28,21.08%,CELF5;TRA2B;RNPC3;RBM7;SRSF6;HNRNPU;CELF4;HNRNPL
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.39123740330886003,0.851734074364204,0.6456808199121523,0.9262392766483679,1.0,2/12,5.98%,PYCARD;APAF1
prerank,cytochrome-c oxidase activity (GO:0004129),-0.31446511490909246,-0.8514187337334929,0.6698412698412698,0.8832963990351753,1.0,5/15,17.38%,COX6B1;COX6A1;COX4I1;COX5B;COX5A
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.3404014759644066,-0.8494076380991042,0.6465256797583081,0.880676274835752,1.0,2/11,13.95%,DDAH2;PADI2
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.35139784719386785,-0.8487217708898505,0.6685393258426966,0.8754539982062572,1.0,2/10,2.53%,CD200;CXADR
prerank,AMP binding (GO:0016208),0.39054574595480934,0.84831734176964,0.6590909090909091,0.9298965681951382,1.0,2/11,2.63%,PYGL;ACSS2
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.30506077209233495,0.847971368623482,0.7095238095238096,0.9281659030402277,1.0,4/48,5.24%,PIEZO2;CALHM6;ATP6V1B2;SLC12A2
prerank,fibroblast growth factor binding (GO:0017134),-0.28086603203874183,-0.8477683729924993,0.6390728476821192,0.8709187052576111,1.0,7/21,15.46%,KL;RPS19;THBS1;RPS2;FGFR2;API5;FGFR4
prerank,nucleoside-triphosphatase activity (GO:0017111),0.26547177415112555,0.8474324004766557,0.8380281690140845,0.9267608196518723,1.0,51/248,19.23%,RHOJ;GNA14;DNM1;KIF20B;RHOD;GNG3;RAB38;RND3;RAP2B;RHOBTB3;RAB14;RALB;ARL1;BMS1;RAB21;RAP1A;CHD3;RABL3;RHOT2;ARL2;DYNC1I1;MRAS;MYO19;GSPT2;GPR88;TBCC;RAB22A;MTG1;RAB1A;RHOH;RHOC;ATL3;ARL8A;RAB3A;GNAI1;ATP2B1;RAB4A;TRIM23;OPA1;GTPBP10;RAP1GAP;ABCG4;ABCD2;RAC3;RAB7A;RHOT1;NRAS;KRAS;RAB3B;KIF2A;RUVBL2
prerank,ribonuclease P RNA binding (GO:0033204),0.404728197271493,0.8439474519295784,0.6450079239302694,0.9305863817395971,1.0,5/10,27.32%,RPP38;POP1;RPP21;RPP30;RPP14
prerank,ubiquitin protein ligase activity (GO:0061630),0.26421227661171365,0.8430052516063896,0.8054711246200608,0.9299200055430358,1.0,44/228,18.13%,PDZRN3;RNF157;CBLB;PRKN;DTX4;HACE1;NFX1;TRIM44;RNF6;ZNRF2;NEURL4;TRIM2;TRIM11;PELI1;UBE2K;RNFT1;VPS11;FBXO27;NEURL1B;CUL3;UHRF2;HUWE1;CBL;TRIM41;RNF121;FBXO17;MEX3C;MYLIP;RNF24;NEDD4L;AREL1;NEURL3;UBE2O;RNF19A;RCHY1;UBOX5;XIAP;RNF111;KCMF1;RNF10;RC3H1;RNF167;TRIM9;MDM2
prerank,GDP binding (GO:0019003),0.29131286043000226,0.8426396024673376,0.7031963470319634,0.9281558412369063,1.0,16/63,18.87%,RASEF;RAP2B;RAB14;ARL3;RALB;RAB21;RAP1A;MRAS;RAB22A;GNAI1;RAB4A;TRIM23;RAB7A;NRAS;KRAS;RAB3B
prerank,metallocarboxypeptidase activity (GO:0004181),0.3387701667395464,0.8425483580738257,0.6967741935483871,0.9259597713973371,1.0,5/26,13.51%,AGBL3;AGBL2;AGBL4;AGBL1;CPD
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.30883271484617314,-0.8425241946784372,0.6527331189710611,0.8747739182308247,1.0,6/14,27.51%,SDHB;CIAO3;ACO1;ACO2;RSAD2;EXO5
prerank,tRNA methyltransferase activity (GO:0008175),-0.29096987422074816,-0.8417409656600743,0.7287066246056783,0.8697321928093991,1.0,4/16,8.47%,TRMT9B;FTSJ1;METTL2B;METTL2A
prerank,ATP binding (GO:0005524),0.26385832245292623,0.8411690871962002,0.8483316481294236,0.9260016333997773,1.0,54/266,18.29%,WNK2;PYGL;PEAK1;STK36;ACVR1;MAP4K4;RHOBTB3;PDXK;IRAK3;WNK3;SIK2;RPS6KA4;MAST2;GSS;UBA2;KSR1;CDKL5;PDK3;SARS2;CDK6;TBCK;ACLY;TLK2;AKT3;LANCL2;SYN1;EIF4G1;MYO9B;PXK;HSPA4;PI4K2A;MSH6;DDX25;SRR;PNPLA8;P2RY1;HARS1;AK6;RTEL1;BMPR1A;ABCB9;ABL1;PAPOLA;BLM;OLA1;NDUFA13;HNRNPU;ABCD2;FICD;ABCF1;EIF2B2;SMC4;HSPA9;PEX1
prerank,calcium-activated potassium channel activity (GO:0015269),0.3892133107195739,0.8402014568787859,0.6584992343032159,0.9253206500494665,1.0,3/11,17.39%,KCNMB2;KCNMB3;KCNMA1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.36460278898965415,0.8400358648284424,0.6822695035460993,0.9232293095674364,1.0,5/17,23.17%,DTYMK;AK3;AK5;AK8;CMPK1
prerank,phosphatidylinositol binding (GO:0035091),0.2769808485132195,0.8375105807293103,0.7298787210584344,0.9250487260638656,1.0,14/91,12.36%,RAG2;SESTD1;DPEP1;PITPNB;NCF1;WDFY3;SH3YL1;RPH3A;HIP1;DENND1C;PASK;SNX10;MREG;ZFYVE9
prerank,phospholipase activator activity (GO:0016004),0.4048699001156124,0.8369897115855016,0.6739811912225705,0.9235876231665335,1.0,1/10,8.06%,FYN
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.39963659856231676,0.8356102667168794,0.6481481481481481,0.9236574970460812,1.0,5/10,21.55%,RPE;GLCE;GALM;GNE;DSEL
prerank,miRNA binding (GO:0035198),-0.2475189994535226,-0.8331582450533652,0.7346938775510204,0.8795404002487182,1.0,7/30,12.43%,YBX1;AGO1;ZC3H7B;DDX21;ELAVL1;TUT7;AGO3
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3507377057233645,0.8314793242648091,0.6892430278884463,0.9283366302439585,1.0,6/21,17.26%,POLN;POLE2;REV3L;POLE3;POLG;REV1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.37558175529906446,0.8292646908668279,0.6789940828402367,0.929700566550029,1.0,4/12,14.61%,ACVR1;TGFBR2;LTBP1;BMPR1A
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.28384412856195074,0.8289475903861775,0.7438202247191011,0.927883668028682,1.0,15/75,19.48%,HSD17B7;HSD17B11;H6PD;AKR1B10;HADHA;PHGDH;RDH10;DHRS3;HIBADH;CBR3;KCNAB2;UGDH;ADH5;EHHADH;LDHB
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.37933829601215885,0.8247414487988982,0.6937869822485208,0.9324106176403116,1.0,6/12,27.54%,GTF2B;TAF1;RUVBL2;TBP;HDAC1;RELA
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.33135455405970166,0.8243613354988598,0.6767015706806283,0.9307273963613132,1.0,4/25,14.24%,POR;SQLE;MTRR;CYP27A1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.2623018559178107,-0.8222942153344606,0.7593984962406015,0.8933389493233714,1.0,6/24,15.14%,ZDHHC14;ZDHHC3;ZDHHC18;ZDHHC7;ZDHHC20;ZDHHC4
prerank,store-operated calcium channel activity (GO:0015279),-0.3409005814822941,-0.8219209578278482,0.717948717948718,0.8875707831602861,1.0,5/10,25.36%,TRPC6;ORAI2;TRPC3;TRPC7;ORAI3
prerank,translation initiation factor activity (GO:0003743),0.30926497035625516,0.8205815546012232,0.7268106734434562,0.9346438259938966,1.0,8/36,17.18%,EIF1B;EIF3C;EIF2B5;EIF3M;EIF4G1;EIF1;EIF4A2;EIF2B2
prerank,exonuclease activity (GO:0004527),0.29514659615592176,0.8203937960150843,0.7120853080568721,0.9326821740697545,1.0,10/46,17.24%,DXO;REV3L;XRN2;EXOSC8;REXO4;EXOSC2;EXD2;AEN;POLG;WRN
prerank,SH2 domain binding (GO:0042169),0.3111958441832493,0.8203912261158265,0.7193675889328063,0.9303954932711923,1.0,1/31,0.33%,DLC1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.3254561312112641,-0.8203693406832571,0.6842105263157895,0.8842736416141205,1.0,5/11,18.07%,MAP3K5;MAP3K20;MAP3K7;MAP3K1;TAOK2
prerank,E-box binding (GO:0070888),0.30936532941423417,0.8195293366536603,0.7196029776674938,0.9295634240994817,1.0,9/34,22.53%,MYC;ZEB1;PER1;GATA3;AHR;SREBF2;PPARG;MITF;SNAI1
prerank,adenylyltransferase activity (GO:0070566),-0.27394708005617546,-0.8187437995418202,0.7298387096774194,0.881100912373204,1.0,8/21,19.33%,NMNAT2;MTPAP;NMNAT1;OAS2;KARS1;FLAD1;TENT4A;TENT4B
prerank,ubiquitin-protein transferase activity (GO:0004842),0.25333282293929,0.8168967582946962,0.891566265060241,0.9316029265170687,1.0,90/346,23.51%,UBE2T;PDZRN3;RNF157;CBLB;PRKN;DTX4;UBE2E2;HACE1;NFX1;TRIM44;RNF6;KLHL13;FBXO7;ZNRF2;DDB2;NEURL4;TRIM2;HECTD3;TRIM11;PELI1;BRCA1;UBE2K;RNFT1;VPS11;FBXO27;NEURL1B;CUL3;UHRF2;UBE2Z;HUWE1;CBL;RSPRY1;UBE2J2;TSPAN17;TRIM41;RNF121;FBXO17;MEX3C;MYLIP;AKTIP;MALT1;RNF24;TRIM23;NEDD4L;TRAF7;AREL1;NEURL3;UBE2O;RNF19A;RCHY1;CDC23;XIAP;RNF111;UBE2Q1;RNF182;MIB1;KCMF1;CUL4B;RNF10;RC3H1;RNF167;TRIM9;FBXO22;MDM2;ANKRD39;RNF4;TAF1;FBXO11;BCOR;UBE2L3;TRAIP;TRIM35;UBE2G1;RNF13;UBE2E1;ANAPC4;MKRN1;RNF114;UBE2D3;RNFT2;TTC3;UBR3;FBXO44;RNF123;SIAH1;PJA2;RNF187;COP1;UBE3C;RNF2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.37188906512725317,0.8149612483679309,0.727540500736377,0.9323158155074678,1.0,2/13,4.40%,TRMT10B;THUMPD3
prerank,acylglycerol lipase activity (GO:0047372),-0.3210070274628955,-0.8112780484072556,0.717391304347826,0.8885913046074807,1.0,5/11,25.43%,MGLL;ABHD2;ABHD12;FAAH;LIPE
prerank,lipase activator activity (GO:0060229),0.39126217250194417,0.8091416448742345,0.6913183279742765,0.939426835144362,1.0,1/10,8.06%,FYN
prerank,diacylglycerol kinase activity (GO:0004143),0.37319930378318134,0.8088034350809901,0.6942771084337349,0.9377325278530472,1.0,7/11,28.51%,DGKI;AGK;DGKA;DGKK;DGKD;DGKZ;DGKQ
prerank,exoribonuclease activity (GO:0004532),0.372734696864471,0.8071272356826936,0.7031963470319634,0.9381246909603599,1.0,2/12,10.32%,EXOSC8;EXOSC2
prerank,transition metal ion binding (GO:0046914),0.25123594255207377,0.8052865437706591,0.924924924924925,0.9387060755446199,1.0,73/397,19.03%,RAG2;GLI2;CSRP1;DHH;DPEP1;CBLB;PRKN;CUTA;EPRS1;KMT2A;SEC24D;PDXK;KDM5B;ITGB1BP2;PRNP;MT3;MBD1;GRIN2B;HHIP;LTA4H;ZEB1;AOC1;AGMO;LOXL3;TRIM2;GALNT1;RPH3A;CHD3;GTF2B;SCD5;TRHDE;SEC24C;PTPN1;LNPEP;MMP16;USP33;MYT1;RBAK;GPC1;SIRT6;PHF8;SOD2;ZFPM2;KPNB1;HPF1;EXD2;SNCA;MDM4;ADAM33;GRIN2A;TRAF7;BAZ1B;GALNT3;PAPPA2;ABL1;RCHY1;PAPOLA;BLM;TP53;TET3;RBSN;RC3H1;WRN;ADH5;SEC24A;PCK2;MDM2;KLF7;ZMYND11;SNCB;PARK7;TAB3;EGR1
prerank,adenyl ribonucleotide binding (GO:0032559),0.2519411819717561,0.8044844070344321,0.89738430583501,0.9376846003918011,1.0,54/291,17.18%,WNK2;PYGL;PEAK1;STK36;ACSS2;ACVR1;MAP4K4;RHOBTB3;PDXK;IRAK3;WNK3;SIK2;RPS6KA4;MAST2;PDE4B;GSS;UBA2;KSR1;CDKL5;PDK3;SARS2;CDK6;TBCK;ACLY;TLK2;AKT3;LANCL2;SYN1;EIF4G1;MYO9B;PXK;HSPA4;PI4K2A;MSH6;DDX25;PDE4D;SRR;PNPLA8;P2RY1;HARS1;AK6;RTEL1;BMPR1A;ABCB9;ABL1;PAPOLA;BLM;OLA1;NDUFA13;HNRNPU;ABCD2;FICD;ABCF1;EIF2B2
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.3716198323226799,0.8040649504234672,0.7039764359351989,0.9361191127342712,1.0,5/11,20.90%,NUDT1;NUDT10;NUDT3;NUDT5;NUDT11
prerank,motor activity (GO:0003774),0.2800989566214629,0.80385162875083,0.7808056872037915,0.9342008655951898,1.0,13/60,19.15%,DNAH2;KIF20B;KIF19;STARD9;KIF21A;DYNC1I1;KIF5C;GPR88;DYNC1I2;KIF22;KIF21B;KIF3A;KIF2A
prerank,5'-3' exonuclease activity (GO:0008409),0.3606630009220333,0.8025095245266579,0.6920684292379471,0.9339834005869195,1.0,2/14,6.69%,DXO;XRN2
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.3511962610671391,0.8005284557083007,0.7008928571428571,0.9347207117039026,1.0,2/15,14.06%,CCR2;ACKR4
prerank,nuclear export signal receptor activity (GO:0005049),0.37594925847352983,0.7998786106970827,0.7216174183514774,0.9335325001747358,1.0,5/11,23.25%,XPO1;EIF4ENIF1;CSE1L;NUP42;XPO5
prerank,DNA polymerase activity (GO:0034061),0.33288096573858506,0.799776188767028,0.7453825857519789,0.9314673371096146,1.0,6/22,17.26%,POLN;POLE2;REV3L;POLE3;POLG;REV1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.32003564554584707,0.7996773353394181,0.7363387978142076,0.9294000949058508,1.0,3/26,8.60%,B3GNT9;CSGALNACT1;CHSY1
prerank,proton transmembrane transporter activity (GO:0015078),0.29774140418229655,0.7991593090153244,0.7422552664188352,0.9280576775997386,1.0,8/39,18.79%,CLCN5;ATP6V1B2;UQCRQ;NDUFA4;COX10;DMAC2L;SLC9A1;CYB5A
prerank,hormone receptor binding (GO:0051427),0.3592882883638504,0.7960783266714245,0.7068452380952381,0.9306687172276629,1.0,3/14,17.11%,PTHLH;TYK2;NPPC
prerank,calcium channel regulator activity (GO:0005246),0.2921243598574905,0.7941448679497348,0.7572692793931732,0.9313751395971814,1.0,9/37,20.88%,CACNG7;NRXN1;SGK3;CALM1;CALM2;SGK1;STIMATE;NPY;STIM2
prerank,regulatory RNA binding (GO:0061980),-0.2231479011482317,-0.7939117168467281,0.8214285714285714,0.9125761903359736,1.0,15/38,30.18%,YBX1;AGO1;ZC3H7B;DDX21;ELAVL1;TUT7;AGO3;MATR3;TARBP2;HNRNPA1;ZC3H10;AGO2;DICER1;PIWIL2;AGO4
prerank,cholesterol transfer activity (GO:0120020),0.3418799115342882,0.7938842063358098,0.7186147186147186,0.9296120008069214,1.0,4/16,13.09%,GRAMD1A;MTTP;GRAMD1C;GRAMD1B
prerank,amino acid:sodium symporter activity (GO:0005283),0.36789483799980327,0.7927911949308525,0.7231726283048211,0.9290650721085414,1.0,1/11,1.03%,SLC1A3
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3136891915370623,0.7923783804727063,0.7344559585492227,0.9274676733635042,1.0,11/27,26.13%,POLR2B;POLRMT;POLR1B;POLR2G;MED21;POLR1D;POLR1C;POLR2A;POLR3K;POLR2F;POLR3F
prerank,carboxy-lyase activity (GO:0016831),-0.25437805647325523,-0.7891505754425585,0.7961538461538461,0.9142493104835938,1.0,7/23,20.15%,ECHDC1;AZIN1;AMD1;DDC;ODC1;PPCDC;BCKDHA
prerank,organic anion transmembrane transporter activity (GO:0008514),0.2553633565108932,0.7859195486615833,0.8596673596673596,0.9350387024117585,1.0,19/134,14.66%,SLC22A3;SLC1A3;SLC27A1;SLC25A2;SLC1A5;MPC1;SLC25A21;SLC36A2;SLCO2B1;SLC25A38;MPC2;SLC2A2;SLC35A1;SLC7A8;SLC25A23;SLC16A1;SLC35B3;SLC25A15;SLC25A25
prerank,glutathione transferase activity (GO:0004364),-0.2539647407428436,-0.7849890030323362,0.8091286307053942,0.9145471732788827,1.0,5/23,13.58%,LANCL1;GSTA4;GSTM1;HPGDS;MGST1
prerank,ferrous iron binding (GO:0008198),-0.25745407108526086,-0.7849595203177296,0.8057553956834532,0.9083240526099036,1.0,9/21,21.72%,PHYH;FTH1;EGLN2;FTL;CDO1;ALKBH3;FXN;EGLN3;DNAJC24
prerank,magnesium ion binding (GO:0000287),0.2532447375729643,0.784935078682698,0.8646694214876033,0.9342710144866103,1.0,22/135,15.65%,IDH2;PSPH;PDXK;IRAK3;SIK2;MAST2;DXO;GSS;PGM1;UBA2;ENDOV;PI4K2A;MSH6;NUDT3;GNAI1;SRR;EXD2;SNCA;IDH3A;OPA1;ABL1;PAPOLA
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.24968438295406647,0.7845277208774516,0.8772819472616633,0.9326354754664393,1.0,38/181,20.31%,MDFIC;NCOA1;PTPRT;TACC1;MTA2;BBS5;NCOA2;LDB2;HIF1A;PIAS2;HDAC2;ATF2;NFE2L2;MAPK14;SP1;NRIP1;ZFPM2;CRY1;NCOR2;DACT1;JUP;TAF4;TP53;TAF4B;MTA3;SMARCE1;NCOA3;DNAJA1;TACC2;TAF1;CPNE1;BCL10;PRRX1;PPARG;JUN;STAT3;SMARCA4;BBS7
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.35802436099136264,0.783546096790885,0.7681818181818182,0.9318931334081614,1.0,4/14,23.17%,DTYMK;AK5;AK8;CMPK1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.3151181273843242,-0.7798288370940661,0.7107438016528925,0.9106486892628138,1.0,2/10,9.83%,OTUD5;STAMBPL1
prerank,vinculin binding (GO:0017166),0.36642874430462,0.7796950531359688,0.7480680061823802,0.9353986409850856,1.0,1/11,1.32%,UTRN
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.34675364205327974,0.77735052530421,0.7572674418604651,0.9365664416269895,1.0,2/14,5.98%,PYCARD;APAF1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.3023517910604043,0.7771035295917156,0.7536231884057971,0.9347864043208395,1.0,10/28,27.32%,ELAC1;ENDOV;RPP38;PRORP;POP1;RPP21;DBR1;RPP30;DROSHA;RPP14
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.35365722354755996,0.774517723031888,0.744807121661721,0.9362879290015508,1.0,1/12,2.07%,NQO1
prerank,ribosome binding (GO:0043022),0.27809211979717025,0.7741589680291074,0.807185628742515,0.9346748142574923,1.0,11/46,18.60%,ETF1;NAA16;EIF3C;CPEB3;EIF6;GTPBP6;CCDC47;CPEB1;NAA10;NAA15;RPSA
prerank,hexosyltransferase activity (GO:0016758),0.2547925031411421,0.7738995604113561,0.8342303552206674,0.9328701284074914,1.0,21/101,20.63%,HAS2;TMTC2;GBA2;EXT1;ALG9;B3GNT9;CSGALNACT1;CHSY1;POMGNT2;ALG5;TMTC3;RFNG;ALG1;DPY19L2;HYAL1;MTAP;POGLUT2;CHSY3;DPY19L3;ALG6;B4GALT6
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.3401380492238689,0.7737966112148196,0.7492537313432835,0.9308843062839579,1.0,3/15,10.37%,SOCS5;SOCS1;PIK3R1
prerank,U6 snRNA binding (GO:0017070),-0.2888360121682994,-0.7720526056949429,0.7692307692307693,0.9162773753996039,1.0,5/14,23.15%,PRPF4;LARP7;EIF5A;SART3;RBM22
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.3535027134374449,0.7715817217695604,0.744776119402985,0.9318370283675016,1.0,2/11,8.53%,PPP1R14C;PPP1R8
prerank,protein kinase regulator activity (GO:0019887),0.2545701362624387,0.769288176329583,0.8364030335861322,0.9329148810494564,1.0,8/95,5.68%,CXCL10;FGF13;CCNJ;CCNC;GPRC5B;MT3;PRKAR1B;SOCS1
prerank,phosphatidate phosphatase activity (GO:0008195),-0.2936456083216237,-0.7650285030246162,0.7958579881656804,0.9207016575863076,1.0,3/13,9.59%,PLPP1;LPIN2;PLPP5
prerank,amino acid binding (GO:0016597),-0.21828526888298916,-0.7639698865430787,0.8604651162790697,0.9160631704994945,1.0,11/31,24.12%,NOS3;AARS1;DDAH2;NOS1;ASS1;GCLC;GLRA2;GRIN3A;GRM7;AGXT;CASTOR1
prerank,dynactin binding (GO:0034452),0.34931189744410585,0.7601749784166895,0.7789317507418397,0.9432328829774631,1.0,3/12,10.80%,BICD1;SNX6;BICD2
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.34423018638216357,0.7591529613529494,0.7808641975308642,0.9424782694102631,1.0,2/12,10.37%,GAB2;PIK3R1
prerank,Notch binding (GO:0005112),-0.2404634795373965,-0.7567422018843936,0.8396946564885496,0.9199491196660915,1.0,8/22,21.27%,SNW1;JAG1;JAG2;NOTCH4;KCTD10;DTX1;DNER;TCIM
prerank,GABA receptor activity (GO:0016917),-0.25140861768451145,-0.7528089738320273,0.8191881918819188,0.9194165831084882,1.0,7/21,28.63%,GPR156;GABRG1;GABRA5;GABRB1;GABRE;GABRB2;GABBR2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.2841082502738376,0.7505753038914024,0.7809278350515464,0.9519071686350729,1.0,6/32,12.16%,KDM8;KDM4B;P4HTM;ALKBH5;HSPBAP1;PHF8
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.2827638171815696,0.7498966359505368,0.8101910828025478,0.9506368068799542,1.0,9/34,20.29%,SUV39H1;SETD3;MEN1;PRDM9;SETD2;SETD4;KMT2E;N6AMT1;SETDB1
prerank,calcium:sodium antiporter activity (GO:0005432),-0.3163730336452224,-0.749231508601082,0.7932011331444759,0.9183576008851368,1.0,3/10,10.26%,SLC8A3;SLC8B1;SLC24A3
prerank,ligand-gated calcium channel activity (GO:0099604),-0.2479955386324369,-0.7468679243891739,0.8413284132841329,0.9154058685344573,1.0,3/19,9.86%,ITPR1;RASA3;MCOLN1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.33297642590267673,0.7459798430380183,0.7792397660818714,0.9536882148677214,1.0,1/14,1.03%,SLC1A3
prerank,water transmembrane transporter activity (GO:0005372),0.3526890958284963,0.7416282738049944,0.7966616084977238,0.9573578169064367,1.0,1/11,5.26%,AQP4
prerank,phosphatase activator activity (GO:0019211),0.32523315555783144,0.7356480833903071,0.7581602373887241,0.9628419853824932,1.0,7/14,26.57%,PPP1R15A;CALM1;CALM2;BMP2;PPP2R5A;PPP2R5E;PPP2R5C
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.29229663413853196,0.7354802970411438,0.7932489451476793,0.9608894037432523,1.0,2/22,5.18%,DUSP4;DUSP6
prerank,death domain binding (GO:0070513),0.34962840905373577,0.7351917388420548,0.7752293577981652,0.95911910129606,1.0,3/11,17.21%,BCL2;CRADD;RIPK1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.25622887985495324,0.7329786767946822,0.8563084112149533,0.9597883373466175,1.0,7/60,8.41%,PTEN;DUSP4;LRRC40;PPP3CB;PPP3CA;PPM1B;PPM1J
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.2788627131428606,0.7316905259770545,0.8249370277078085,0.9592625082912337,1.0,10/34,19.41%,CKS1B;CAB39L;ALS2;CDK5R1;CALM1;CDK5R2;IQGAP1;CALM2;DBF4;CAB39
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.3088312207324871,-0.7298319198205562,0.8221024258760108,0.931164571125703,1.0,4/10,12.95%,ECHDC1;ECHDC2;ECHDC3;ECI1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.270579864824678,-0.7293452836888366,0.8606811145510835,0.9257442360354524,1.0,8/13,35.04%,DNASE1L1;DNA2;DICER1;GEN1;ZGRF1;DNASE1L2;EXO1;FAN1
prerank,protein kinase activator activity (GO:0030295),0.25457066131610245,0.728985895055839,0.8653624856156502,0.960591747607018,1.0,14/60,19.41%,ERBB3;FGF13;GPRC5B;MT3;CAB39L;ALS2;GRM5;CDK5R1;CALM1;IQGAP1;CALM2;RPTOR;DBF4;CAB39
prerank,mRNA methyltransferase activity (GO:0008174),0.33287413330357607,0.7255383618887573,0.7876106194690266,0.962755634469803,1.0,4/12,20.16%,METTL3;RNMT;CMTR2;NSUN2
prerank,alpha-actinin binding (GO:0051393),-0.22660520879360999,-0.7248493496707683,0.8423423423423423,0.9252804969056864,1.0,2/24,0.90%,CACNA1C;PDLIM5
prerank,DNA polymerase binding (GO:0070182),0.30575605156265856,0.7200977407864274,0.8089260808926081,0.9673489357561537,1.0,8/18,27.58%,RTEL1;POLG2;SMG6;FANCI;SMARCA4;ACD;NABP2;LONP1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.34198815557536727,0.7191805045575297,0.8015625,0.9662949921258889,1.0,4/10,18.50%,CASP6;CASP12;CASP2;CASP7
prerank,thioesterase binding (GO:0031996),0.3311854177235699,0.7173786975572296,0.7996965098634294,0.9663261017545042,1.0,1/11,4.68%,TRAF4
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.21748161066426416,-0.717366136334919,0.8977777777777778,0.9277517137118191,1.0,9/27,25.31%,DCUN1D3;RNF144B;DCUN1D1;AUP1;SIAH2;SIAH3;RNF125;ANKIB1;ZMYM2
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.3399874450721909,0.7140725088258608,0.815668202764977,0.9679971593664225,1.0,11/11,66.02%,HCN1;HCN2;KCNA10;CNGA1;CNGA3;CNGA4;CNGA2;AQP1;CNGB3;HCN4;CNGB1
prerank,P-type ion transporter activity (GO:0015662),0.32438829508224937,0.7133369107422082,0.8173913043478261,0.9667326725968547,1.0,2/12,12.92%,ATP2B3;ATP2B1
prerank,retinoic acid receptor binding (GO:0042974),0.30576204506048366,0.7117436336481143,0.8386167146974063,0.9665557871396712,1.0,6/17,21.43%,TACC1;RARG;NRIP1;MED25;PPARG;NSD1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.32692955158977677,0.708607437657351,0.8204747774480712,0.968076428899139,1.0,6/12,23.42%,PAPOLA;TENT2;TENT5D;TENT5A;TENT5C;TUT1
prerank,MAP kinase kinase activity (GO:0004708),0.31540851485158294,0.7043787974745602,0.8345642540620384,0.9707481171827529,1.0,3/15,11.13%,MAPKAPK3;MAPK14;MAP2K4
prerank,palmitoyltransferase activity (GO:0016409),-0.20923248250350143,-0.697376513643626,0.9330708661417323,0.9430676215911,1.0,6/28,15.14%,ZDHHC14;ZDHHC3;ZDHHC18;ZDHHC7;ZDHHC20;ZDHHC4
prerank,carboxylic acid binding (GO:0031406),-0.19065849104432508,-0.6962576522061237,0.9344262295081968,0.9384237434115604,1.0,10/38,24.12%,NOS3;EPDR1;PHYH;SESN2;NOS1;GCLC;GLRA2;GRIN3A;GRM7;CASTOR1
prerank,rRNA binding (GO:0019843),0.2547902334246418,0.6962009976521979,0.8880597014925373,0.9779033176727091,1.0,4/42,6.29%,TST;MRPS18A;NGRN;MRPL16
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.2591532631858806,0.695359538779988,0.8949880668257757,0.9767131304022487,1.0,2/38,8.22%,A2M;SERPINE2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.28298603316366433,0.6922782912782223,0.8342391304347826,0.9778822303212006,1.0,7/22,22.71%,ZRANB3;OTUD7B;ZBTB1;OTUD7A;TAB3;WDR81;TAB2
prerank,mannosyltransferase activity (GO:0000030),0.2863544849745771,0.6879050840782527,0.8456284153005464,0.9806260019737574,1.0,8/21,19.08%,TMTC2;ALG9;TMTC3;ALG1;DPY19L2;ALG8;DPM1;DPY19L3
prerank,peptidoglycan binding (GO:0042834),-0.28021577244329826,-0.6844182634429431,0.855191256830601,0.9439817796116518,1.0,6/10,41.58%,PGLYRP1;NOD1;NOD2;JCHAIN;NLRP3;TLR2
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.31411875026349634,0.6835872968432769,0.8411497730711044,0.9830792204531289,1.0,1/11,6.69%,AKR1B10
prerank,ATP hydrolysis activity (GO:0140603),0.24957672074590848,0.6793607360333098,0.8970223325062034,0.9854855742018895,1.0,13/41,25.22%,KIF20B;RHOBTB3;CHD3;MYO19;ATP2B1;ABCG4;ABCD2;RUVBL2;DDX4;CHD1L;HSPA1A;MYO18A;SMCHD1
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.2882262178873903,0.6787800206250121,0.8733624454148472,0.9839972110999384,1.0,3/18,10.37%,SOCS5;SOCS1;PIK3R1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.23008960068493617,0.6784344140307565,0.9060402684563759,0.9822488132326019,1.0,10/70,18.14%,HAS2;EXT1;B3GNT9;CSGALNACT1;CHSY1;POMGNT2;RFNG;HYAL1;POGLUT2;CHSY3
prerank,channel activity (GO:0015267),0.24667333182773066,0.6721478929227669,0.8933333333333333,0.9864363027078329,1.0,2/41,5.26%,BCL2;AQP4
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.30351224224049933,0.6720229684164285,0.8524096385542169,0.9844546130218024,1.0,7/13,27.61%,GABRG2;GABRA3;GLRB;GABRA2;GABRG3;GABRA4;GLRA3
prerank,pseudouridine synthase activity (GO:0009982),0.30033411951492717,0.6693846092782344,0.8624420401854714,0.985003162049516,1.0,3/13,15.71%,PUSL1;PUS7;PUS1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3213481476093536,0.6687833250459524,0.8771653543307086,0.9835315167274427,1.0,3/10,18.52%,NAA16;NAA10;NAA15
prerank,inward rectifier potassium channel activity (GO:0005242),0.2679698706526606,0.6684749195757701,0.8713692946058091,0.9817940693982098,1.0,7/24,25.24%,KCNK1;KCNJ3;KCNJ10;KCNH2;KCNK6;KCNJ13;KCNN2
prerank,DNA-binding transcription factor binding (GO:0140297),0.21035648788286604,0.6649892488733279,0.9663608562691132,0.983154823341092,1.0,32/189,20.31%,PRDM16;MYC;BCL2;CRTC1;TLE1;YWHAZ;MTA2;BBS5;LDB2;PIAS2;HDAC2;ATF2;NFE2L2;SP1;TAF9;ZFPM2;CREM;DACT1;TP53;MTA3;TLE3;CTBP1;TLE4;PSMD9;PARK7;TAF1;CGGBP1;PRRX1;PPARG;JUN;STAT3;BBS7
prerank,MHC class II protein complex binding (GO:0023026),0.3094263906922471,0.6635806998771335,0.8599695585996956,0.9824269951473998,1.0,3/11,18.22%,ANXA11;CD74;MS4A1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.25332374131168256,0.6633591366509687,0.9121447028423773,0.9805791414090592,1.0,6/34,16.29%,USB1;XRN2;PNLDC1;EXOSC2;EXD2;PNPT1
prerank,actinin binding (GO:0042805),0.27495029241472196,0.6632492635669953,0.876010781671159,0.9786511850346484,1.0,7/21,21.49%,CSRP1;PDLIM4;MAGI1;KCNA5;PPARG;NFKB1;PKD2
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.2586041829964441,-0.6611002207964516,0.890625,0.9582749420995252,1.0,5/12,24.31%,GABRG1;GABRA5;GABRB1;GABRE;GABRB2
prerank,tRNA binding (GO:0000049),0.24279815199679436,0.6607045402108145,0.9334140435835351,0.9789221404656606,1.0,15/43,25.19%,TRMT10B;SARS2;FARS2;DALRD3;ELP5;XPOT;PUS1;SSB;PSTK;NSUN2;ALKBH8;ALKBH1;DARS2;PTCD1;CARS1
prerank,kinesin binding (GO:0019894),0.25925210993401115,0.6590830891821255,0.9131016042780749,0.9783965638377136,1.0,6/27,17.58%,ARHGEF10;AP1G1;SNCA;CLSTN1;SPAG9;AP1AR
prerank,methyltransferase activity (GO:0008168),0.23991258541897223,0.658955318956835,0.9220462850182704,0.9764747458949568,1.0,11/46,20.16%,SUV39H1;COMT;METTL3;AS3MT;PRMT1;COQ5;LRTOMT;MEPCE;AMT;N6AMT1;NSUN2
prerank,RNA cap binding (GO:0000339),-0.22913428106714848,-0.6567927707493051,0.9341692789968652,0.9559556857261207,1.0,4/16,21.08%,LSM1;NCBP3;EIF3D;EIF4E3
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.30797656520714406,0.6558152805950351,0.886676875957121,0.9772814373847868,1.0,5/11,27.25%,NAA16;NAA10;NAA15;NAA40;NAA50
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.25607909912537347,0.6531065693438348,0.8875816993464052,0.9776833499049664,1.0,2/29,3.13%,SLC1A5;SLC25A21
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.2521254860162253,0.6508235763200675,0.9102402022756005,0.9776664669208341,1.0,7/29,17.88%,GBA2;GALC;CTBS;GANC;MOGS;PGGHG;ABHD10
prerank,hormone activity (GO:0005179),0.22804295914123723,0.6462011018111484,0.9294117647058824,0.9796465600953365,1.0,2/54,3.66%,CRH;PTHLH
prerank,signaling receptor complex adaptor activity (GO:0030159),0.23926173073188053,0.6449321013290507,0.9337423312883436,0.9787372814641948,1.0,7/38,14.56%,SAV1;GAB2;PIK3R1;PTPN11;MAGI2;NCK1;SPAG9
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.23205820968590632,0.6364149238778506,0.932285368802902,0.9838697293845056,1.0,7/46,14.03%,EXT1;B3GNT9;MGAT3;PIGP;POMGNT2;PIGA;RFNG
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.2938636341641791,0.6361844757750085,0.8748114630467572,0.9820482036415017,1.0,1/12,6.46%,B3GNT9
prerank,nuclease activity (GO:0004518),0.2268228724316669,0.635129724593966,0.9445114595898673,0.9809024903719102,1.0,8/52,17.24%,RNASE6;ERCC5;SETMAR;XRN2;REXO4;AEN;N4BP1;WRN
prerank,ligand-gated anion channel activity (GO:0099095),-0.2198718896098657,-0.6348094759542635,0.9438943894389439,0.9661054538168244,1.0,6/17,24.31%,GABRG1;GABRA5;GLRA2;GABRB1;GABRE;GABRB2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.2718632032682925,0.6305778640419437,0.9104046242774566,0.9826661270690618,1.0,3/16,16.03%,SLC1A5;SLC25A10;SLC25A11
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.3006185319955496,0.6292407742076535,0.8963893249607535,0.9816093129321244,1.0,5/10,26.55%,GABRG2;GABRA3;GABRA2;GABRG3;GABRA4
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.2389436230956744,0.6273438370720237,0.9312581063553826,0.9810057543100895,1.0,6/33,16.29%,USB1;XRN2;PNLDC1;EXOSC2;EXD2;PNPT1
prerank,death receptor activity (GO:0005035),0.2854070862506981,0.623449128079318,0.9106317411402157,0.9817995028786424,1.0,2/11,10.58%,TNFRSF10B;NGFR
prerank,kinase inhibitor activity (GO:0019210),0.23666613601036146,0.6232177568607711,0.9380530973451328,0.9800022151890454,1.0,5/33,14.00%,SOCS1;TAOK3;RHOH;SNCA;NCK1
prerank,signal sequence binding (GO:0005048),0.23152533823774962,0.6138745472094894,0.9504950495049505,0.984679809952872,1.0,14/35,25.99%,TOMM20;KDELR2;KPNB1;KPNA6;KDELR3;KPNA1;POM121;CAT;IPO5;KPNA3;PEX5L;CEMIP;TNPO2;SEC61A2
prerank,protein kinase inhibitor activity (GO:0004860),0.22193597035265886,0.6137429567880363,0.9524390243902439,0.9827811852359178,1.0,8/42,18.44%,SOCS1;SPRED2;SPRED1;TAOK3;SNCA;NCK1;RPTOR;INKA1
prerank,mannose binding (GO:0005537),-0.2385105088426272,-0.6120634583499664,0.9395770392749244,0.9744312058484198,1.0,9/12,55.05%,CLN5;ACR;COLEC11;LMAN1L;CLEC4D;LMAN2L;LMAN2;CLEC6A;CD207
prerank,cAMP binding (GO:0030552),0.28437946098931677,0.6099550222767672,0.9107142857142857,0.9833035458250081,1.0,4/11,21.62%,PDE4B;PDE4D;HCN1;PDE10A
prerank,N-methyltransferase activity (GO:0008170),0.2522275822024769,0.6036222533335268,0.9340659340659341,0.9855719997252346,1.0,5/20,19.52%,SETD3;FDXACB1;PRMT1;RNMT;N6AMT1
prerank,single-stranded RNA binding (GO:0003727),0.21677209078489032,0.600931687546212,0.9647630619684082,0.9853034814225002,1.0,7/43,16.44%,DDX11;ADARB2;ENDOV;POLR2G;RBM7;PUS1;HNRNPU
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.19431813942667953,-0.5992797491340303,0.9583333333333334,0.9752581540200435,1.0,5/22,15.44%,ATP6V0C;ATP6V0D1;ATP6V0A4;ATP6V0A2;ATP2A3
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.23661355217667945,0.5987461381255941,0.946949602122016,0.9846642041467004,1.0,6/28,16.79%,MAPKAPK3;MAPK14;MAP2K4;PRKACA;RPS6KA2;SGK1
prerank,snoRNA binding (GO:0030515),0.22611365109646953,0.5913636125818963,0.9467680608365019,0.987217652476463,1.0,4/30,8.61%,NUDT1;BMS1;UTP6;HEATR1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.23777651345920264,0.5861182898791041,0.9320905459387483,0.9882337418614209,1.0,3/24,14.11%,DTYMK;AK3;AK5
prerank,kinase activity (GO:0016301),0.19150279353828661,0.579362699018315,0.9904458598726115,0.9899790728175497,1.0,21/109,19.79%,MAP4K4;PDXK;NEK1;PAPSS2;PI4KB;CDKL5;STK39;PKMYT1;DGKI;CDK5R1;RFK;ETNK1;SHPK;TRRAP;ABL1;PKN2;AGK;TAF1;BCKDK;PSTK;CERKL
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.24740518787130705,0.5765230974972024,0.9439655172413793,0.9876040569128403,1.0,7/16,27.65%,ATP6V1B2;ATP6V1C1;ATP6V0E2;ATP6V0E1;TCIRG1;ATP6V1D;ATP5F1B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.24740518787130705,0.5765230974972024,0.9439655172413793,0.9876040569128403,1.0,7/16,27.65%,ATP6V1B2;ATP6V1C1;ATP6V0E2;ATP6V0E1;TCIRG1;ATP6V1D;ATP5F1B
prerank,GABA-A receptor activity (GO:0004890),-0.19980467564382004,-0.5705746346822629,0.9714285714285714,0.9821540276826871,1.0,5/18,24.31%,GABRG1;GABRA5;GABRB1;GABRE;GABRB2
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.2589663315049143,0.5690408775457515,0.9378787878787879,0.9895417966143009,1.0,2/12,14.94%,NCBP1;CYFIP1
prerank,CARD domain binding (GO:0050700),0.2525825958224047,0.5663857671529102,0.9450867052023122,0.9889936761770894,1.0,6/14,25.61%,CARD9;BCL10;CARD11;CARD16;MAVS;CARD10
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.1904049854457372,0.5621997855870022,0.9933110367892977,0.9890439137609014,1.0,25/74,27.85%,PDXK;PAPSS2;PI4KB;ADK;DGKI;RFK;ETNK1;SHPK;FGGY;GNE;GALK2;AGK;HK2;FAM20C;HYKK;HK1;NT5C3A;DGKA;FCSK;DGKK;PIK3CA;DGKD;GK;PIK3C3;DGKZ
prerank,muscle alpha-actinin binding (GO:0051371),0.24242176453161912,0.5572732899183288,0.9637377963737797,0.9892648060480919,1.0,3/15,14.47%,PDLIM4;PALLD;LDB3
prerank,NADPH binding (GO:0070402),0.24948327861946618,0.5467211080922656,0.9540740740740741,0.9916976396013308,1.0,4/13,24.09%,MTRR;CBR3;DECR1;HMGCR
prerank,MHC class I protein binding (GO:0042288),-0.20207674773637221,-0.5393775507748164,0.9754601226993865,0.9871490897822572,1.0,2/13,17.92%,TAPBP;TUBB4B
prerank,histone methyltransferase binding (GO:1990226),0.24947552552790903,0.5389262749683268,0.9460708782742681,0.9927477584565279,1.0,3/11,15.97%,LCOR;NOP56;LCORL
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.20160826175197247,0.5331601561009747,0.9848675914249685,0.9928800935367323,1.0,13/33,30.09%,PRKN;UBA2;TOLLIP;RNF19A;PARK7;SIAH1;PPARA;UBE3D;DCUN1D5;TCERG1;TRAF6;ARIH1;RNF217
prerank,transferrin receptor binding (GO:1990459),0.24554116278462995,0.5158111033045327,0.9614197530864198,0.9964315842114255,1.0,3/10,22.72%,SNX1;CHUK;SNX4
prerank,nucleotide diphosphatase activity (GO:0004551),0.22739220940826735,0.5093322159327893,0.9689265536723164,0.9962917667641493,1.0,5/14,24.93%,NUDT10;NUDT3;NUDT6;NUDT11;FHIT
prerank,lipid phosphatase activity (GO:0042577),-0.18504230158175475,-0.5080252156008491,0.9933110367892977,0.9890757044845558,1.0,1/14,2.38%,PLPP1
prerank,lysine N-methyltransferase activity (GO:0016278),0.19970678348801424,0.48065829662331605,0.9863760217983651,1.0,1.0,2/20,9.87%,SETD3;SETD2
prerank,snRNA binding (GO:0017069),0.16948938725936216,0.4633999902584615,0.9950920245398773,1.0,1.0,11/42,25.39%,RNPC3;SNRPB2;RBM7;MEPCE;SNRPA;HNRNPU;SF3B3;CDK9;TUT1;CCNT2;SNRPA1
prerank,single-stranded DNA helicase activity (GO:0017116),0.19318338697355292,0.45520482305488125,0.9902777777777778,1.0,1.0,3/19,19.84%,CHTF18;HELQ;WRNIP1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.20656992203815022,0.4428621755765139,0.9889415481832543,1.0,1.0,3/11,22.92%,NEIL1;HMCES;ALKBH1
prerank,titin binding (GO:0031432),0.19335518602226387,0.4300496856790973,0.9984802431610942,0.9998900529626075,1.0,3/13,22.65%,CALM1;CALM2;CAMK2D
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.1861151214613021,0.38513018802474813,0.9968354430379747,1.0,1.0,10/10,81.40%,EXD2;MGME1;DCLRE1A;TATDN1;FEN1;APEX1;EXO1;POLD1;DCLRE1C;DCLRE1B
prerank,MHC protein binding (GO:0042287),0.15919182566074097,0.3830841226678516,0.9985915492957746,0.9988679860704727,1.0,3/20,20.95%,ABCB9;CD74;TAP1
